#MIM_Number	Location	Phenotype	Phenotype_MIM_number	Inheritance	Phenotype_mapping_key
300137	Xq26.1	Hypothyroidism, central, and testicular enlargement	300888	XLR	3
176450	7q36.3	Currarino syndrome	176450	AD	3
106165	3q24	Renal tubular dysgenesis	267430	AR	3
106165	3q24	{Hypertension, essential}	145500	Mu	3
253260	3p25.1	Biotinidase deficiency	253260	AR	3
259720	6q21	Osteopetrosis, autosomal recessive 5	259720	AR	3
190351	8q23.3	Trichorhinophalangeal syndrome, type III	190351	AD	3
147060	17q21.2	Hyper-IgE recurrent infection syndrome	147060	AD	3
109760	5q12.3	Periodic fever, menstrual cycle dependent	614674	AD	3
148067	17q21.2	Pachyonychia congenita 1	167200	AD	3
148067	17q21.2	Palmoplantar keratoderma, nonepidermolytic, focal	613000	AD	3
157600	18q21.2	Mirror movements 1 and/or agenesis of the corpus callosum	157600	AD	3
160800	7q34	Myotonia congenita, dominant	160800	AD	3
185020	17q21.31	Cryohydrocytosis	185020	AD	3
147280	6q25.3	Hepatocellular carcinoma, somatic	114550	_	3
101800	17q24.2	Acrodysostosis 1, with or without hormone resistance	101800	AD	3
120650	1q32.2	Immunodeficiency, common variable, 7	614699	AR	3
120650	1q32.2	{Systemic lupus erythematosus, susceptibility to, 9}	610927	_	3
204690	17q24.2	Amelogenesis imperfecta, type IG (enamel-renal syndrome)	204690	AR	3
191040	3p21.1	Cardiomyopathy, dilated, 1Z	611879	_	3
191040	3p21.1	Cardiomyopathy, hypertrophic, 13	613243	AD	3
139350	12q13.13	Epidermolytic hyperkeratosis	113800	AR,AD	3
139350	12q13.13	Ichthyosis histrix, Curth-Macklin type	146590	AD	3
139350	12q13.13	Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	AD	3
139350	12q13.13	Keratosis palmoplantaris striata III	607654	_	3
139350	12q13.13	Palmoplantar keratoderma, epidermolytic	144200	AD	3
139350	12q13.13	Palmoplantar keratoderma, nonepidermolytic	600962	AD	3
164690	1q25.2	Leukemia, acute myeloid, with eosinophilia	_	_	1
156225	6q22.33	Muscular dystrophy, congenital, merosin deficient or partially deficient	607855	AR	3
156225	6q22.33	Muscular dystrophy, limb-girdle, autosomal recessive 23	618138	AR	3
217000	6p21.33	C2 deficiency	217000	AR	3
129900	7q11.2-q21.3	?EEC syndrome-1	129900	AD	2
232200	17q21.31	Glycogen storage disease Ia	232200	AR	3
201100	8q24.3	Acrodermatitis enteropathica	201100	AR	3
130720	19p13.12	Lateral meningocele syndrome	130720	AD	3
125255	12q21.33	Corneal dystrophy, congenital stromal	610048	AD	3
300368	Xp11.3	Intellectual developmental disorder, X-linked 108	301024	XLR	3
218400	6q22.31	Craniometaphyseal dysplasia, autosomal recessive	218400	AR	3
300138	Xq28	?Mental retardation, X-linked, syndromic 32	300886	XLR	3
176261	21q22.12	Jervell and Lange-Nielsen syndrome 2	612347	AR	3
176261	21q22.12	Long QT syndrome 5	613695	AD	3
114078	5q32	?Mental retardation, autosomal recessive 63	618095	AR	3
114078	5q32	Mental retardation, autosomal dominant 53	617798	AD	3
251900	19p13.2	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	251900	AR	3
253270	21q22.13	Holocarboxylase synthetase deficiency	253270	AR	3
208500	15q13	Short-rib thoracic dysplasia 1 with or without polydactyly	208500	AR	2
138079	7p13	Diabetes mellitus, noninsulin-dependent, late onset	125853	AD	3
138079	7p13	Diabetes mellitus, permanent neonatal	606176	AR,AD	3
138079	7p13	Hyperinsulinemic hypoglycemia, familial, 3	602485	AD	3
138079	7p13	MODY, type II	125851	AD	3
152950	10q23.33	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	AD	3
228980	1p36.13	[Fleck retina, familial benign]	228980	AR	3
162030	1p13.2	Neuropathy, hereditary sensory and autonomic, type V	608654	AR	3
138570	19q13.33	Glycogen storage disease 0, muscle	611556	AR	3
137295	3q21.3	Emberger syndrome	614038	AD	3
137295	3q21.3	Immunodeficiency 21	614172	AD	3
137295	3q21.3	{Leukemia, acute myeloid, susceptibility to}	601626	SMu,AD	3
137295	3q21.3	{Myelodysplastic syndrome, susceptibility to}	614286	_	3
176500	13q14.2	Dementia, familial British	176500	AD	3
162400	9q22.31	Neuropathy, hereditary sensory and autonomic, type IA	162400	AD	3
269920	6q13	Sialic acid storage disorder, infantile	269920	AR	3
122860	17q21.31	Craniodiaphyseal dysplasia, autosomal dominant	122860	AD	3
137140	4p12	{Alcohol dependence, susceptibility to}	103780	Mu	3
135100	2q24.1	Fibrodysplasia ossificans progressiva	135100	AD	3
142445	8p12	{?Schizophrenia, susceptibility to}	603013	_	1
174800	20q13.32	McCune-Albright syndrome, somatic, mosaic	174800	_	3
300500	Xp22.2	Ocular albinism, type I, Nettleship-Falls type	300500	XL	3
116920	21q22.3	Leukocyte adhesion deficiency	116920	AR	3
148069	17q21.2	Pachyonychia congenita 2	167210	AD	3
148069	17q21.2	Steatocystoma multiplex	184500	AD	3
217030	4q25	Complement factor I deficiency	610984	AR	3
217030	4q25	{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	AD	3
217030	4q25	{Macular degeneration, age-related, 13, susceptibility to}	615439	AD	3
120070	2q36.3	Alport syndrome 2, autosomal recessive	203780	AR	3
120070	2q36.3	Alport syndrome 3, autosomal dominant	104200	AD	3
120070	2q36.3	Hematuria, benign familial	141200	AD	3
300534	Xp11.22	Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	XLR	3
151460	1q31.3-q32.1	Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive	608971	AR	3
151460	1q31.3-q32.1	{Hepatitis C virus, susceptibility to}	609532	_	3
192150	6p21.33	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy	617802	AR	3
300005	Xq28	Encephalopathy, neonatal severe	300673	XLR	3
300005	Xq28	Mental retardation, X-linked syndromic, Lubs type	300260	XLR	3
300005	Xq28	Mental retardation, X-linked, syndromic 13	300055	XLR	3
300005	Xq28	Rett syndrome	312750	XLD	3
300005	Xq28	Rett syndrome, atypical	312750	XLD	3
300005	Xq28	Rett syndrome, preserved speech variant	312750	XLD	3
300005	Xq28	{Autism susceptibility, X-linked 3}	300496	XL	3
115660	17q24	Cataract 7	115660	AD	2
122880	2q36.1	Craniofacial-deafness-hand syndrome	122880	AD	3
208530	19p13.11	Right atrial isomerism (Ivemark)	208530	AR	3
174810	18q21.33	Osteolysis, familial expansile	174810	AD	3
148070	12q13.13	Cirrhosis, cryptogenic	215600	AR	3
148070	12q13.13	{Cirrhosis, noncryptogenic, susceptibility to}	215600	AR	3
108145	18p11.22-p11.21	Arthrogryposis, distal, type 5	108145	AD	3
229000	4q35.2	Fletcher factor (prekallikrein) deficiency	612423	AR	3
300170	Xp22.2	?Retinitis pigmentosa 23	300424	XLR	3
300170	Xp22.2	Joubert syndrome 10	300804	XLR	3
300170	Xp22.2	Orofaciodigital syndrome I	311200	XLD	3
300170	Xp22.2	Simpson-Golabi-Behmel syndrome, type 2	300209	XLR	3
300896	Xp11.23	Congenital disorder of glycosylation, type IIm	300896	SMo,XLD	3
217050	5p13.1	C6 deficiency	612446	_	3
217050	5p13.1	Combined C6/C7 deficiency	_	_	3
300830	Xp22.11	{Autism, susceptibility to, X-linked 4}	300830	XLR	3
302045	Xp21.2-p21.1	Cardiomyopathy, dilated, 3B	302045	XL	3
115665	1pter-p36.13	Cataract 8, multiple types	115665	AD	2
301040	Xq21.1	Alpha-thalassemia/mental retardation syndrome	301040	XLD	3
300699	Xq25	Mental retardation, X-linked 94	300699	XLR	3
149700	1p13.1	?Lacrimal duct defect	149700	AR	3
269921	9p13.3	Sialuria	269921	AD	3
120080	7q21.12	{Colchicine resistance}	120080	_	3
135150	17p11.2	Birt-Hogg-Dube syndrome	135150	AD	3
208540	3q22.1	Renal-hepatic-pancreatic dysplasia 1	208540	AR	3
125264	6p22.3	Leukemia, acute nonlymphocytic	125264	_	2
300502	Xp22.12	Pyruvate dehydrogenase E1-alpha deficiency	312170	XLD	3
300700	Xq24-q26	Albinism-deafness syndrome	300700	XL	2
120090	13q34	Brain small vessel disease 2	614483	AD	3
120090	13q34	{Hemorrhage, intracerebral, susceptibility to}	614519	_	3
135290	5q22.2	Desmoid disease, hereditary	135290	AD	3
304020	Xp11.4	Cone-rod dystrophy, X-linked, 1	304020	XL	3
217070	5p13.1	C7 deficiency	610102	_	3
600019	17q23.3	Orthostatic hypotension 2	618182	AR	3
312060	Xp11.23	Properdin deficiency, X-linked	312060	XLR	3
600943	11q13.5	Osteogenesis imperfecta, type X	613848	AR	3
600943	11q13.5	{Preterm premature rupture of the membranes, susceptibility to}	610504	_	3
601405	1p36.21	{Pancreatitis, chronic, susceptibility to}	167800	AD	3
601570	3p25.1	Fuhrmann syndrome	228930	AR	3
601570	3p25.1	Ulna and fibula, absence of, with severe limb deficiency	276820	AR	3
125270	9q32	Porphyria, acute hepatic	612740	AR	3
125270	9q32	{Lead poisoning, susceptibility to}	612740	AR	3
601768	19p13.3	Leukemia, acute myeloid	601626	SMu,AD	1
600118	2q21.3	Warburg micro syndrome 1	600118	AR	3
601042	1p34.2	Dystonia 9	601042	AD	3
601471	3q21-q22	Facial paresis, hereditary congenital, 1	601471	AD	2
600251	22q11.23	?Facial clefting, oblique, 1	600251	AD	3
600548	5q31.2	Anemia, sideroblastic, 4	182170	AD	3
600548	5q31.2	Even-plus syndrome	616854	AR	3
600712	9q21.32	Au-Kline syndrome	616580	AD	3
217080	2q11.2	Jalili syndrome	217080	AR	3
601900	6p25.3	[Skin/hair/eye pigmentation, variation in, 8]	611724	_	3
601604	19p13.11	Immunodeficiency 30	614891	AR	3
601439	12p12.1	Atrial fibrillation, familial, 12	614050	AD	3
601439	12p12.1	Cardiomyopathy, dilated, 1O	608569	_	3
601439	12p12.1	Hypertrichotic osteochondrodysplasia	239850	AD	3
600778	12p13.1	Multiple endocrine neoplasia, type IV	610755	AD	3
600119	17q21.33	Muscular dystrophy, limb-girdle, autosomal recessive 3	608099	AR	3
601538	5q35.3	Pituitary hormone deficiency, combined, 2	262600	AR	3
601472	7p14.3	Charcot-Marie-Tooth disease, type 2D	601472	AD	3
602296	7q22.1	Spastic paraplegia 50, autosomal recessive	612936	AR	3
600316	17p11.2	Deafness, autosomal recessive 3	600316	AR	3
601406	12q24.31	B-cell non-Hodgkin lymphoma, high-grade	_	_	3
300505	Xp11.3-q22.3	Mental retardation, X-linked 84	300505	XLR	2
601440	17q22	Nephrotic syndrome, type 7	615008	AR	3
601440	17q22	{Hemolytic uremic syndrome, atypical, susceptibility to, 7}	615008	AR	3
601802	3p14.3	Growth hormone deficiency with pituitary anomalies	182230	AR,AD	3
601802	3p14.3	Pituitary hormone deficiency, combined, 5	182230	AR,AD	3
601802	3p14.3	Septooptic dysplasia	182230	AR,AD	3
602593	6p21.33	Hypotrichosis 2	146520	AD	3
602593	6p21.33	Peeling skin syndrome 1	270300	AR	3
600582	8q12.3	Traboulsi syndrome	601552	AR	3
601769	12q13.11	?Osteoporosis, involutional	166710	AD	1
601769	12q13.11	Rickets, vitamin D-resistant, type IIA	277440	AR	3
601902	1p32.3	Meier-Gorlin syndrome 1	224690	AR	3
602298	3q21.3	Charcot-Marie-Tooth disease, type 2B	600882	AD	3
602332	2q11.2	?Microcephaly 23, primary, autosomal recessive	617985	AR	3
601903	4q13.2	{Bone mineral density QTL 12, osteoporosis}	612560	_	3
602956	9p13.3	Fanconi anemia, complementation group G	614082	_	3
602334	16p13.13	Nephrotic syndrome, type 10	615861	AR	3
603122	5q35.1	Immunodeficiency 40	616433	AR	3
603550	6q23.2	?Cardiomyopathy, dilated, 1J	605362	AD	3
603550	6q23.2	Deafness, autosomal dominant 10	601316	AD	3
602959	20q13.33	Epileptic encephalopathy, early infantile, 33	616409	AD	3
602959	20q13.33	Mental retardation, autosomal dominant 38	616393	AD	3
603123	3p21.2	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia	618292	AR	3
603517	1p22.3	?Immunodeficiency 37	616098	AR	3
603517	1p22.3	Lymphoma, MALT, somatic	137245	_	3
603517	1p22.3	{Lymphoma, follicular, somatic}	605027	_	3
603517	1p22.3	{Male germ cell tumor, somatic}	273300	_	3
603517	1p22.3	{Mesothelioma, somatic}	156240	_	3
603517	1p22.3	{Sezary syndrome, somatic}	_	_	3
602694	5q11.2	Mitochondrial complex I deficiency, nuclear type 1	252010	AR	3
603683	5q14.2	Brachycephaly, trichomegaly, and developmental delay	617412	AD	3
603783	4p16-q34	{Intelligence QTL1}	603783	_	2
603716	6p24.2	Hyperparathyroidism 4	617343	AD	3
603716	6p24.2	Hypoparathyroidism, familial isolated	146200	AR,AD	3
603518	2p13.3	Welander distal myopathy	604454	AR,AD	3
603816	16p13.3	?Caudal duplication anomaly	607864	_	3
603816	16p13.3	Hepatocellular carcinoma, somatic	114550	_	3
604144	19q13.11	Cystinuria	220100	AR,AD	3
604210	1q31.3	Leber congenital amaurosis 8	613835	_	3
604210	1q31.3	Pigmented paravenous chorioretinal atrophy	172870	AD	3
604210	1q31.3	Retinitis pigmentosa-12	600105	AR	3
604277	2p22.3	Spastic paraplegia 4, autosomal dominant	182601	AD	3
604607	17q21.32	{Prostate cancer, hereditary, 9}	610997	_	3
604278	4q13.3	Renal tubular acidosis, proximal, with ocular abnormalities	604278	AR	3
603718	3q28	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	607626	AR	3
604507	5p15.33	Mosaic variegated aneuploidy syndrome 3	617598	AR	3
605101	6q25.1	Congenital heart defects, nonsyndromic, 2	614980	AD	3
604705	2q13	Retinitis pigmentosa 38	613862	AR	3
603720	15q15.3	Deafness, autosomal recessive 16	603720	AR	3
605629	12q24.23	Microcephaly 17, primary, autosomal recessive	617090	AR	3
605728	15q21-q22	Cataract 25	605728	_	2
605795	8p12	Spermatogenic failure 25	617960	AR	3
212093	3q26.31	Cardiac valvular defect, developmental	212093	AR	3
177820	17p13.2	von Willebrand disease, platelet-type	177820	AD	3
123680	2q33.3	Cataract 2, multiple types	604307	AD	3
123690	2q33.3	Cataract 4, multiple types	115700	AD	3
606190	1p11	Meningioma, radiation-induced	606190	_	2
212112	1q22	Malouf syndrome	212112	AD	3
300238	Xq26.3	?Mental retardation, X-linked, syndromic 11, Shashi type	300238	XLR	3
606060	10q21.3	Hyperphenylalaninemia, mild, non-BH4-deficient	617384	AR	3
606256	7q31.3	{Stature QTL 2}	606256	_	2
606061	7p14.2	Atrial septal defect 4	611363	_	3
606257	12p11.2-q14	{Stature QTL 3}	606257	_	2
177850	16p13.11	Pseudoxanthoma elasticum, forme fruste	177850	AD	3
136680	11p13	Frasier syndrome	136680	SMu,AD	3
606062	10q25.2	Cornelia de Lange syndrome 3	610759	AD	3
606454	14q24.3	Leukoencephalopathy with vanishing white matter	603896	AR	3
606454	14q24.3	Ovarioleukodystrophy	603896	AR	3
606421	20q13.12	Vascular malformation, primary intraosseous	606893	AR	3
217085	2p15	?Congenital heart defects, hamartomas of tongue, and polysyndactyly	217085	AR	3
300932	Xq22.3	[Thyroxine-binding globulin QTL]	300932	XL	3
300933	Xq22.3	Ciliary dyskinesia, primary, 36, X-linked	300991	XLR	3
606554	1q42	Episodic ataxia, type 3	606554	AD	2
229050	17q11.2	Folate malabsorption, hereditary	229050	AR	3
606652	5q33.3	T-cell lymphoma, subcutaneous panniculitis-like	618398	AR	3
300934	Xq28	Congenital disorder of glycosylation, type Iy	300934	XLR	3
606883	12q12	Invasive pneumococcal disease, recurrent isolated, 1	610799	_	3
606883	12q12	IRAK4 deficiency	607676	_	3
602032	12q13.13	Ectodermal dysplasia 4, hair/nail type	602032	AR	3
600977	17p13.2-p13.1	Cone-rod dystrophy 5	600977	AD	3
607246	19p13.3	?Hermansky-Pudlak syndrome 10	617050	AR	3
601606	16q12.1	Trichoepithelioma, multiple familial, 1	None	_	_
607642	17p11.2	Smith-Magenis syndrome	182290	IC,AD	3
600980	4q22.1	Hypophosphatemic rickets, AR	241520	AR	3
601771	2p22.2	Anterior segment dysgenesis 6, multiple subtypes	617315	_	3
601771	2p22.2	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	AR	3
607544	2p21	Leigh syndrome, French-Canadian type	220111	AR	3
603386	19p13.2	Thyroid carcinoma, nonmedullary, with cell oxyphilia	603386	_	2
608040	9p21.2	?Bardet-Biedl syndrome 20	617119	AR	3
608137	9q34.3	Hypogonadotropic hypogonadism 9 with or without anosmia	614838	AD	3
608203	22q13.1	Neutrophil immunodeficiency syndrome	608203	_	3
608041	4q21.21	Hyaline fibromatosis syndrome	228600	AR	3
608104	11q14.1	Congenital disorder of glycosylation, type Ih	608104	AR	3
608236	8p23.3	?Slowed nerve conduction velocity, AD	608236	AD	3
604804	9q33.2	Microcephaly 3, primary, autosomal recessive	604804	AR	3
604805	19q13.32	Spastic paraplegia 12, autosomal dominant	604805	AD	3
608500	12q12	Epilepsy, progressive myoclonic 1B	612437	AR	3
608533	5q32	Neuronopathy, distal hereditary motor, type IID	615575	AD	3
605073	17q22	Mulibrey nanism	253250	AR	3
605597	3q22.3	Blepharophimosis, epicanthus inversus, and ptosis, type 1	110100	AD	3
605597	3q22.3	Blepharophimosis, epicanthus inversus, and ptosis, type 2	110100	AD	3
605597	3q22.3	Premature ovarian failure 3	608996	AD	3
608797	22q13.2	Hydatidiform mole, recurrent, 3	618431	_	3
605598	5q31.1-q33.1	{Diabetes mellitus, insulin-dependent, 18}	605598	_	2
608765	8q12	{Scoliosis, isolated, susceptibility to, 3}	608765	_	2
608995	1p36-p34	{Dyslexia, susceptibility to, 8}	608995	Mu,AD	2
605763	1p36.23	Intellectual developmental disorder with neuropsychiatric features	617532	AR	3
123700	7q11.23	Cutis laxa, autosomal dominant	123700	AD	3
609259	8p23	Myopia 10	609259	Mu	2
609260	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2A	609260	AD	3
609161	5q13.3	Striatal degeneration, autosomal dominant	609161	AD	3
609261	12q24.1	Stuttering, familial persistent, 2	609261	_	2
132900	16p13.11	Aortic aneurysm, familial thoracic 4	132900	AD	3
609129	13q21.2	Auditory neuropathy, autosomal dominant, 1	609129	AD	3
609523	17p11.2	Sjogren-Larsson syndrome	270200	AR	3
609457	12q23.1	[Histidinemia]	235800	AR,AD	3
606392	13q12.2	MODY, type IV	606392	_	3
606785	2q37.1	Crigler-Najjar syndrome, type II	606785	AR	3
609787	9p13.3	Spastic paraplegia 80, autosomal dominant	618418	AD	3
609754	5q31-q33	{Celiac disease, susceptibility to, 2}	609754	_	2
609853	1p34.2	Cardiomyopathy, dilated, 2C	618189	AR	3
609886	16p12.3	Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	_	3
609887	5q22.1	Glaucoma 1, open angle, G	609887	_	3
609888	10p13	{Leprosy, paucibacillary type, susceptibility to}	609888	_	2
609524	7q32.1	Myopathy, myofibrillar, 5	609524	AD	3
609985	4q31-q34	Panic disorder 3	609985	_	2
610084	11q14.1	Essential tremor, hereditary, 5	616736	AD	3
602531	1q22	Grange syndrome	602531	AR	3
610150	5p15.2	Neuropathy, hereditary sensory, with spastic paraplegia	256840	AR	3
609988	4q24	?Sudden cardiac failure, alcohol-induced	617223	AR	3
609988	4q24	Sudden cardiac failure, infantile	617222	AR	3
610282	1q22	Retinitis pigmentosa 35	610282	AR,AD	3
610217	22q13.1	Neurodegeneration with brain iron accumulation 2B	610217	AR	3
610153	5q13.2	Deafness, autosomal recessive 49	610153	AR	3
608864	1q32.2	{Orofacial cleft 6}	608864	AD	3
608732	4q24	Congenital disorder of glycosylation, type IIn	616721	AR	3
610154	7p12.3	?Deafness, autosomal recessive 44	610154	AR	3
610678	16p11.2	Combined oxidative phosphorylation deficiency 4	610678	AR	3
610612	1q32.3	Leber congenital amaurosis 12	610612	AR	3
610613	8q24.3	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	AR	3
610613	8q24.3	Aldosteronism, glucocorticoid-remediable	103900	AD	3
610513	1p36.13	Kufor-Rakeb syndrome	606693	AR	3
610513	1p36.13	Spastic paraplegia 78, autosomal recessive	617225	AR	3
609755	2q33.2	{Celiac disease, susceptibility to, 3}	609755	_	3
611140	16p13.3	You-Hoover-Fong syndrome	616954	AR	3
610087	16q22.1	Short stature, brachydactyly, intellectual developmental disability, and seizures	617157	AR	3
611536	6q23-q24	{Major affective disorder 6}	611536	_	2
611801	17q12	Hyperphosphatasia with mental retardation syndrome 4	615716	AR	3
611705	2q31.2	Salih myopathy	611705	AR	3
611867	22q11.2	Chromosome 22q11.2 deletion syndrome, distal	611867	_	4
611868	2p15	{Prostate cancer, hereditary, 12}	611868	_	3
612034	19p13.3	?Sotos syndrome 3	617169	AR	3
612035	6p21.1	Combined oxidative phosphorylation deficiency 8	614096	AR	3
612035	6p21.1	Leukoencephalopathy, progressive, with ovarian failure	615889	AR	3
612036	1p32.3	Epileptic encephalopathy, early infantile, 75	618437	AR	3
612067	2q31.2	Dystonia 16	612067	AR	3
612073	13q14.2	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	612073	AR	3
612074	7q32.1	?Alopecia, neurologic defects, and endocrinopathy syndrome	612079	AR	3
612041	4p16.3	Recombination rate QTL 1	612042	_	3
612042	4p16.3	Recombination rate QTL 1	612042	_	3
612078	16q24.2	Brittle cornea syndrome 1	229200	AR	3
612079	7q32.1	?Alopecia, neurologic defects, and endocrinopathy syndrome	612079	AR	3
612163	11q13.3	[Skin/hair/eye pigmentation 10, blond/brown hair]	612267	_	3
612080	5q31.1	Mitochondrial complex III deficiency, nuclear type 4	615159	AR	3
612199	17p13.1	Cerebroretinal microangiopathy with calcifications and cysts	612199	AR	3
612201	1p36.22	Atrial fibrillation, familial, 6	612201	AD	3
612229	18q21.1	{Colorectal cancer, susceptibility to, 3}	612229	_	3
612230	10p14	{Colorectal cancer, susceptibility to, 5}	612230	_	2
612231	8q23	{Colorectal cancer, susceptibility to, 6}	612231	_	2
612262	5p13.1	{Inflammatory bowel disease 18}	612262	_	2
612263	20q11.2	{Melanoma, cutaneous malignant, 7}	612263	_	2
612098	15q14	Cardiomyopathy, hypertrophic, 11	612098	AD	3
612099	9p21	Trichoepithelioma, multiple familial, 2	612099	_	2
612100	7q35-q36	{Autism susceptibility 15}	612100	_	3
612267	11q13.3	[Skin/hair/eye pigmentation 10, blond/brown hair]	612267	_	3
131230	4q27	{Pregnancy loss, recurrent, susceptibility to, 3}	614391	AD	3
201710	8p11.23	Lipoid adrenal hyperplasia	201710	AR	3
159595	21q11.2	Leukemia, transient, of Down syndrome	159595	_	2
245660	18q11.2	Laryngoonychocutaneous syndrome	245660	AR	3
272750	5q33.1	GM2-gangliosidosis, AB variant	272750	AR	3
121360	16q22.1	Myeloid leukemia, acute, M4/M4Eo subtype, somatic	601626	_	1
214350	21q22.3	CHAND syndrome	214350	AR	3
123730	3q27.3	Cataract 20, multiple types	116100	AD	3
181600	4q22.3	Huriez syndrome	181600	AD	3
235700	10q22.1	Hemolytic anemia due to hexokinase deficiency	235700	AR	3
261650	14q11-q12	PEPCK deficiency, mitochondrial	261650	AR	1
142690	1q23.2	Acne inversa, familial, 1	142690	AD	3
120700	19p13.3	C3 deficiency	613779	AR	3
120700	19p13.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 5}	612925	AD	3
120700	19p13.3	{Macular degeneration, age-related, 9}	611378	_	3
111620	1p34.2	[Blood group, Radin]	111620	_	3
182340	1q23.2	Alternating hemiplegia of childhood 1	104290	AD	3
182340	1q23.2	Migraine, familial basilar	602481	AD	3
182340	1q23.2	Migraine, familial hemiplegic, 2	602481	AD	3
236792	14q21.3	L-2-hydroxyglutaric aciduria	236792	AR	3
255700	7q34	Myotonia congenita, recessive	255700	AR	3
160775	22q12.3	Deafness, autosomal dominant 17	603622	AD	3
160775	22q12.3	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	155100	AD	3
172460	14q23.3	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	617780	AR	3
172460	14q23.3	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
222900	3q26.1	Sucrase-isomaltase deficiency, congenital	222900	AR	3
231670	19p13.13	Glutaricaciduria, type I	231670	AR	3
123870	11q13.1	?Mitochondrial complex IV deficiency	220110	Mi,AR	3
118485	15q24.1	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	613743	_	3
113650	8q13.3	Branchiootorenal syndrome 1, with or without cataracts	113650	AD	3
108770	1q21.2	Atrial standstill, digenic (GJA5/SCN5A)	108770	AD	3
176790	17q25.3	Cole-Carpenter syndrome 1	112240	AD	3
187270	5p15.33	{Dyskeratosis congenita, autosomal dominant 2}	613989	AR,AD	3
187270	5p15.33	{Dyskeratosis congenita, autosomal recessive 4}	613989	AR,AD	3
187270	5p15.33	{Leukemia, acute myeloid}	601626	SMu,AD	3
187270	5p15.33	{Melanoma, cutaneous malignant, 9}	615134	_	3
187270	5p15.33	{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}	614742	AD	3
125420	4q22.1	Dentin dysplasia, type II	125420	AD	3
144250	8p21.3	Combined hyperlipidemia, familial	144250	AD	3
169400	1q42.12	Pelger-Huet anomaly	169400	AD	3
106190	12p11.23	?Anhidrosis, isolated, with normal sweat glands	106190	AR	3
263450	13q13.3-q21	Polydactyly, postaxial, type A5	263450	AR	2
114220	11q13.1	Spastic paraplegia 76, autosomal recessive	616907	AR	3
248800	5q31.2	Marinesco-Sjogren syndrome	248800	AR	3
251280	5q31.3	Microcephaly, seizures, spasticity, and brain calcification	251280	AR	3
100070	19q13	Aortic aneurysm, familial abdominal 1	100070	AD	2
300550	Xp22.11	Hypophosphatemic rickets, X-linked dominant	307800	XLD	3
277300	19q13.2	Spondylocostal dysostosis 1, autosomal recessive	277300	AR	3
300414	Xq26.2	Borjeson-Forssman-Lehmann syndrome	301900	XLR	3
108300	12q13.11	Stickler syndrome, type I	108300	AD	3
210600	3q23	Seckel syndrome 1	210600	AR	3
300019	Xq28	Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )	309541	XLR	3
186300	2q31.1	Syndactyly, type V	186300	AD	3
131750	3p21.31	Epidermolysis bullosa dystrophica, AD	131750	AD	3
148820	2q36.1	Waardenburg syndrome, type 3	148820	AR,AD	3
300779	Xq25	Corneal dystrophy, endothelial, X-linked	300779	XLD	2
154100	7q11.23	Epileptic encephalopathy, early infantile, 51	617339	AR	3
185490	4p15.2	[Superoxide dismutase, elevated extracellular]	_	_	3
109350	13q14	Gastroesophageal reflux	109350	AD	2
300115	Xp11.3-p11.21	Mental retardation, X-linked 50	300115	XL	2
275900	13q13.3	Troyer syndrome	275900	AR	3
150325	3p21.31	Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	_	3
150325	3p21.31	Pierson syndrome	609049	AR	3
153454	1p36.22	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	225400	AR	3
300844	Xp22.12	Mental retardation, X-linked 19	300844	XLD	3
252800	4p16.3	Mucopolysaccharidosis Ih	607014	AR	3
252800	4p16.3	Mucopolysaccharidosis Ih/s	607015	AR	3
252800	4p16.3	Mucopolysaccharidosis Is	607016	AR	3
118490	10q11.23	Myasthenic syndrome, congenital, 6, presynaptic	254210	AR	3
278700	9q22.33	Xeroderma pigmentosum, group A	278700	AR	3
231675	4q32.1	Glutaric acidemia IIC	231680	AR	3
174300	1q32.1	Orofaciodigital syndrome V	174300	AR	3
264470	17q25.1	Peroxisomal acyl-CoA oxidase deficiency	264470	AR	3
233710	1q25.3	Chronic granulomatous disease due to deficiency of NCF-2	233710	AR	3
168400	12q24.11	Parastremmatic dwarfism	168400	AD	3
239100	17q21.31	Van Buchem disease	239100	AR	3
300909	Xq26.1	{Angioedema induced by ACE inhibitors, susceptibility to}	300909	_	3
235730	2q22.3	Mowat-Wilson syndrome	235730	AD	3
123740	16p12.2	Deafness, autosomal dominant 40	616357	AD	3
125851	7p13	MODY, type II	125851	AD	3
300982	Xp22.11	Mental retardation, X-linked 103	300982	XLR	3
187900	9q34.13	Bleeding disorder, platelet-type, 17	187900	AR,AD	3
169500	5q23.2	Leukodystrophy, adult-onset, autosomal dominant	169500	AD	3
111680	1p36.11	[Rh-negative blood type]	_	_	3
251290	5q13.2	Pseudo-TORCH syndrome 1	251290	AR	3
170715	8q21.13	Charcot-Marie-Tooth disease, demyelinating, type 1G	618279	AD	3
156530	12q24.11	Metatropic dysplasia	156530	AD	3
194363	5q14.2	Short stature, microcephaly, and endocrine dysfunction	616541	AR	3
147750	20q13.2	IVIC syndrome	147750	AD	3
188450	8q24.22	Thyroid dyshormonogenesis 3	274700	AR	3
188450	8q24.22	{Autoimmune thyroid disease, susceptibility to, 3}	608175	_	3
301835	Xq22.3	Arts syndrome	301835	XLR	3
300614	Xq26.1	Deafness, X-linked 5	300614	XLR	3
203500	3q13.33	Alkaptonuria	203500	AR	3
300516	Xq27.1	?Hemolytic anemia, congenital, X-linked	301015	XLR	3
241410	1q42.3	Hypoparathyroidism-retardation-dysmorphism syndrome	241410	AR	3
153455	5q23.1	Aortic aneurysm, familial thoracic 10	617168	AD	3
124092	1q32.1	{Graft-versus-host disease, protection against}	614395	_	3
124092	1q32.1	{HIV-1, susceptibility to}	609423	_	3
124092	1q32.1	{Rheumatoid arthritis, progression of}	180300	_	3
162330	12q13.3	Hypogonadotropic hypogonadism 10 with or without anosmia	614839	AR	3
117650	20p13	Cerebrocostomandibular syndrome	117650	AD	3
108780	1p36.22	Atrial fibrillation, familial, 6	612201	AD	3
108780	1p36.22	Atrial standstill 2	615745	AR	3
176880	3q11.1	Thrombophilia due to protein S deficiency, autosomal dominant	612336	AD	3
176880	3q11.1	Thrombophilia due to protein S deficiency, autosomal recessive	614514	AR	3
245800	19p13.2	?Laurence-Moon syndrome	245800	AR	3
176960	17q24.2	Pituitary tumor, invasive	_	_	3
278720	3p25.1	Xeroderma pigmentosum, group C	278720	AR	3
302960	Xp11.23	Chondrodysplasia punctata, X-linked dominant	302960	XLD	3
103500	3p13	Tietz albinism-deafness syndrome	103500	AD	3
300951	Xq24	?Trichothiodystrophy 5, nonphotosensitive	300953	XLD	3
236800	2q22.2	?Hydroxykynureninuria	236800	AR	3
266265	11p11.2	Congenital disorder of glycosylation, type IIc	266265	AR	3
120790	11q12.1	Complement component 4, partial deficiency of	120790	AD	3
276000	7q34	Pancreatitis, hereditary	167800	AD	3
276000	7q34	Trypsinogen deficiency	614044	AR	1
102582	17q21.2	Autoimmune disease, multisystem, infantile-onset, 1	615952	AD	3
102582	17q21.2	Hyper-IgE recurrent infection syndrome	147060	AD	3
261670	7p13	Glycogen storage disease X	261670	AR	3
309590	Xp11.22	Mental retardation, X-linked syndromic, Turner type	309590	XL	3
109480	19p13.3	[Blood group, OK]	111380	_	3
138246	11q22.3	Neurodevelopmental disorder with or without seizures and gait abnormalities	617864	AD	3
223000	2q21.3	Lactase deficiency, congenital	223000	AR	3
101850	2p25-p12	?Keratoderma, palmoplantar, punctate type 3	101850	AD	2
147520	20p13	Epileptic encephalopathy, early infantile, 35	616647	AR	3
147520	20p13	[Inosine triphosphatase deficiency]	613850	_	3
142700	13q22	Developmental dysplasia of the hip 1	142700	Mu	2
121400	12q21.33	Cornea plana 1, autosomal dominant	121400	AD	2
300845	Xq28	Moyamoya disease 4	300845	XLR	4
107720	11q23.3	Apolipoprotein C-III deficiency	614028	_	3
201750	7q11.23	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	201750	AR	3
300415	Xq28	Myotubular myopathy, X-linked	310400	XLR	3
182860	1q23.1	Elliptocytosis-2	130600	AD	3
182860	1q23.1	Pyropoikilocytosis	266140	AR	3
182860	1q23.1	Spherocytosis, type 3	270970	AR	3
252900	17q25.3	Mucopolysaccharidosis type IIIA (Sanfilippo A)	252900	AR	3
300084	Xq13.1	Mental retardation, X-linked, syndromic 34	300967	XL	3
125852	11p15.5	Diabetes mellitus, insulin-dependent, 2	125852	AD	3
300746	Xq27.1	Hemophilia B	306900	XLR	3
300746	Xq27.1	Thrombophilia, X-linked, due to factor IX defect	300807	_	3
300746	Xq27.1	{Deep venous thrombosis, protection against}	300807	_	3
300746	Xq27.1	{Warfarin sensitivity}	122700	AD	3
307800	Xp22.11	Hypophosphatemic rickets, X-linked dominant	307800	XLD	3
100100	1q43	?Prune belly syndrome	100100	AR	3
123790	10q26.13	Beare-Stevenson cutis gyrata syndrome	123790	AD	3
212720	1q41	Martsolf syndrome	212720	AR	3
185500	7q11.23	Supravalvar aortic stenosis	185500	AD	3
108800	5p	Atrial septal defect 1	108800	AD	2
193230	2q37.1	Snowflake vitreoretinal degeneration	193230	AD	3
158105	17q12	{Coronary artery disease, modifier of}	_	_	3
158105	17q12	{HIV-1, resistance to}	609423	_	3
158105	17q12	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
158105	17q12	{Spina bifida, susceptibility to}	182940	AD	3
164820	12q13.12	Osteogenesis imperfecta, type XV	615220	AR	3
164820	12q13.12	{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	_	3
241500	1p36.12	Hypophosphatasia, infantile	241500	AR	3
278730	19q13.32	Xeroderma pigmentosum, group D	278730	AR	3
251300	15q25.2	Galloway-Mowat syndrome 1	251300	AR	3
114090	5q15	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	616295	AR	3
300679	Xp21	Chromosome Xp21 deletion syndrome	300679	_	4
210710	2q14.2	Microcephalic osteodysplastic primordial dwarfism, type I	210710	AR	3
310468	Xp11.23	Nephrolithiasis, type I	310468	XLR	3
147245	17q23.3	Agammaglobulinemia 6	612692	AR	3
228300	19q13.33	Hypogonadotropic hypogonadism 23 with or without anosmia	228300	AR	3
300910	Xq23	Bone mineral density QTL18, osteoporosis	300910	XLD	3
300952	Xp11.3	Linear skin defects with multiple congenital anomalies 3	300952	XLD	3
300552	Xp22.2	Opitz GBBB syndrome, type I	300000	XLR	3
191329	16p12.2	Mitochondrial complex III deficiency, nuclear type 5	615160	AR	3
254130	2p13.2	Miyoshi muscular dystrophy 1	254130	AR	3
137780	17q21.31	Alexander disease	203450	AD	3
311770	Xp22.2	Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	XLR	3
311770	Xp22.2	Paroxysmal nocturnal hemoglobinuria, somatic	300818	_	3
209300	3q22.1	Atransferrinemia	209300	AR	3
303100	Xq21.2	Choroideremia	303100	XLD	3
107269	11p13	[Blood group, Indian system]	609027	_	3
123000	5p15.2	Craniometaphyseal dysplasia	123000	AD	3
301845	Xq24-q27	Bazex syndrome	301845	XLD	2
400047	Yp11.2	?Deafness, Y-linked 2	400047	YL	3
248900	15q22.31	Mast syndrome	248900	AR	3
201810	1p12	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	201810	AR	3
600002	3p21.31	Eiken syndrome	600002	AR	3
138945	17q21.31	Aphasia, primary progressive	607485	AD	3
138945	17q21.31	Ceroid lipofuscinosis, neuronal, 11	614706	AR	3
138945	17q21.31	Frontotemporal lobar degeneration with ubiquitin-positive inclusions	607485	AD	3
103580	20q13.32	Pseudohypoparathyroidism Ia	103580	AD	3
314580	Xq11.2	Wieacker-Wolff syndrome	314580	XLR	3
300350	Xq23	Megalocornea 1, X-linked	309300	XLR	3
239200	3q13.3-q21.1	Hyperparathyroidism, neonatal	239200	AR,AD	3
300085	Xq27	Cone dystrophy, progressive X-linked, 2	300085	XL	2
252920	17q21.2	Mucopolysaccharidosis type IIIB (Sanfilippo B)	252920	AR	3
300715	Xq21.1	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	_	3
224690	1p32.3	Meier-Gorlin syndrome 1	224690	AR	3
300584	Xq28	Immunodeficiency, isolated	300584	_	3
600133	6q21	Cardiomyopathy, dilated, 1JJ	615235	AD	3
139300	15q21.2	Aromatase excess syndrome	139300	AD	3
214400	8q21.11	Charcot-Marie-Tooth disease, type 4A	214400	AR	3
120810	6p21.33	C4a deficiency	614380	AR	3
120810	6p21.33	[Blood group, Rodgers]	614374	_	3
245900	16q22.1	Norum disease	245900	AR	3
154230	9p24.3	46XY sex reversal 4	154230	_	4
313475	Xp11.23	Mental retardation, X-linked 96	300802	XLR	3
108900	5q35.1	Atrial septal defect 7, with or without AV conduction defects	108900	AD	3
259440	15q22.31	Osteogenesis imperfecta, type IX	259440	AR	3
117700	3q24-q25	Cerebellar ataxia	604290	AR	3
117700	3q24-q25	Hemosiderosis, systemic, due to aceruloplasminemia	604290	AR	3
117700	3q24-q25	[Hypoceruloplasminemia, hereditary]	604290	AR	3
120100	1q44	Familial cold inflammatory syndrome 1	120100	AD	3
130160	7q11.23	Cutis laxa, autosomal dominant	123700	AD	3
130160	7q11.23	Supravalvar aortic stenosis	185500	AD	3
300983	Xp22.2	Mental retardation, X-linked 104	300983	XL	3
300953	Xq24	?Trichothiodystrophy 5, nonphotosensitive	300953	XLD	3
300911	Xp11.4	?Parkinsonism with spasticity, X-linked	300911	XLR	3
147250	7q36.3	Single median maxillary central incisor	147250	AD	3
270685	11q12.3	Silver spastic paraplegia syndrome	270685	AD	3
168450	11p15.3	Hypoparathyroidism, autosomal dominant	146200	AR,AD	3
168450	11p15.3	Hypoparathyroidism, autosomal recessive	146200	AR,AD	3
200500	7q36.3	Acheiropody	200500	AR	3
182870	14q23.3	Anemia, neonatal hemolytic, fatal or near-fatal	617948	_	3
182870	14q23.3	Elliptocytosis-3	617948	_	3
182870	14q23.3	Spherocytosis, type 2	616649	AD	3
211900	2q24.3	Tumoral calcinosis, hyperphosphatemic, familial, 1	211900	AR	3
241510	1p36.12	Hypophosphatasia, childhood	241510	AR	3
300747	Xp22.31	Ichthyosis, X-linked	308100	XLR	3
600003	10p12.33-p12.31	Brugada syndrome 4	611876	_	3
205950	3p22.1	Anemia, sideroblastic, 2, pyridoxine-refractory	205950	AR	3
180240	17q21.2	Leukemia, acute promyelocytic	612376	_	1
210720	21q22.3	Microcephalic osteodysplastic primordial dwarfism, type II	210720	AR	3
300518	Xq24-q25	Mental retardation, X-linked 82	300518	XLR	2
193235	11q13.5	Vitreoretinopathy, neovascular inflammatory	193235	AD	3
177650	15q24.1	{Exfoliation syndrome, susceptibility to}	177650	AD	3
131850	3p21.31	Epidermolysis bullosa, pretibial	131850	AR,AD	3
114240	15q15.1	Muscular dystrophy, limb-girdle, autosomal dominant 4	618129	AD	3
114240	15q15.1	Muscular dystrophy, limb-girdle, autosomal recessive 1	253600	AR	3
118494	1q43	?Prune belly syndrome	100100	AR	3
123805	12p12.2	Hypertension and brachydactyly syndrome	112410	AD	3
274300	3p24.2	Thyroid hormone resistance, autosomal recessive	274300	AR	3
189500	4p16.2	Ectodermal dysplasia 3, Witkop type	189500	AD	3
300351	Xp11	{Graves disease, susceptibility to, X-linked}	300351	_	2
191330	8q22.1	Mitochondrial complex III deficiency, nuclear type 3	615158	AR	3
278740	11p11.2	Xeroderma pigmentosum, group E, DDB-negative subtype	278740	AR	3
277380	6q13	Methylmalonic aciduria and homocystinuria, cblF type	277380	AR	3
600361	4q34.3-q35.2	Hereditary motor and sensory neuropathy V	600361	AD	2
166600	16p13.3	Osteopetrosis, autosomal dominant 2	166600	AD	3
300984	Xp11.23	Mental retardation, X-linked 105	300984	XLR	3
214450	15q21.2	Griscelli syndrome, type 1	214450	AR	3
242860	20q11.21	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	242860	AR	3
154235	6p24.2	Retinitis pigmentosa 62	614181	AR	3
239300	1p36.11	Hyperphosphatasia with mental retardation syndrome 1	239300	AR	3
194380	16q24.3	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	AD	3
300716	Chr.X	Mental retardation, X-linked 95	300716	XLD	2
176400	19p13.3	?Precocious puberty, central, 1	176400	AD	3
270700	14q24.1	Spastic paraplegia 15, autosomal recessive	270700	AR	3
186357	1p35.2	{Obesity, association with}	601665	AR,Mu,AD	3
300912	Xq13.3	Mental retardation, X-linked 98	300912	XLD	3
263520	4q33	Short-rib thoracic dysplasia 6 with or without polydactyly	263520	AR,DR	3
300519	Chr.X	Mental retardation, X-linked, syndromic, Martin-Probst type	300519	XLR	2
216340	6q21	Yunis-Varon syndrome	216340	AR	3
120820	6p21.33	C4B deficiency	614379	_	3
114105	4q24	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	618265	AD	3
114105	4q24	Epileptic encephalopathy, infantile or early childhood, 1	617711	AD	3
301018	Xq22.1	?Deafness, X-linked 7	301018	XLR	3
155100	22q12.3	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	155100	AD	3
169600	3q22.1	Hailey-Hailey disease	169600	AD	3
120110	6q22.1	Metaphyseal chondrodysplasia, Schmid type	156500	AD	3
134350	19p13.3	Complement factor D deficiency	613912	AR	3
600522	1q31.1	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	618372	AR	3
300481	Xp21.1-p11.4	Chronic granulomatous disease, X-linked	306400	XLR	3
300481	Xp21.1-p11.4	Immunodeficiency 34, mycobacteriosis, X-linked	300645	XLR	3
274400	19p13.11	Thyroid dyshormonogenesis 1	274400	AR	3
136550	6q16.2	Macular dystrophy, North Carolina type	136550	AD	3
266280	8q24.3	RAPADILINO syndrome	266280	AR	3
300985	Xp22.13	Congenital bilateral absence of vas deferens, X-linked	300985	XL	3
600625	14q22.2	Orofacial cleft 11	600625	_	3
600035	10q26.11	Schizencephaly	269160	_	3
305000	Xq28	Dyskeratosis congenita, X-linked	305000	XLR	3
271640	1p36.33	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	AR	3
259450	17q21.2	Bruck syndrome 1	259450	AR	3
123810	2q33.3	Histiocytoma, angiomatoid fibrous, somatic	612160	_	3
185535	2p21	Colorectal cancer, hereditary nonpolyposis, type 8	613244	_	3
185535	2p21	Diarrhea 5, with tufting enteropathy, congenital	613217	AR	3
156540	9p21.3	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	AD	3
160777	15q21.2	Griscelli syndrome, type 1	214450	AR	3
177700	12q14	Glaucoma 1, open angle, P	177700	AD	4
300717	Xq26.3	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	300717	XLD	3
189964	8p12	Trichothiodystrophy 6, nonphotosensitive	616943	AR	3
264600	2p23.1	Pseudovaginal perineoscrotal hypospadias	264600	AR	3
312600	Xp11.3	Retinitis pigmentosa 2	312600	XL	3
142704	15q21.2	{Gilles de la Tourette syndrome, susceptibility to}	137580	AD	3
300087	Xq13.2	X-inactivation, familial skewed	300087	_	3
206100	12q13.12	Anemia, hypochromic microcytic, with iron overload 1	206100	AR	3
137035	11q13.2	?Epilepsy, familial temporal lobe, 8	616461	AD	3
311800	Xq21.1	Phosphoglycerate kinase 1 deficiency	300653	XLR	3
120328	21q22.3	Knobloch syndrome, type 1	267750	AR	3
600792	14q12	Deafness, autosomal recessive 5	600792	AR	2
159900	7q21.3	Dystonia-11, myoclonic	159900	AD	3
300352	Xq28	Cerebral creatine deficiency syndrome 1	300352	XLR	3
241520	4q22.1	Hypophosphatemic rickets, AR	241520	AR	3
600757	19q13	Orofacial cleft 3	600757	?AD	2
300749	Xp11.4	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	XLD	3
600101	1p34.2	Deafness, autosomal dominant 2A	600101	AD	3
131240	6p24.1	Auriculocondylar syndrome 3	615706	AR	3
131240	6p24.1	Question mark ears, isolated	612798	AD	3
131240	6p24.1	{High density lipoprotein cholesterol level QTL 7}	_	_	3
212780	11p11.2	Cenani-Lenz syndactyly syndrome	212780	AR	3
104760	21q21.3	Alzheimer disease 1, familial	104300	AD	3
104760	21q21.3	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	AD	3
147582	15q25.1	?Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	618451	AR	3
168461	11q13.3	{Colorectal cancer, susceptibility to}	114500	SMu,AD	3
168461	11q13.3	{Multiple myeloma, susceptibility to}	254500	SMu	3
168461	11q13.3	{von Hippel-Lindau syndrome, modifier of}	193300	AD	3
214500	1q42.3	Chediak-Higashi syndrome	214500	AR	3
600824	11p15.1	?Cardiomyopathy, dilated, 1M	607482	_	3
600824	11p15.1	Cardiomyopathy, hypertrophic, 12	612124	AD	3
147781	16p12.1	{AIDS, slow progression to}	609423	_	3
147781	16p12.1	{Atopy, susceptibility to}	147050	AD	3
303110	Xq21	Choroideremia, deafness, and mental retardation	303110	XLR	4
137920	17q12	Renal cysts and diabetes syndrome	137920	AD	3
127400	1q21.3	Dyschromatosis symmetrica hereditaria	127400	AD	3
246200	19p13.2	Leprechaunism	246200	AR	3
300847	Xq28	{Autism, susceptibility to, X-linked 5}	300847	_	3
134370	1q31.3	Basal laminar drusen	126700	AD	3
134370	1q31.3	Complement factor H deficiency	609814	AR,AD	3
134370	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 1}	235400	AR,AD	3
134370	1q31.3	{Macular degeneration, age-related, 4}	610698	_	3
138420	12q13.12	Hypertriglyceridemia, transient infantile	614480	AR	3
600363	15q11.2	Spastic paraplegia 6, autosomal dominant	600363	AD	3
300419	Xp21.3	Mental retardation, X-linked 29 and others	300419	XLR	3
600928	16p13.3	Epilepsy, familial focal, with variable foci 3	617118	AD	3
224750	2q35	Schopf-Schulz-Passarge syndrome	224750	AR	3
264700	12q14.1	Vitamin D-dependent rickets, type I	264700	AR	3
300913	Xq28	Myopathy, X-linked, with excessive autophagy	310440	XLR	3
300718	Xq26.3	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	300718	XL	3
125860	16q22.1	{Benzene toxicity, susceptibility to}	_	_	3
125860	16q22.1	{Breast cancer, poor survival after chemotherapy for}	_	_	3
125860	16q22.1	{Leukemia, post-chemotherapy, susceptibility to}	_	_	3
241530	9q34.3	Hypophosphatemic rickets with hypercalciuria	241530	AR	3
156550	12q13.11	Kniest dysplasia	156550	AD	3
314670	Xq13.2	X-inactivation, familial skewed	300087	_	3
237300	2q34	Carbamoylphosphate synthetase I deficiency	237300	AR	3
120330	10q24.31	Papillorenal syndrome	120330	AD	3
100300	3q13.32-q13.33	Adams-Oliver syndrome 1	100300	AD	3
160780	2q34	Myopathy, congenital, with fast-twitch (type II) fiber atrophy	618414	AR	3
300553	Xq21.1	Mental retardation, X-linked 93	300659	XLR	3
104770	1q23.2	{?Amyloidosis, secondary, susceptibility to}	_	_	1
260500	17p13.1	{Choroid plexus papilloma}	260500	AD	3
600627	4q32.1	[?Hypertryptophanemia]	600627	AR	3
188000	10p12.1	Thrombocytopenia 2	188000	AD	3
176258	11p15.1	Epilepsy, progressive myoclonic 7	616187	AD	3
600229	2p14	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	616657	AR	3
137940	20q13.33	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	137940	AD	3
600397	20q13.13	Epileptic encephalopathy, early infantile, 26	616056	AD	3
600201	20q11.22	[Skin/hair/eye pigmentation 9, brown/nonbrown eyes]	611742	_	3
600201	20q11.22	[Skin/hair/eye pigmentation 9, dark/light hair]	611742	_	3
300120	Xq28	Hypospadias 2, X-linked	300758	XLR	3
600998	9q21.2	Capillary malformations, congenital, 1, somatic, mosaic	163000	_	3
600998	9q21.2	Sturge-Weber syndrome, somatic, mosaic	185300	_	3
313500	Xq13.1	Tooth agenesis, selective, X-linked 1	313500	XLD	3
189967	11p15.3	Sveinsson chorioretinal atrophy	108985	AD	3
214700	7q22.3-q31.1	Diarrhea 1, secretory chloride, congenital	214700	AR	3
600929	22q12.1	Cataract 17, multiple types	611544	AR,AD	3
300750	Xq24-q25	Spastic paraplegia 34, X-linked	300750	XLR	2
206200	22q12.3	Iron-refractory iron deficiency anemia	206200	AR	3
600364	6p21.1	Cone dystrophy-3	602093	AD	3
600364	6p21.1	Cone-rod dystrophy 14	602093	AD	3
601454	4q	{Psoriasis susceptibility 3}	601454	_	2
601321	17q11.2	Neurofibromatosis-Noonan syndrome	601321	AD	3
300088	Xq22.1	Epileptic encephalopathy, early infantile, 9	300088	XL	3
600492	2q31.2	Immunodeficiency, developmental delay, and hypohomocysteinemia	617744	AD	3
312610	Xp11.4	Cone-rod dystrophy, X-linked, 1	304020	XL	3
312610	Xp11.4	Macular degeneration, X-linked atrophic	300834	XLR	3
312610	Xp11.4	Retinitis pigmentosa 3	300029	_	3
312610	Xp11.4	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	_	3
134371	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	AR,AD	3
134371	1q31.3	{Macular degeneration, age-related, reduced risk of}	603075	AD	3
123100	7p21.1	Craniosynostosis 1	123100	AD	3
600165	11p	Nanophthalmos-1	600165	AD	2
114250	1q23.2	Myopathy, vacuolar, with CASQ1 aggregates	616231	AD	3
300719	Chr.X	Deafness, cataract, retinitis pigmentosa, and sperm abnormalities	300719	XLR	2
300914	Xq22.3	?Deafness, X-linked 6	300914	XLR	3
190195	14q12	Ichthyosis, congenital, autosomal recessive 1	242300	AR	3
600660	15q26.3	{Coronary artery disease, autosomal dominant, 1}	608320	AD	3
107730	2p24.1	Hypercholesterolemia, familial, 2	144010	AD	3
107730	2p24.1	Hypobetalipoproteinemia	615558	AR	3
601489	16p13.3	Acid-labile subunit, deficiency of	615961	_	3
203650	3q26.3-q27.3	Alopecia-mental retardation syndrome 1	203650	AR	2
314690	Xp11.22	Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	XLR	3
600825	15q22.2	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	618060	AD	3
600724	16q21	Retinitis pigmentosa 45	613767	AR	3
164360	18q21.1	?Combined oxidative phosphorylation deficiency 22	616045	AR	3
164360	18q21.1	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4	615228	AR	3
309610	Xp11-q21	Prieto syndrome	309610	XLR	2
311850	Xq22.3	Arts syndrome	301835	XLR	3
311850	Xq22.3	Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	XLR	3
311850	Xq22.3	Deafness, X-linked 1	304500	XL	3
311850	Xq22.3	Gout, PRPS-related	300661	XLR	3
311850	Xq22.3	Phosphoribosylpyrophosphate synthetase superactivity	300661	XLR	3
226200	21q21.1	Enterokinase deficiency	226200	AR	3
176885	20q13.13	{Insulin resistance, susceptibility to}	125853	AD	3
218330	3q21.3-q22.1	Cranioectodermal dysplasia 1	218330	AR	3
137950	1q32	Glomerulopathy with fibronectin deposits 1	137950	AD	2
160781	12q24.11	Cardiomyopathy, hypertrophic, 10	608758	AD	3
601194	4p14	{Leprosy, protection against}	613223	_	3
601194	4p14	{Leprosy, susceptibility to, 5}	613223	_	3
237310	17q21.31	N-acetylglutamate synthase deficiency	237310	AR	3
276400	2p16.3	Ovarian response to FSH stimulation	276400	AR	3
300218	Xp11.3-q22	Mental retardation, X-linked syndromic 7	300218	_	2
176260	12p13.32	Episodic ataxia/myokymia syndrome	160120	AD	3
600037	14q22.3	Microphthalmia, syndromic 5	610125	AD	3
600037	14q22.3	Pituitary hormone deficiency, combined, 6	613986	AD	3
600037	14q22.3	Retinal dystrophy, early-onset, with or without pituitary dysfunction	610125	AD	3
300121	Xq23	Lissencephaly, X-linked	300067	XL	3
300121	Xq23	Subcortical laminal heterotopia, X-linked	300067	XL	3
300484	Chr.X	Orofaciodigital syndrome VIII	300484	XLR	2
300751	Xp11.21	Anemia, sideroblastic, 1	300751	XLR	3
601455	8q24.22	Charcot-Marie-Tooth disease, type 4D	601455	AR	3
131242	20q13.32	Central hypoventilation syndrome, congenital	209880	AD	3
131242	20q13.32	Waardenburg syndrome, type 4B	613265	AR,AD	3
131242	20q13.32	{Hirschsprung disease, susceptibility to, 4}	613712	AD	3
156560	12q13.3	Charcot-Marie-Tooth disease, axonal, type 2U	616280	AD	3
156560	12q13.3	Interstitial lung and liver disease	615486	AR	3
168468	3p21.31	Chondrodysplasia, Blomstrand type	215045	AR	3
168468	3p21.31	Eiken syndrome	600002	AR	3
168468	3p21.31	Failure of tooth eruption, primary	125350	AD	3
168468	3p21.31	Metaphyseal chondrodysplasia, Murk Jansen type	156400	AD	3
158170	9p	Chromosome 9p deletion syndrome	158170	AD	4
138971	1p34.3	Neutropenia, severe congenital, 7, autosomal recessive	617014	AR	3
127500	6q24.2-q25.2	Dyschromatosis universalis hereditaria 1	127500	AD	2
151410	22q11.23	Leukemia, acute lymphocytic, somatic	613065	_	3
151410	22q11.23	Leukemia, chronic myeloid, somatic	608232	_	3
415000	Yq11.221	Spermatogenic failure, Y-linked, 2	415000	YL	3
123101	5q35.2	Craniosynostosis 2	604757	AD	3
123101	5q35.2	Parietal foramina 1	168500	AD	3
123101	5q35.2	Parietal foramina with cleidocranial dysplasia	168550	AD	3
159950	8p22	Spinal muscular atrophy with progressive myoclonic epilepsy	159950	AR	3
260540	17q21.31	Supranuclear palsy, progressive atypical	260540	AR	3
147020	14q32.33	Agammaglobulinemia 1	601495	AR	3
156100	22q12.1	Meningioma	607174	AD	3
600005	16p13.13	Bare lymphocyte syndrome, type II, complementation group A	209920	AR	3
600005	16p13.13	{Rheumatoid arthritis, susceptibility to}	180300	_	3
249000	17q22	Meckel syndrome 1	249000	AR	3
303400	Xq21.1	Cleft palate with ankyloglossia	303400	XL	3
270750	1q32.1	Spastic paraplegia 23	270750	AR	3
600759	1q42.13	Alzheimer disease-4	606889	AD	3
600759	1q42.13	Cardiomyopathy, dilated, 1V	613697	AD	3
600332	1q41	Rippling muscle disease-1	600332	AD	2
203655	8p21.3	Alopecia universalis	203655	AR	3
224900	2q13	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	AR	3
120350	10q22.1	Myasthenic syndrome, congenital, 19	616720	AR	3
179590	1p34.2	?Breasts and/or nipples, aplasia or hypoplasia of, 2	616001	AR	3
216400	5q12.1	Cockayne syndrome, type A	216400	AR	3
601129	10q23.33	{Drug metabolism, altered, CYP2C8-related}	618018	_	3
314700	Xpter-p22.32	[Blood group, XG system]	_	_	3
601556	6p22.3	Spinocerebellar ataxia 1	164400	AD	3
601259	4q13.3	Amelogenesis imperfecta, type IF	616270	AR	3
601860	5q23.1	D-bifunctional protein deficiency	261515	AR	3
601860	5q23.1	Perrault syndrome 1	233400	AR	3
214900	15q	Cholestasis-lymphedema syndrome	214900	AR	2
602026	10p13	Refsum disease	266500	AR	3
601385	8p22	Mental retardation, autosomal recessive 7	611093	AR	3
600725	7q36.3	Holoprosencephaly 3	142945	AD	3
600725	7q36.3	Microphthalmia with coloboma 5	611638	AD	3
600725	7q36.3	Schizencephaly	269160	_	3
600725	7q36.3	Single median maxillary central incisor	147250	AD	3
137960	2p23.3	Charcot-Marie-Tooth disease, axonal, type 2EE	618400	AR	3
137960	2p23.3	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	256810	AR	3
277440	12q13.11	Rickets, vitamin D-resistant, type IIA	277440	AR	3
120900	9q33.2	C5 deficiency	609536	_	3
120900	9q33.2	[Eculizumab, poor response to]	615749	AD	3
309620	Xq28	Mental retardation-skeletal dysplasia	309620	XL	2
306250	Xp22.33	Surfactant metabolism dysfunction, pulmonary, 4	300770	_	3
305100	Xq13.1	Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	XLR	3
259600	16q12.2	Multicentric osteolysis, nodulosis, and arthropathy	259600	AR	3
188025	11q23	?Thrombocytopenia, Paris-Trousseau type	188025	IC	4
131243	4q31.22-q31.23	Mandibulofacial dysostosis with alopecia	616367	AD	3
131243	4q31.22-q31.23	{Migraine, resistance to}	157300	AD	3
118502	8p21.2	Epilepsy, nocturnal frontal lobe, type 4	610353	AD	3
602358	17q21.2	?Narcolepsy 1	161400	AD	3
601756	2q24.3	Tumoral calcinosis, hyperphosphatemic, familial, 1	211900	AR	3
300752	Xp11.21	Protoporphyria, erythropoietic, X-linked	300752	XL	3
303600	Xp22.12	Coffin-Lowry syndrome	303600	XLD	3
105120	9q33.2	Amyloidosis, Finnish type	105120	AD	3
218340	12p13.31	Temtamy syndrome	218340	AR	3
600429	6p24.3-p24.2	Adult i phenotype without cataract	110800	AD	3
600429	6p24.3-p24.2	Cataract 13 with adult i phenotype	116700	AR	3
600429	6p24.3-p24.2	[Blood group, Ii]	110800	AD	3
300915	Xq28	?Microphthalmia, syndromic 13	300915	XL	3
203700	15q26.1	Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	AR	3
602690	11q23.1	Mitochondrial complex II deficiency	252011	AR	3
602690	11q23.1	Paraganglioma and gastric stromal sarcoma	606864	_	3
602690	11q23.1	Paragangliomas 1, with or without deafness	168000	AD	3
602690	11q23.1	Pheochromocytoma	171300	AD	3
176262	1p13.3	Epileptic encephalopathy, early infantile, 32	616366	AD	3
176430	15q15.1	[Premature chromatid separation trait]	176430	AD	3
160790	3p21.31	Cardiomyopathy, hypertrophic, 8	608751	AR,AD	3
602594	16p12.3-p12.1	Retinitis pigmentosa 22	602594	_	2
601724	2q31.3	Maturity-onset diabetes of the young 6	606394	_	3
601724	2q31.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
246300	4q31.3	{Leprosy, susceptibility to}	246300	AD	3
190197	1q32.1	?Epilepsy, myoclonic, familial adult, 5	615400	AR	3
601861	13q13.3	Bare lymphocyte syndrome, type II, complementation group D	209920	AR	3
214950	5p13.2	Bile acid synthesis defect, congenital, 4	214950	AR	3
249100	16p13.3	Familial Mediterranean fever, AR	249100	AR	3
600726	2q35	Acrocapitofemoral dysplasia	607778	AR	3
600726	2q35	Brachydactyly, type A1	112500	AD	3
300882	Xq13.1	Cornelia de Lange syndrome 5	300882	XLD	3
212840	7p22.1	Cerebellar ataxia and hypogonadotropic hypogonadism	212840	AR	3
601757	6q23.3	Peroxisome biogenesis disorder 9B	614879	AR	3
601757	6q23.3	Rhizomelic chondrodysplasia punctata, type 1	215100	AR	3
601130	10q23.33	Tolbutamide poor metabolizer	_	_	3
601130	10q23.33	Warfarin sensitivity	122700	AD	3
300321	Xq28	?FG syndrome 2	300321	XL	3
600202	6p22-p21	{Dyslexia, susceptibility to, 2}	600202	AD	2
105150	20p11.21	Cerebral amyloid angiopathy	105150	AD	3
203740	7p13	Alpha-ketoglutarate dehydrogenase deficiency	203740	AR	1
102600	16q24.3	Adenine phosphoribosyltransferase deficiency	614723	AR	3
600430	2q37	Chromosome 2q37 deletion syndrome	600430	AD	4
602490	21q11.2-q21.1	?Congenital anomalies of kidney and urinary tract 3	618270	AD	3
602286	11q23.3-q24.1	Lathosterolosis	607330	AR	3
118100	8q22.1	Klippel-Feil syndrome 1, autosomal dominant	118100	AD	3
313650	Xq13.1	Dystonia-Parkinsonism, X-linked	314250	XLR	3
313650	Xq13.1	Mental retardation, X-linked, syndromic 33	300966	XLR	3
277450	2p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 1	277450	AR	3
602124	18p	Dystonia-7, torsion	602124	AD	2
216550	8q22.2	Cohen syndrome	216550	AR	3
600760	16p12.2	Bronchiectasis with or without elevated sweat chloride 1	211400	AD	3
600760	16p12.2	Liddle syndrome 1	177200	AD	3
600760	16p12.2	Pseudohypoaldosteronism, type I	264350	AR	3
138000	1p22.1	Glomuvenous malformations	138000	AD	3
600827	10q23.33	Cone dystrophy 4	613093	AR	3
190198	9q34.3	Adams-Oliver syndrome 5	616028	AD	3
190198	9q34.3	Aortic valve disease 1	109730	AD	3
149000	8q22.3	Klippel-Trenaunay-Weber syndrome	149000	IC	2
107741	19q13.32	Alzheimer disease-2	104310	AD	3
107741	19q13.32	Hyperlipoproteinemia, type III	617347	_	3
107741	19q13.32	Lipoprotein glomerulopathy	611771	_	3
107741	19q13.32	Sea-blue histiocyte disease	269600	AR	3
107741	19q13.32	{?Macular degeneration, age-related}	603075	AD	3
107741	19q13.32	{Coronary artery disease, severe, susceptibility to}	617347	_	3
600962	12q13.13	Palmoplantar keratoderma, nonepidermolytic	600962	AD	3
600727	1p31.3	Brain malformations with or without urinary tract defects	613735	AD	3
601197	11p15.4	?Retinal dystrophy and obesity	616188	AR	3
158300	17p13.1	Trismus-pseudocamptodactyly syndrome	158300	AD	3
188030	1q23.3	Thrombocytopenic purpura, autoimmune	188030	AD	1
264900	4q35.2	Factor XI deficiency, autosomal dominant	612416	_	3
264900	4q35.2	Factor XI deficiency, autosomal recessive	612416	_	3
600334	2q31.2	Tibial muscular dystrophy, tardive	600334	AD	3
603546	16p11.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	AD	3
237500	10q24.2	Dubin-Johnson syndrome	237500	AR	3
102610	1q42.13	?Myopathy, scapulohumeroperoneal	616852	AD	3
102610	1q42.13	Myopathy, actin, congenital, with cores	161800	AR,AD	3
102610	1q42.13	Myopathy, actin, congenital, with excess of thin myofilaments	161800	AR,AD	3
102610	1q42.13	Myopathy, congenital, with fiber-type disproportion 1	255310	AR,AD	3
102610	1q42.13	Nemaline myopathy 3, autosomal dominant or recessive	161800	AR,AD	3
602491	1q23.3	{Hyperlipidemia, familial combined, susceptibility to}	602491	_	3
300322	Xq26.2-q26.3	Lesch-Nyhan syndrome	300322	XLR	3
176610	17p13.2	Amyotrophic lateral sclerosis 18	614808	_	3
601097	17p12	?Neuropathy, inflammatory demyelinating	139393	?AD	3
601097	17p12	Charcot-Marie-Tooth disease, type 1A	118220	AD	3
601097	17p12	Charcot-Marie-Tooth disease, type 1E	118300	AD	3
601097	17p12	Dejerine-Sottas disease	145900	AR,AD	3
601097	17p12	Neuropathy, recurrent, with pressure palsies	162500	AD	3
601097	17p12	Roussy-Levy syndrome	180800	AD	3
601228	15q15.3-q22.1	Polyposis syndrome, mixed hereditary 1	601228	AD	4
601228	15q15.3-q22.1	{Colorectal cancer, susceptibility to, 4}	601228	AD	4
159990	12q21.31	Ophthalmoplegia, external, with rib and vertebral anomalies	618155	AR	3
601758	17q12	Peroxisome biogenesis disorder 3A (Zellweger)	614859	AR	3
601758	17q12	Peroxisome biogenesis disorder 3B	266510	AR	3
600864	17q25.3	Advanced sleep-phase syndrome, familial, 2	615224	AD	3
602125	17p12	Leigh syndrome due to mitochondrial COX4 deficiency	256000	Mi,AR	3
602125	17p12	Mitochondrial complex IV deficiency	220110	Mi,AR	3
311870	Xq13.1	Muscle glycogenosis	300559	XLR	3
179605	6p21.1	Choroidal dystrophy, central areolar 2	613105	AD	3
179605	6p21.1	Leber congenital amaurosis 18	608133	AR,AD	3
179605	6p21.1	Macular dystrophy, patterned, 1	169150	AD	3
179605	6p21.1	Macular dystrophy, vitelliform, 3	608161	AD	3
179605	6p21.1	Retinitis pigmentosa 7 and digenic form	608133	AR,AD	3
179605	6p21.1	Retinitis punctata albescens	136880	AR,AD	3
265000	2q37.1	Escobar syndrome	265000	AR	3
602954	17q12	{Breast-ovarian cancer, familial, susceptibility to, 4}	614291	_	3
303630	Xq22.3	Alport syndrome 1, X-linked	301050	XLD	3
601725	17q12	Epileptic encephalopathy, early infantile, 72	618374	AD	3
277460	8q12.3	Ataxia with isolated vitamin E deficiency	277460	AR	3
603218	20p13	Huntington disease-like 1	603218	AD	3
425500	Yq	?Hairy ears, Y-linked	425500	YL	2
603951	5q35.1	{Hypertension, diastolic, resistance to}	608622	AD	3
600963	19q13.32	Branchiootorenal syndrome 2	610896	_	3
601863	1q21.3	Bare lymphocyte syndrome, type II, complementation group C	209920	AR	3
601863	1q21.3	Bare lymphocyte syndrome, type II, complementation group E	209920	AR	3
300755	Xq22.1	Agammaglobulinemia, X-linked 1	300755	XLR	3
600008	11q23.2	Homocysteine plasma level	600008	_	2
602627	17q21.2	?Meier-Gorlin syndrome 5	613805	AR	3
600728	9p23-p22	Macrocephaly, acquired, with impaired intellectual development	618286	AD	3
603855	19q13.2-q13.4	{Meconium ileus in cystic fibrosis, susceptibility to}	603855	_	2
602457	11q13.3	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations	613759	AR	3
600761	16p12.2	Bronchiectasis with or without elevated sweat chloride 3	613071	AD	3
600761	16p12.2	Liddle syndrome 2	618114	AD	3
600761	16p12.2	Pseudohypoaldosteronism, type I	264350	AR	3
260565	17q12	PEHO syndrome	260565	AR	3
601098	16p13.13	Charcot-Marie-Tooth disease, type 1C	601098	AD	3
189800	2p13	Preeclampsia/eclampsia 1	189800	AD	2
600231	12q13.12	Palmoplantar keratoderma, Bothnian type	600231	AD	3
601002	20q11.22	Glutathione synthetase deficiency	266130	AR	3
601002	20q11.22	Hemolytic anemia due to glutathione synthetase deficiency	231900	AR	3
600204	1p34.2	Epiphyseal dysplasia, multiple, 2	600204	AD	3
300323	Xq26.2-q26.3	HPRT-related gout	300323	XLR	3
602322	3q26.2	Dyskeratosis congenita, autosomal dominant 1	127550	AD	3
602322	3q26.2	{Aplastic anemia}	614743	AD	3
602322	3q26.2	{Pulmonary fibrosis, idiopathic, susceptibility to}	614743	AD	3
130410	19q13.41	Glutaric acidemia IIB	231680	AR	3
600829	11q13.4	Opsismodysplasia	258480	AR	3
602955	7q22.1	Alazami-Yuan syndrome	617126	AR	3
265050	2p25.3	3MC syndrome 2	265050	AR	3
603349	2p21	Erythrocytosis, familial, 4	611783	_	3
110300	9q34.2	[Blood group, ABO system]	616093	_	3
303631	Xq22.3	?Deafness, X-linked 6	300914	XLR	3
603644	17p13.1	Mitochondrial complex IV deficiency	220110	Mi,AR	3
300221	Xpter-p22.32	{Hodgkin disease susceptibility, pseudoautosomal}	300221	_	2
601627	5q13.2	{Spinal muscular atrophy, type III, modifier of}	253400	AR	3
602821	12q13.3	Myoclonus, intractable, neonatal	617235	AD	3
602821	12q13.3	Spastic paraplegia 10, autosomal dominant	604187	AD	3
602821	12q13.3	{Amyotrophic lateral sclerosis, susceptibility to, 25}	617921	AD	3
314850	Xp21.1	McLeod syndrome with or without chronic granulomatous disease	300842	XL	3
602458	1p13.3	[Low density lipoprotein cholesterol level QTL6]	613589	AD	3
149200	13q12.11	Bart-Pumphrey syndrome	149200	AD	3
112500	2q35	Brachydactyly, type A1	112500	AD	3
203750	11q22.3	Alpha-methylacetoacetic aciduria	203750	AR	3
602991	17q22	Brachydactyly, type B2	611377	AD	3
602991	17q22	Multiple synostoses syndrome 1	186500	AD	3
602991	17q22	Stapes ankylosis with broad thumbs and toes	184460	AD	3
602991	17q22	Symphalangism, proximal, 1A	185800	AD	3
602991	17q22	Tarsal-carpal coalition syndrome	186570	AD	3
300918	Xp22.12	?Olmsted syndrome, X-linked	300918	XLR	3
604250	7q22.1	Hemochromatosis, type 3	604250	AR	3
108370	7q21.3	Asparagine synthetase deficiency	615574	AR	3
603056	2q23.1	Meier-Gorlin syndrome 2	613800	AR	3
605283	15q11.2	Schaaf-Yang syndrome	615547	AD	3
603856	15q11.2	Precocious puberty, central, 2	615346	AD	3
600232	5q34	Epileptic encephalopathy, infantile or early childhood, 2	617829	AD	3
604217	4p15.2	Pulmonary alveolar microlithiasis	265100	AR	3
605588	1q22	Charcot-Marie-Tooth disease, type 2B1	605588	AR	3
603155	1q32-q41	Choanal atresia and lymphedema	613611	AR	3
604285	2q37.3	Hyperoxaluria, primary, type 1	259900	AR	3
605518	2p25.1	Myoglobinuria, acute recurrent, autosomal recessive	268200	AR	3
605419	15q15	{Schizophrenia 10}	605419	AD	2
300919	Xp11.4	Mental retardation, X-linked 99	300919	XLR	3
216820	14q11.2	?Coloboma, ocular, autosomal recessive	216820	AR	3
605010	5q32	Netherton syndrome	256500	AR	3
601388	2q33.2	{Diabetes mellitus, insulin-dependent, 12}	601388	_	3
600965	4p16.1	Deafness, autosomal dominant 6/14/38	600965	AD	3
605725	19q13.2	Charcot-Marie-Tooth disease, type 4F	614895	AR	3
605725	19q13.2	Dejerine-Sottas disease	145900	AR,AD	3
605120	10q11.22	Telangiectasia, hereditary hemorrhagic, type 5	615506	AD	3
604649	17q25.3	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	617193	AR	3
605218	2q37.3	{Systemic lupus erythematosus, susceptibility to, 2}	605218	_	3
604882	10q22.1	Diarrhea 4, malabsorptive, congenital	610370	AR	3
604218	3q26.1	Encephalopathy, familial, with neuroserpin inclusion bodies	604218	AD	3
603646	10q24.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2	615119	AR	3
603646	10q24.2	Leigh syndrome due to cytochrome c oxidase deficiency	256000	Mi,AR	3
265100	4p15.2	Pulmonary alveolar microlithiasis	265100	AR	3
601003	16p11.2	Brody myopathy	601003	AR	3
605420	11p11.2	Frontonasal dysplasia 2	613451	AR	3
605420	11p11.2	Parietal foramina 2	609597	AD	3
605420	11p11.2	{Craniosynostosis 5, susceptibility to}	615529	AD	3
605589	19q13.33	?Charcot-Marie-Tooth disease, type 2B2	605589	AR	3
311900	Xp11.3	TARP syndrome	311900	XLR	3
605519	18p11.31	Majeed syndrome	609628	_	3
600495	3q27.1	{Parkinson disease 18}	614251	AD	3
188040	20p11.21	Thrombophilia due to thrombomodulin defect	614486	_	3
188040	20p11.21	{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	AD	3
601231	1p36.22	Focal cortical dysplasia, type II, somatic	607341	_	3
601231	1p36.22	Smith-Kingsmore syndrome	616638	AD	3
605284	9q34.13	Focal cortical dysplasia, type II, somatic	607341	_	3
605284	9q34.13	Lymphangioleiomyomatosis	606690	_	3
605284	9q34.13	Tuberous sclerosis-1	191100	AD	3
300324	Xq22.2-q26	Mental retardation, X-linked 53	300324	XLR	2
601101	5q31.3-q32	Telangiectasia, hereditary hemorrhagic, type 3	601101	_	2
604416	15q24.3	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416	AD	3
601358	9p24.3	Nicolaides-Baraitser syndrome	601358	AD	3
605185	15q15.1	Adams-Oliver syndrome 6	616589	AD	3
605011	4q13.3	Hennekam lymphangiectasia-lymphedema syndrome 3	618154	AR	3
605557	1p36.32	Cardiomyopathy, dilated, 1LL	615373	AD	3
605557	1p36.32	Left ventricular noncompaction 8	615373	AD	3
605726	9p13.3	?Spinal muscular atrophy, distal, autosomal recessive, 2	605726	AR	3
600234	1p12	HMG-CoA synthase-2 deficiency	605911	AR	3
600496	12q24.31	MODY, type III	600496	AD	3
312000	Xq27.1	Panhypopituitarism, X-linked	312000	XL	3
604219	21q22.3	Cataract 9, multiple types	604219	AR,AD	3
603157	19p13.11	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	603387	AD	3
606230	22q13.33	Phelan-McDermid syndrome	606232	AD	3
606230	22q13.33	{Schizophrenia 15}	613950	AD	3
605355	19q13.42	Nemaline myopathy 5, Amish type	605355	AR	3
606100	19p13.12	Vibratory urticaria	125630	AD	3
265120	2p11.2	Surfactant metabolism dysfunction, pulmonary, 1	265120	AR	3
605285	10q22.1	Neuropathy, hereditary motor and sensory, Russe type	605285	AR	3
601390	11p15.4	Van Maldergem syndrome 1	601390	AR	3
603220	2p23.3	Pulmonary hypertension, primary, 4	615344	AD	3
216900	2q11.2	Achromatopsia 2	216900	AR	3
606164	19p13.2	Diamond Blackfan anemia 15 with mandibulofacial dysostosis	606164	AD	3
160120	12p13.32	Episodic ataxia/myokymia syndrome	160120	AD	3
138030	2q24.2	[?Hyperproglucagonemia]	_	_	1
603956	4p16.3	Cervical cancer, somatic	603956	_	3
190220	1q41	Loeys-Dietz syndrome 4	614816	AD	3
604417	5q31.1	CHOPS syndrome	616368	AD	3
149400	5q33.1	Hyperekplexia 1	149400	AR,AD	3
603711	8q12.3	Bile acid synthesis defect, congenital, 3	613812	AR	3
603711	8q12.3	Spastic paraplegia 5A, autosomal recessive	270800	AR	3
607060	12q12	{Parkinson disease 8}	607060	AD	3
605558	8p22	?Renal hypodysplasia/aplasia 2	615721	AR	3
604185	10q21.3-q22.1	Facial paresis, hereditary congenital, 2	604185	AD	2
605219	12q24.31	Deafness, autosomal dominant 64	614152	AD	3
607381	19q13.2	3-methylglutaconic aciduria, type IX	617698	AR	3
605286	2q37.3	{Diabetes mellitus, noninsulin-dependent 1}	601283	_	3
607317	1p36.22-p36.21	Spinocerebellar ataxia, autosomal recessive 4	607317	AR	3
604254	2p16-p15	{Dyslexia, susceptibility to, 3}	604254	_	2
218600	8q24.3	Baller-Gerold syndrome	218600	AR	3
603158	15q21.2	Pituitary adenoma 4, ACTH-secreting, somatic	219090	_	3
603221	12q21-q23	Myopia-3	603221	AD	2
605356	7q11.23	Epileptic encephalopathy, early infantile, 56	617665	AD	3
607640	3p14.1	Spinocerebellar ataxia 7	164500	AD	3
606568	3p21.31	Bardet-Biedl syndrome 17	615994	AR	3
203800	2p13.1	Alstrom syndrome	203800	AR	3
190230	14q24.3	Arrhythmogenic right ventricular dysplasia 1	107970	AD	3
190230	14q24.3	Loeys-Dietz syndrome 5	615582	AD	3
607608	11p15.4	Niemann-Pick disease, type A	257200	AR	3
607608	11p15.4	Niemann-Pick disease, type B	607616	AR	3
602568	5p15.31	Homocystinuria-megaloblastic anemia, cbl E type	236270	AR	3
602568	5p15.31	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
600936	5q34	{Breast cancer, susceptibility to}	114480	SMu,AD	3
603921	13q14.2	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	612073	AR	3
110500	17q21.31	[Blood group, Diego]	110500	_	3
605764	6p22.3	Spinocerebellar ataxia, autosomal recessive 23	616949	AR	3
607803	10q24.32	Hypomagnesemia 6, renal	613882	AD	3
607803	10q24.32	Hypomagnesemia, seizures, and mental retardation	616418	AR,AD	3
603824	9p13.3	Nonaka myopathy	605820	AR	3
603824	9p13.3	Sialuria	269921	AD	3
606960	22q12.1-q12.2	Insulinoma	_	_	1
607836	1p31.3	{Autoimmune disease, susceptibility to, 1}	607836	AD	3
607932	14q22.2	Microphthalmia, syndromic 6	607932	AD	3
605727	7q34-q36	Otosclerosis 2	605727	_	2
607478	12q21.1	{Attention deficit-hyperactivity disorder, susceptibility to, 7}	613003	_	3
607478	12q21.1	{Unipolar depression, susceptibility to}	608516	_	3
607900	20p12.3	Kindler syndrome	173650	AR	3
608770	11q23.1	Pyruvate dehydrogenase E2 deficiency	245348	AR	3
608736	8p21.3	?Hyperostosis cranalis interna	144755	AD	3
608736	8p21.3	Hypermanganesemia with dystonia 2	617013	AR	3
608439	17q23.2	Mental retardation, autosomal dominant 57	618050	AD	3
604383	9q34.13	Bleeding disorder, platelet-type, 17	187900	AR,AD	3
608507	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2A	609260	AD	3
608507	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2B	617087	AR	3
608507	1p36.22	Hereditary motor and sensory neuropathy VIA	601152	AD	3
607837	8p23.3	Ceroid lipofuscinosis, neuronal, 8	600143	AR	3
607837	8p23.3	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	610003	AR	3
608968	20q12	Duane retraction syndrome 3	617041	AD	3
608968	20q12	Multicentric carpotarsal osteolysis syndrome	166300	AD	3
110600	12p12.3	[Blood group, Dombrock]	616060	_	3
607479	18p11.22	Hypotrichosis 1	605389	AD	3
608605	3p23	?Congenital disorder of glycosylation, type Ix	615597	AR	3
607446	6q23-q25	[Body mass index QTL3]	607446	_	2
607093	1p36.22	Homocystinuria due to MTHFR deficiency	236250	AR	3
607093	1p36.22	{Neural tube defects, susceptibility to}	601634	AR	3
607093	1p36.22	{Schizophrenia, susceptibility to}	181500	AD	3
607093	1p36.22	{Thromboembolism, susceptibility to}	188050	AD	3
607093	1p36.22	{Vascular disease, susceptibility to}	_	_	3
607901	11q13.1	Leukocyte adhesion deficiency, type III	612840	AR	3
606232	22q13.33	Phelan-McDermid syndrome	606232	AD	3
605013	16p13.11	?Microhydranencephaly	605013	AR	3
166750	11q13	Otodental dysplasia chromosome deletion syndrome	166750	AD	4
606797	11q24.3	Ichthyosis, congenital, autosomal recessive 11	602400	AR	3
608100	2p13.3	Multiple mitochondrial dysfunctions syndrome 1	605711	AR	3
608803	1q42.13	Leukodystrophy, hypomyelinating, 2	608804	AR	3
608803	1q42.13	Lymphatic malformation 3	613480	AD	3
608803	1q42.13	Spastic paraplegia 44, autosomal recessive	613206	AR	3
602997	10p13	Megaloblastic anemia-1, Finnish type	261100	AR	3
603317	12q21.31	Deafness, autosomal dominant 73	617663	AD	3
603317	12q21.31	Deafness, autosomal recessive 84A	613391	AR	3
608508	16q24.2	Chronic granulomatous disease, autosomal, due to deficiency of CYBA	233690	AR	3
607352	8p21.3	Epileptic encephalopathy, early infantile, 64	618004	AD	3
607838	16p13.3	Mucolipidosis III gamma	252605	AR	3
602569	5q35.2	Dementia, Lewy body	127750	AD	3
607706	8q21.11	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706	AR	3
605289	3q28	Split-hand/foot malformation 4	605289	AD	3
608935	6q23-q25	{Lung cancer susceptibility}	608935	_	2
312040	Xp22.1-p21.3	Pigmentary disorder, reticulate, with systemic manifestations, X-linked	301220	XLR	3
110700	1q23.2	[Blood group, Duffy system]	110700	AR,AD	3
607447	11q13.4	{Obesity, susceptibility to, BMIQ4}	607447	_	3
608171	12p13.33	Retinal cone dystrophy 4	610478	AR	3
605967	7q36	Acropectoral syndrome	605967	AD	2
609529	17p11.2	Immunoglobulin A deficiency 2	609529	_	3
204000	17p13.1	Leber congenital amaurosis 1	204000	AR	3
602498	3q12.2	?Spastic paraplegia 57, autosomal recessive	615658	AR	3
602498	3q12.2	Hereditary motor and sensory neuropathy, Okinawa type	604484	AD	3
607839	3p12.2	Glycogen storage disease IV	232500	AR	3
607839	3p12.2	Polyglucosan body disease, adult form	263570	AR	3
608474	17q21-q22	Myopia 5	608474	AD	2
609033	1q32.3	Ataxia, posterior column, with retinitis pigmentosa	609033	AR	3
609300	10q24.32	17,20-lyase deficiency, isolated	202110	AR	3
609300	10q24.32	17-alpha-hydroxylase/17,20-lyase deficiency	202110	AR	3
607707	7p13	Mental retardation, autosomal dominant 54	617799	AD	3
138033	17q25.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
604685	7p15.2	?Microtia, hearing impairment, and cleft palate (AR)	612290	AR,AD	3
604685	7p15.2	Microtia with or without hearing impairment (AD)	612290	AR,AD	3
609823	22q13.1	Deafness, autosomal recessive 28	609823	AR	3
606995	3q22	Senior-Loken syndrome 3	606995	AR	2
609757	7q11.23	Chromosome 7q11.23 duplication syndrome	609757	AD	4
606068	2p15	Retinitis pigmentosa 28	606068	_	3
609791	15q24.3	Mental retardation, autosomal recessive 64	618103	AR	3
608771	12q24.21	Mental retardation and distinctive facial features with or without cardiac defects	616789	AD	3
608771	12q24.21	Transposition of the great arteries, dextro-looped 1	608808	AD	3
609530	4q32.1	?Epilepsy, familial adult myoclonic, 7	618075	_	3
608903	16p13	{Attention deficit-hyperactivity disorder}	143465	AD	2
204100	1p31.3	Leber congenital amaurosis 2	204100	AR	3
609856	3q26.31	?Spermatogenic failure 6	102530	AR	3
604384	3q22.1	Hailey-Hailey disease	169600	AD	3
610093	14q24.3	Microphthalmia, isolated 2	610093	_	3
166760	12p13.31	{Otitis media, susceptibility to}	166760	AD	3
190300	3q13.31	{Essential tremor, hereditary, 1}	190300	AD	3
606731	20q13.33	Deafness, autosomal dominant 67	616340	AD	3
602499	2p22.2	Macrophthalmia, colobomatous, with microcornea	602499	AD	4
160500	14q11.2	Laing distal myopathy	160500	AD	3
607840	12q23.2	Mucolipidosis II alpha/beta	252500	AR	3
607840	12q23.2	Mucolipidosis III alpha/beta	252600	AR	3
609562	8q13.2	Epilepsy, familial temporal lobe, 5	614417	AR,AD	3
609562	8q13.2	Febrile seizures, familial, 11	614418	AR	3
609891	6q14.2	?Spondylocostal dysostosis 6	616566	AR	3
610263	11q13.4	Ciliary dyskinesia, primary, 34	617091	AR	3
610127	11p15.5	Ceroid lipofuscinosis, neuronal, 10	610127	AR	3
604717	17q25.3	Deafness, autosomal dominant 20/26	604717	AD	3
605290	3q29	?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)	616896	_	3
605290	3q29	Behr syndrome	210000	AR	3
605290	3q29	Optic atrophy 1	165500	AD	3
605290	3q29	Optic atrophy plus syndrome	125250	AD	3
605290	3q29	{Glaucoma, normal tension, susceptibility to}	606657	_	3
610362	19p13.3	?Macular degeneration, age-related, 6	613757	_	3
610362	19p13.3	Cone-rod dystrophy 11	610381	AD	3
609595	1p34.3	Palmoplantar hyperkeratosis and true hermaphroditism	610644	AR	3
609595	1p34.3	Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal	610644	AR	3
606996	1p36.31	Senior-Loken syndrome 4	606996	AR	3
608102	13q22.3	Ceroid lipofuscinosis, neuronal, 5	256731	AR	3
606069	2q32.2	Hemochromatosis, type 4	606069	AD	3
609270	11p15.4	Spinocerebellar ataxia, autosomal recessive 7	609270	AR	3
604187	12q13.3	Spastic paraplegia 10, autosomal dominant	604187	AD	3
150000	11p15.1	Glycogen storage disease XI	612933	AR	3
608970	5q21.3-q33.2	Macular dystrophy, butterfly-shaped pigmentary, 2	608970	AD	2
605014	6q24.2	Hemophagocytic lymphohistiocytosis, familial, 4	603552	AR	3
602572	10q22.3	Amytrophic lateral sclerosis 23	617839	AD	3
608836	1p32.3	CPT II deficiency, lethal neonatal	608836	AR	3
608172	1p36.11	?Congenital disorder of glycosylation, type 1bb	613861	AR	3
608172	1p36.11	Developmental delay and seizures with or without movement abnormalities	617836	AD	3
608172	1p36.11	Retinitis pigmentosa 59	613861	AR	3
607254	22q12.3	{Schizophrenia}	181500	AD	1
609661	19q13.42	Hydatidiform mole, recurrent, 1	231090	AR	3
608103	11q14.1	Congenital disorder of glycosylation, type Ih	608104	AR	3
608103	11q14.1	Polycystic liver disease 3 with or without kidney cysts	617874	AD	3
600733	13q12.2	MODY, type IV	606392	_	3
600733	13q12.2	Pancreatic agenesis 1	260370	AR	3
600733	13q12.2	{Diabetes mellitus, type II, susceptibility to}	125853	AD	3
609136	22q13.1	PCWH syndrome	609136	AD	3
609302	11p15.5	Epileptic encephalopathy, early infantile, 3	609304	AR	3
604188	1q21.3	Extraoral halitosis due to MTO deficiency	618148	AR	3
608904	17p11	{Attention deficit-hyperactivity disorder}	143465	AD	2
608673	12q24.23	Charcot-Marie-Tooth disease, axonal, type 2L	608673	AD	3
611307	11p14.3	Muscular dystrophy, limb-girdle, autosomal recessive 12	611307	AR	3
607903	18q12.1	Hypotrichosis 6	607903	AR	3
611211	11q13.4	Amelogenesis imperfecta, type IIIC	618386	AR	3
604385	3p22.2	Episodic pain syndrome, familial, 3	615552	AD	3
604385	3p22.2	Neuropathy, hereditary sensory and autonomic, type VII	615548	AD	3
610883	17p11.2	Potocki-Lupski syndrome	610883	IC	4
611014	18q21.2	{Hypertension, essential, susceptibility to, 8}	611014	_	2
609628	18p11.31	Majeed syndrome	609628	_	3
610624	1p34.3	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures	618170	AR	3
607095	9p13.3	Anauxetic dysplasia 1	607095	AR	3
609271	2p24	Keratoconus 4	609271	_	2
608173	6p11	{Autoimmune thyroid disease, susceptibility to, 1}	608173	_	2
607613	1q42.13	?Galloway-Mowat syndrome 8	618349	AR	3
607613	1q42.13	Nephrotic syndrome, type 18	618177	AR	3
607936	3q21.1	Peeling skin syndrome 4	607936	AR	3
606603	1q42-q43	Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant	614940	AD	3
606603	1q42-q43	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	AR	3
610852	7p14.1	Ciliary dyskinesia, primary, 6	610852	AR	3
602501	3q26.32	Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	_	3
611147	2q31	Paroxysmal nonkinesigenic dyskinesia 2	611147	AD	2
605124	19q13.2	Diarrhea 3, secretory sodium, congenital, syndromic	270420	AR	3
605361	19q13.42	Spinocerebellar ataxia 14	605361	AD	3
605225	1p36	{Inflammatory bowel disease 7}	605225	_	2
110750	2q14.3	[Blood group, Gerbich]	616089	_	3
110750	2q14.3	{Malaria, resistance to}	611162	_	3
608105	16p12-p11.2	Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp	608105	AR	2
607386	2p23.3	Retinitis pigmentosa 71	616394	AR	3
607386	2p23.3	Short-rib thoracic dysplasia 10 with or without polydactyly	615630	AR	3
610949	1q32.2	?Spinocerebellar ataxia, autosomal recessive 11	614229	AR	3
610916	5p15.31	Mental retardation, autosomal recessive 5	611091	AR	3
606070	5q31.2	Amyotrophic lateral sclerosis 21	606070	AD	3
608837	17p13.1	Carney complex variant	608837	_	3
610329	11q13.1	Aicardi-Goutieres syndrome 3	610329	AR	3
607614	11p11.2	?Nephrotic syndrome, type 19	618178	AR	3
611081	2q37.1	{Inflammatory bowel disease (Crohn disease) 10}	611081	_	3
608703	2p21-p13	Spinocerebellar ataxia 25	608703	AD	2
611958	11q13	{Prostate cancer, hereditary, 14}	611958	_	2
607904	16p13.3	Hyperaldosteronism, familial, type IV	617027	AD	3
607904	16p13.3	{Epilepsy, childhood absence, susceptibility to, 6}	611942	_	3
607904	16p13.3	{Epilepsy, idiopathic generalized, susceptibility to, 6}	611942	_	3
610460	6p22.3	{Thiopurines, poor metabolism of, 1}	610460	AR	3
611570	9q22.32	Fructose-1,6-bisphosphatase deficiency	229700	AR	3
600734	11q24.3	Hyperaldosteronism, familial, type III	613677	AD	3
600734	11q24.3	Long QT syndrome 13	613485	AD	3
605362	6q23.2	?Cardiomyopathy, dilated, 1J	605362	AD	3
611276	2p16-p15	Glaucoma 1, open angle, H	611276	_	2
609825	4q21.23	Coenzyme Q10 deficiency, primary, 1	607426	AR	3
609825	4q21.23	{Multiple system atrophy, susceptibility to}	146500	AR,AD	3
604687	14q22.1	{Asthma, susceptibility to, 1}	607277	_	3
612311	2q21.1	{Attention deficit-hyperactivity disorder, susceptibility to, 5}	612311	_	2
608512	7q11.23	Chronic granulomatous disease due to deficiency of NCF-1	233700	AR	3
611501	1p36.31-p36.23	Cerebellar ataxia, nonprogressive, with mental retardation	614756	AD	3
604386	8q23.3	Trichorhinophalangeal syndrome, type I	190350	AD	3
604386	8q23.3	Trichorhinophalangeal syndrome, type III	190351	AD	3
611893	19q13.2	Leukodystrophy and acquired microcephaly with or without dystonia	616763	AR	3
612241	3p21.3	{Inflammatory bowel disease 12}	612241	_	2
611927	8q24.3	Amelogenesis imperfecta, type IIIA	130900	AD	3
609304	11p15.5	Epileptic encephalopathy, early infantile, 3	609304	AR	3
611082	22q12.1	{Myocardial infarction, susceptibility to}	608446	_	3
610330	11q13.1	Aicardi-Goutieres syndrome 3	610329	AR	3
609893	15q25.3-q26.1	Hypothyroidism, congenital, nongoitrous, 3	609893	_	2
612567	21q22.11	Inflammatory bowel disease 25, early onset, autosomal recessive	612567	AR	3
610397	14q21.1	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy	617862	AR	3
612631	9q34.11	Hemolytic anemia due to adenylate kinase deficiency	612631	AR	3
607905	9q22.33	?Congenital disorder of glycosylation, type Ii	607906	AR	3
607905	9q22.33	Myasthenic syndrome, congenital, 14, with tubular aggregates	616228	AR	3
605226	1p36.23	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	616975	AD	3
612312	13q12.11	{Attention deficit-hyperactivity disorder, susceptibility to, 6}	612312	_	2
612279	8p23-p21	Epilepsy, generalized, with febrile seizures plus, type 6	612279	_	2
611469	8q24	{Colorectal cancer, susceptibility to, 2}	611469	_	2
605363	2q31.1	?Cerebral palsy, spastic quadriplegic, 1	603513	AR	3
608340	8q21.11	Charcot-Marie-Tooth disease, recessive intermediate, A	608340	AR	3
611706	10q22-q23	{Migraine, with or without aura, susceptibility to, 12}	611706	AD	2
611571	16q22.1-q23.1	{Otosclerosis 4}	611571	AD	2
609826	9q34.3	Hypophosphatemic rickets with hypercalciuria	241530	AR	3
609273	15q22.31	Nemaline myopathy 6, autosomal dominant	609273	AD	3
609994	4q22-q27	Myopia 11	609994	_	2
609630	11p11	{Leukemia, chronic lymphocytic, susceptibility to, 1}	609630	_	2
608106	12q24.11	Immunodeficiency with hyper IgM, type 5	608106	AR	3
611407	10q22.2	Cardiomyopathy, dilated, 1W	611407	_	3
611535	2q22-q24	{Major affective disorder 5}	611535	_	2
612599	5q31.1-q33.1	{Psoriasis susceptibility 11}	612599	_	2
612242	10q23	Chromosome 10q22.3-q23.2 deletion syndrome	612242	_	4
613079	18q21.1	Deafness, autosomal recessive 77	613079	AR	3
612951	6q27	Leukoencephalopathy, cystic, without megalencephaly	612951	AR	3
204200	16p12.1	Ceroid lipofuscinosis, neuronal, 3	204200	AR	3
134570	6p25.1	Factor XIIIA deficiency	613225	AR	3
134570	6p25.1	{Myocardial infarction, protection against}	608446	_	3
134570	6p25.1	{Venous thrombosis, protection against}	188050	AD	3
610657	8q24.13	Ritscher-Schinzel syndrome 1	220210	AR	3
610657	8q24.13	Spastic paraplegia 8, autosomal dominant	603563	AD	3
612632	15q22-q23	Usher syndrome, type 1H	612632	_	2
608480	6p21.31	Spermatogenic failure 3	606766	AD	3
604387	3q22.1	Nephronophthisis 3	604387	AR	3
608204	11q13.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}	610551	_	3
612313	2q33.1	Glass syndrome	612313	AD	3
611669	19p13.13	Mental retardation, autosomal recessive 68	618302	AR	3
612243	6q24.2	Lethal congenital contracture syndrome 9	616503	AR	3
607258	4q33-qter	Hypercalciuria, absorptive	607258	_	2
613239	17p11.2	{Thyrotoxic periodic paralysis, susceptibility to, 2}	613239	AD	3
612952	20q11.23	Aicardi-Goutieres syndrome 5	612952	AR	3
612759	2q24.1	Synesthesia	612759	_	2
134580	1q31.3	Factor XIIIB deficiency	613235	AR	3
613463	2p23.3	[Fasting plasma glucose level QTL 5]	613463	_	3
613015	6p22	{Neuroblastoma, susceptibility to, 4}	613015	_	2
613399	17q22	{Breast-ovarian cancer, familial, susceptibility to, 3}	613399	_	3
609631	9p21.1	Singleton-Merten syndrome 2	616298	AD	3
611341	3q27.3	Polycystic kidney disease 6 with or without polycystic liver disease	618061	AD	3
610819	3p22.1	Anemia, sideroblastic, 2, pyridoxine-refractory	205950	AR	3
612792	8q22.1	Lenz-Majewski hyperostotic dwarfism	151050	AD	3
612244	7q21.12	{Inflammatory bowel disease 13}	612244	_	3
614039	16q24.3	Cortical dysplasia, complex, with other brain malformations 1	614039	AD	3
604720	7q22.1	Hemochromatosis, type 3	604250	AR	3
608205	1p35.3	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	617282	AR	3
607259	16q24.3	Spastic paraplegia 7, autosomal recessive	607259	AR,AD	3
613495	11q12.2	Immunodeficiency, common variable, 5	613495	AR	3
613719	12q14.3	Deafness, autosomal recessive 74	613718	AR	3
611572	6q13-q16.1	Otosclerosis 7	611572	AD	2
613655	10q25.3	{Migraine, with or without aura, susceptibility to, 13}	613656	_	3
613080	17q25.3	?46XY sex reversal 5	613080	AR	3
613751	3p22.2	Heterotaxy, visceral, 4, autosomal	613751	_	3
606071	12q24.11	Hereditary motor and sensory neuropathy, type IIc	606071	AD	3
600770	11p15.5	{Pulmonary fibrosis, idiopathic, susceptibility to}	178500	AD	3
613943	10q23.31	Ichthyosis, congenital, autosomal recessive 8	613943	AR	3
613815	6p21.33	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency	201910	AR	3
613815	6p21.33	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	201910	AR	3
609432	17p13.3	Syndactyly, mesoaxial synostotic, with phalangeal reduction	609432	AR	3
613559	12q24.31	Combined oxidative phosphorylation deficiency 7	613559	AR	3
608515	1q25.3	Chronic granulomatous disease due to deficiency of NCF-2	233710	AR	3
614327	3p21.1	Tumor predisposition syndrome	614327	AD	3
614199	3p21.31	Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	_	3
613847	10q24.1	Joubert syndrome 18	614815	AR	3
613847	10q24.1	Orofaciodigital syndrome IV	258860	AR	3
614295	10q21.1	{Renal dysplasia, cystic, susceptibility to}	601331	AD	3
614135	6q13	?Epiphyseal dysplasia, multiple, 6	614135	AD	3
603826	12q23.1	Cholestasis, progressive familial intrahepatic, 5	617049	AR	3
612633	7q21.3	{Microvascular complications of diabetes 5}	612633	_	3
613464	14q31.3	?Retinitis pigmentosa 51	613464	AR	3
609275	1q41	Martsolf syndrome	212720	AR	3
609275	1q41	Warburg micro syndrome 2	614225	AR	3
613016	2q35	{Neuroblastoma, susceptibility to, 5}	613016	_	2
612089	13q13.1	Hypophosphatemic rickets and hyperparathyroidism	612089	AD	2
611994	16p13.3	Combined oxidative phosphorylation deficiency 32	617664	AR	3
610098	6q22.31	Ovarian dysgenesis 4	616185	AR	3
613656	10q25.3	{Migraine, with or without aura, susceptibility to, 13}	613656	_	3
606072	3p25.3	Rippling muscle disease 2	606072	AD	3
608206	5q32	Charcot-Marie-Tooth disease, type 4C	601596	AR	3
608206	5q32	Mononeuropathy of the median nerve, mild	613353	AD	3
614455	14q32.33	Charcot-Marie-Tooth disease, dominant intermediate E	614455	AD	3
614200	5q11.2	?Glycoprotein Ia deficiency	614200	AD	1
204300	15q23	Ceroid lipofuscinosis, neuronal, Kufs type, adult onset	204300	AR	3
611895	14q11.2	Amyotrophic lateral sclerosis 9	611895	_	3
614391	4q27	{Pregnancy loss, recurrent, susceptibility to, 3}	614391	AD	3
605229	3q27-q28	Spastic paraplegia 14, autosomal recessive	605229	AR	2
614328	2p25.1	?Inflammatory skin and bowel disease, neonatal, 1	614328	AR	3
613207	9q33	{Asthma-related traits, susceptibility to, 8}	613207	_	2
610099	8p22-q11	Myopathy, distal 3	610099	AD	2
613657	15q26.1	D-2-hydroxyglutaric aciduria 2	613657	_	3
611959	19q13.4	{Prostate cancer, hereditary, 15}	611959	_	2
612794	15q14	Atrial septal defect 5	612794	AD	3
613017	1q21.1	{Neuroblastoma, susceptibility to, 6}	613017	_	2
608207	22q12	{Kala-azar, susceptibility to, 1}	608207	_	2
612570	5q23.3	Contractural arachnodactyly, congenital	121050	AD	3
612570	5q23.3	Macular degeneration, early-onset	616118	AD	3
614201	19q13.42	Bleeding disorder, platelet-type, 11	614201	AR	3
612858	8q24.3	Orofacial cleft 12	612858	_	2
614807	16p13.3	?Centronuclear myopathy 4	614807	AD	3
613848	11q13.5	Osteogenesis imperfecta, type X	613848	AR	3
613145	1q21-q23	{Systemic lupus erythematosus, susceptibility to, 14}	613145	_	2
613370	11p15.5	Maturity-onset diabetes of the young, type 10	613370	AD	3
613912	19p13.3	Complement factor D deficiency	613912	AR	3
610100	1q23.2	?Giant axonal neuropathy 2, autosomal dominant	610100	AD	3
614871	1p36.32	Peroxisome biogenesis disorder 6B	614871	AR	3
614839	12q13.3	Hypogonadotropic hypogonadism 10 with or without anosmia	614839	AR	3
614041	13q14.2	Bladder cancer, somatic	109800	_	3
614041	13q14.2	Osteosarcoma, somatic	259500	_	3
614041	13q14.2	Retinoblastoma	180200	SMu,AD	3
614041	13q14.2	Retinoblastoma, trilateral	180200	SMu,AD	3
614041	13q14.2	Small cell cancer of the lung, somatic	182280	_	3
614679	17q21.31	Ciliary dyskinesia, primary, 17	614679	AR	3
614583	17q25.3	Baraitser-Winter syndrome 2	614583	AD	3
609139	2p11.2	?Neuronopathy, distal hereditary motor, type VB	614751	AD	3
609139	2p11.2	Spastic paraplegia 31, autosomal dominant	610250	AD	3
612761	4q22.3	Adermatoglyphia	136000	AD	3
612761	4q22.3	Basan syndrome	129200	AD	3
612761	4q22.3	Huriez syndrome	181600	AD	3
615192	6p22.3	[Birth weight QTL4]	615192	_	2
134600	15q15.3	Fanconi renotubular syndrome 1	134600	AD	2
615032	14q11.2	{Autism, susceptibility to, 18}	615032	AD	3
614296	4p16.1	Wolfram-like syndrome, autosomal dominant	614296	AD	3
614521	9p24.1	Thrombocythemia 3	614521	SMu,AD	3
611960	1q32.1	{Asthma-related traits, susceptibility to, 7}	611960	_	3
613658	2q36.2	Rajab syndrome	613658	AR	2
615160	16p12.2	Mitochondrial complex III deficiency, nuclear type 5	615160	AR	3
604723	12q14.1	Combined oxidative phosphorylation deficiency 3	610505	AR	3
613944	2q36	{IgA nephropathy, susceptibility to, 2}	613944	?AD	2
609435	19p13.11	?Mitochondrial complex I deficiency, nuclear type 28	618249	AR	3
609435	19p13.11	{Thyroid carcinoma, Hurthle cell}	607464	_	3
614202	9q34.3	Mental retardation, autosomal recessive 15	614202	AR	3
614776	11q23.3	?Spondyloepimetaphyseal dysplasia, Krakow type	618162	AR	3
615224	17q25.3	Advanced sleep-phase syndrome, familial, 2	615224	AD	3
613561	12p11.21	Myopathy, lactic acidosis, and sideroblastic anemia 2	613561	AR	3
613018	16q22.2	Tyrosinemia, type II	276600	AR	3
613371	4q34.3-q35.1	?Spinocerebellar ataxia 30	613371	AD	2
605018	16q12.1	Brooke-Spiegler syndrome	605041	AD	3
605018	16q12.1	Cylindromatosis, familial	132700	AD	3
605018	16q12.1	Trichoepithelioma, multiple familial, 1	601606	AD	3
613146	15q25.1	EDICT syndrome	614303	AD	3
613720	20q13.33	Epileptic encephalopathy, early infantile, 7	613720	AD	3
610197	19q13.33	?Charcot-Marie-Tooth disease, type 2B2	605589	AR	3
610197	19q13.33	Basel-Vanagait-Smirin-Yosef syndrome	616449	AR	3
614872	22q11.21	Peroxisome biogenesis disorder 7A (Zellweger)	614872	AR	3
614647	14q24.3	Coenzyme Q10 deficiency, primary, 6	614650	AR	3
612571	5p15.33	{Lung cancer susceptibility 3}	612571	_	2
609633	21q22.13	{Major affective disorder 3, early onset}	609633	_	2
613849	12q13.13	Osteogenesis imperfecta, type XII	613849	AR	3
613208	3p25.1	Xeroderma pigmentosum, group C	278720	AR	3
615544	6q27	?Periventricular nodular heterotopia 6	615544	AD	3
615000	14q32.31	Spastic paraplegia 49, autosomal recessive	615031	AR	3
612795	11q12-q13.1	[Polyunsaturated fatty acids plasma level QTL1]	612795	_	2
614680	11p15.5	{Influenza, severe, susceptibility to}	614680	_	3
613401	14q24.3	Arthrogryposis, renal dysfunction, and cholestasis 2	613404	AR	3
614456	3p13	{Melanoma, cutaneous malignant, susceptibility to, 8}	614456	_	3
614808	17p13.2	Amyotrophic lateral sclerosis 18	614808	_	3
614042	10q23.31	Moyamoya disease 5	614042	_	3
615288	2p23.3	Ciliary dyskinesia, primary, 21	615294	AR	3
614265	16q24.3	Combined malonic and methylmalonic aciduria	614265	_	3
614297	19q12	?Spastic paraplegia 43, autosomal recessive	615043	AR	3
614297	19q12	Neurodegeneration with brain iron accumulation 4	614298	AR	3
611313	10q26.13	{Macular degeneration, age-related, 8}	613778	_	3
612192	6p22.1	Diabetes mellitus, transient neonatal, 1	601410	AD	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	AR	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14	615351	AR	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	AR	3
134610	16p13.3	Familial Mediterranean fever, AD	134610	AD	3
613529	15q21.1	Microcephaly 9, primary, autosomal recessive	614852	AR	3
613529	15q21.1	Seckel syndrome 5	613823	AR	3
615416	17p13.3	?Camptosynpolydactyly, complex	607539	AR	3
615416	17p13.3	Syndactyly, mesoaxial synostotic, with phalangeal reduction	609432	AR	3
613721	2q24.3	Epileptic encephalopathy, early infantile, 11	613721	AD	3
611897	2q11-q14	Nanophthalmos 3	611897	_	2
615225	17p13.2	Palmoplantar carcinoma, multiple self-healing	615225	AD	3
615897	1p34.2	Immunodeficiency 24	615897	AR	3
612572	20p13	Retinitis pigmentosa 46	612572	_	3
616025	17q12	Glycosylphosphatidylinositol biosynthesis defect 11	616025	AR	3
614203	16q11.2	{Parkinson disease 17}	614203	AD	3
615993	1q43-q44	Bardet-Biedl syndrome 16	615993	AR	3
609140	1p34.3	Corneal dystrophy, posterior polymorphous 2	609140	AD	3
610198	3q26.33	3-methylglutaconic aciduria, type V	610198	AR	3
615961	16p13.3	Acid-labile subunit, deficiency of	615961	_	3
614873	22q11.21	Peroxisome biogenesis disorder 7B	614873	AR	3
613402	19q13.33	Microcephaly, seizures, and developmental delay	613402	AR	3
616089	2q14.3	[Blood group, Gerbich]	616089	_	3
610168	3p24.1	Loeys-Dietz syndrome 2	610168	AD	3
204500	11p15.4	Ceroid lipofuscinosis, neuronal, 2	204500	AR	3
614457	6q14.1	Ichthyosis, spastic quadriplegia, and mental retardation	614457	AR	3
615833	12p13.31	?Epileptic encephalopathy, early infantile, 21	615833	AR	3
615512	12p13.31	Hemolytic anemia due to triosephosphate isomerase deficiency	615512	AR	3
611603	12q13.12	Lissencephaly 3	611603	AD	3
616217	6p22.3	Nephronophthisis 19	616217	AR	3
614585	19p13.2	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	251900	AR	3
613689	22q12.3-q13.1	Mammary-digital-nail syndrome	613689	AD	2
616185	6q22.31	Ovarian dysgenesis 4	616185	AR	3
615481	21q22.3	Ciliary dyskinesia, primary, 24	615481	AR	3
614809	1q31.3	Nephropathy due to CFHR5 deficiency	614809	AD	3
614138	4q35.1	Muscular dystrophy, limb-girdle, autosomal recessive 18	615356	AR	3
616441	20p11.23	Corneal dystrophy, posterior polymorphous, 1	122000	AD	3
616249	2p21	Long QT syndrome 15	616249	AD	3
616281	16q11.2	Mental retardation, autosomal recessive 49	616281	AR	3
615705	3q29	?Spinocerebellar ataxia, autosomal recessive 15	615705	AR	3
615866	2p25.2	Mental retardation, autosomal dominant 27	615866	AD	3
150100	12p12.1	[Lactate dehydrogenase-B deficiency]	614128	_	3
610199	9p24.2	Diabetes mellitus, neonatal, with congenital hypothyroidism	610199	AR	3
609141	10p11.22	Corneal dystrophy, posterior polymorphous, 3	609141	_	3
614874	7p22.3	Ciliary dyskinesia, primary, 18	614874	AR	3
613752	20q11.22	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	613752	AR	3
614298	19q12	Neurodegeneration with brain iron accumulation 4	614298	AR	3
614649	8p11.21	Ataxia, sensory, 1, autosomal dominant	608984	AD	3
613243	3p21.1	Cardiomyopathy, hypertrophic, 13	613243	AD	3
613403	2q11.2	{Pheochromocytoma, susceptibility to}	171300	AD	3
615226	4p16.3	?Polydactyly, postaxial, type A6	615226	AR	3
615577	10q24.32	Immunodeficiency, common variable, 10	615577	AD	3
614458	7q35	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	614458	AR	3
612573	12q24.31	[Mean platelet volume QTL1]	612573	_	2
615545	9p13.2	{Leukemia, acute lymphoblastic, susceptibility to, 3}	615545	_	3
610661	3p24.2	Congenital disorder of deglycosylation	615273	AR	3
616345	11p15.5	?Immunodeficiency 39	616345	AR	3
613722	20p12.3	Epileptic encephalopathy, early infantile, 12	613722	AR	3
615770	5p13.2	?Atrial fibrillation 15	615770	AR	3
615513	1p36.22	Immunodeficiency 14	615513	AD	3
609634	2q24.3	Migraine, familial hemiplegic, 3	609634	AD	3
613690	19q13.42	Cardiomyopathy, hypertrophic, 7	613690	AD	3
616186	11p15.5	Beckwith-Wiedemann syndrome	130650	AD	3
600740	19q13.32	Hypocalciuric hypercalcemia, type III	600740	AD	3
616697	12q21.32	Deafness, autosomal dominant 69, unilateral or asymmetric	616697	AD	3
616538	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9	616538	AR	3
612410	18p11.23	{Psoriasis susceptibility 10}	612410	_	2
616282	19q13.33	?Spastic paraplegia 73, autosomal dominant	616282	AD	3
615706	6p24.1	Auriculocondylar syndrome 3	615706	AR	3
615834	7q11.22	Mental retardation, autosomal dominant 26	615834	AD	3
615994	3p21.31	Bardet-Biedl syndrome 17	615994	AR	3
614810	12p13.31	{Multiple sclerosis, susceptibility to, 5}	614810	_	3
614650	14q24.3	Coenzyme Q10 deficiency, primary, 6	614650	AR	3
612634	6q25.3	{Microvascular complications of diabetes 6}	612634	_	3
614459	11q12.2	Joubert syndrome 16	614465	AR	3
617082	6q22.1	?Congenital disorder of glycosylation, type 1aa	617082	AR	3
616154	11p15.3	Peroxisomal fatty acyl-CoA reductase 1 disorder	616154	AR	3
613404	14q24.3	Arthrogryposis, renal dysfunction, and cholestasis 2	613404	AR	3
615418	4q35.1	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	615418	AR	3
612862	6p21.3	{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to}	612862	_	2
612574	3p21-p13	[Mean platelet volume QTL2]	612574	_	2
204650	4q13.3	Amelogenesis imperfecta, type IC	204650	AR	3
617114	3q22.2	Myopathy, myofibrillar, 7	617114	AR	3
610662	4q22.1	Hyperphosphatasia with mental retardation syndrome 6	616809	AR	3
615771	6p21.33	Cortical dysplasia, complex, with other brain malformations 6	615771	AD	3
608742	12p12.2-p12.1	{Hypertension, essential, susceptibility to, 4}	145500	Mu	2
616730	12q15	Nephrotic syndrome, type 11	616730	AR	3
616187	11p15.1	Epilepsy, progressive myoclonic 7	616187	AD	3
615546	4q28.1	Van Maldergem syndrome 2	615546	AR	3
617018	3q25.2	?Spinocerebellar ataxia 43	617018	AD	3
616026	20q13.12	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	616026	AD	3
616539	14q23.1	Combined oxidative phosphorylation deficiency 26	616539	AR	3
613148	11q23.3	Inflammatory bowel disease 28, early onset, autosomal recessive	613148	AR	3
617242	4q13.1	Ventricular tachycardia, catecholaminergic polymorphic, 3	614021	AR	3
614840	4q24	Hypogonadotropic hypogonadism 11 with or without anosmia	614840	AR	3
616155	11q13.3	Charcot-Marie-Tooth disease, axonal, type 2S	616155	AR	3
616283	11q24.2	Mental retardation, autosomal recessive 55	617051	AR	3
616602	3q24	Craniosynostosis 6	616602	AD	3
616858	20p11.23	?Cowden syndrome 7	616858	AD	3
613468	8p22	Farber lipogranulomatosis	228000	AR	3
613468	8p22	Spinal muscular atrophy with progressive myoclonic epilepsy	159950	AR	3
617306	3p13	COMMAD syndrome	617306	AR	3
613818	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	613818	AR	3
611604	10q24.31	Spastic paraplegia 62	615681	AR	3
612863	6q24-q25	Chromosome 6q25-q25 deletion syndrome	612863	_	4
612411	4q28.1	Hennekam lymphangiectasia-lymphedema syndrome 2	616006	AR	3
612411	4q28.1	Van Maldergem syndrome 2	615546	AR	3
614204	2q14.1	Psoriasis 14, pustular	614204	AR	3
616794	3p14.1	Combined oxidative phosphorylation deficiency 28	616794	AR	3
613405	9q34.11	[Bone mineral density QTL 15]	613418	AR,AD	3
612575	17q11.2	[Mean platelet volume QTL3]	612575	_	2
615578	10q26.11	Combined oxidative phosphorylation deficiency 18	615578	AR	3
615419	13q32.3-q33.1	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	615419	AR	3
617083	2p21	Short-rib thoracic dysplasia 15 with polydactyly	617088	AR	3
615003	8p11.23	Spastic paraplegia 54, autosomal recessive	615033	AR	3
617370	6q24.2	?Peroxisome biogenesis disorder 10B	617370	AR	3
617402	22q11.21	Cutis laxa, autosomal recessive, type IIC	617402	AR	3
614588	2q14.3-q21.3	Dystonia 21	614588	AD	2
609636	7q36	Alzheimer disease-10	609636	AD	2
614779	18q21.1	Heterotaxy, visceral, 6, autosomal recessive	614779	AR	3
612635	6p22.2	{Microvascular complications of diabetes 7}	612635	_	3
615962	5q31.3	Glucocorticoid resistance	615962	AD	3
611317	17p13.1	Ataxia-oculomotor apraxia 3	615217	AR	3
615515	2q34	Amyotrophic lateral sclerosis 19	615515	AD	3
615611	15q22.31	?Protoporphyria, erythropoietic, 2	618015	AD	3
616890	2q31.1	Split-foot malformation with mesoaxial polydactyly	616890	AR	3
204700	19q13.41	Amelogenesis imperfecta, type IIA1	204700	AR	3
617243	1p36.22	?Fanconi anemia, complementation group V	617243	AR	3
613819	2q24.3	Short-rib thoracic dysplasia 4 with or without polydactyly	613819	AR	3
616603	10q24.1	Cutis laxa, autosomal dominant 3	616603	AD	3
616188	11p15.4	?Retinal dystrophy and obesity	616188	AR	3
614205	19q13.32	3-M syndrome 3	614205	AR	3
611605	8p11.23	Spastic paraplegia 18, autosomal recessive	611225	AR	3
615290	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	615290	AD	3
616027	7p14.2	Focal segmental glomerulosclerosis 8	616032	AD	3
616859	14q32.13	Spasticity, childhood-onset, with hyperglycinemia	616859	AR	3
616284	1q21.3	Peeling skin syndrome 6	618084	AR	3
614841	8p21.2	?Hypogonadotropic hypogonadism 12 with or without anosmia	614841	AR	3
613723	8q24.3	Muscular dystrophy, limb-girdle, autosomal recessive 17	613723	AR	3
617690	9q34.3	Ovarian dysgenesis 5	617690	AR	3
615420	4q35.1	Myopia 22, autosomal dominant	615420	AD	3
617403	3q13.31	Cutis laxa, autosomal recessive, type IID	617403	AR	3
614876	11p11.2	Peroxisome biogenesis disorder 8A (Zellweger)	614876	AR	3
615612	3p22.2	Developmental dysplasia of the hip 2	615612	AD	2
616059	22q13.1	?Mirror movements 3	616059	AR	3
616795	17q21.33	Spinocerebellar ataxia 42	616795	AD	3
615963	6p21.33-p21.32	Vesicoureteral reflux 8	615963	AD	3
613211	15q21.3	Amelogenesis imperfecta, type IIA3	613211	AR	3
617180	19q13.2	Chitayat syndrome	617180	AD	3
617466	14q23.1	?Townes-Brocks syndrome 2	617466	AD	3
608488	14q24.2	Microphthalmia with limb anomalies	206920	AR	3
613406	15q24.2	Witteveen-Kolk syndrome	613406	AD	3
613150	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	AR	3
617435	4p16.3	Lopes-Maciel-Rodan syndrome	617435	AR	3
613820	2q24.3	Nephronophthisis 12	613820	AR,AD	3
617531	19p13.11	Brain small vessel disease 3	618360	AR	3
615516	15q13.1	Mental retardation, autosomal recessive 38	615516	AR	3
615291	1p36.33	Ehlers-Danlos syndrome, spondylodysplastic type, 2	615349	AR	3
615291	1p36.33	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	AR	3
616860	14q32.13	Anemia, sideroblastic, 3, pyridoxine-refractory	616860	AR	3
611606	7q32.2	Deafness, autosomal dominant 50	613074	AD	3
615837	5q32	?Deafness, autosomal recessive 101	615837	AR	3
617146	18p11.22-p11.21	Arthrogryposis, distal, with impaired proprioception and touch	617146	AR	3
617691	6q24.3	Spinocerebellar ataxia 44	617691	AD	3
614877	11p11.2	Peroxisome biogenesis disorder 8B	614877	AR	3
615004	4q25	Night blindness, congenital stationary (complete), 1F, autosomal recessive	615058	AR	3
616445	3p25.3	Candidiasis, familial, 9	616445	AR	3
613469	10q24.2	Urofacial syndrome 1	236730	AR	3
617050	19p13.3	?Hermansky-Pudlak syndrome 10	617050	AR	3
614589	5q15	Trichohepatoenteric syndrome 1	222470	AR	3
618076	1q23.3	Neurodevelopmental disorder with spasticity and poor growth	618076	AR	3
617915	4p16.3	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	617915	AD	3
608489	7q22.1	Premature ovarian failure 8	615723	AR	3
612576	17p13.3-p13.1	Split-hand/foot malformation with long bone deficiency 3	612576	AD	4
616636	12q13.3	Immunodeficiency 44	616636	AR	3
617755	17q24.2	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	617755	AD	3
613724	1p32.3	?Leukoencephalopathy with dystonia and motor neuropathy	613724	AR	3
613407	13q14.11	{Leprosy, susceptibility to, 6}	613407	_	2
615995	10q25.2	?Bardet-Biedl syndrome 18	615995	AR	3
617020	1q42.2	Epileptic encephalopathy, early infantile, 38	617020	AR	3
615421	4q35.1	Myopia 22, autosomal dominant	615420	AD	3
617532	1p36.23	Intellectual developmental disorder with neuropsychiatric features	617532	AR	3
615517	11q12.3	?Hemochromatosis, type 5	615517	AD	3
617626	4q12	Fibromatosis, gingival, 5	617626	AD	3
612444	17q25.1	Ciliary dyskinesia, primary, 9, with or without situs inversus	612444	_	3
614813	3p21.2	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813	AR	3
613151	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3	613151	AR	3
615547	15q11.2	Schaaf-Yang syndrome	615547	AD	3
618204	8p11.21	Immunodeficiency 15A	618204	AD	3
150200	17q23.3	[Placental lactogen deficiency]	_	_	1
615005	9q34.3	Epilepsy, nocturnal frontal lobe, 5	615005	AD	3
616060	12p12.3	[Blood group, Dombrock]	616060	_	3
618108	6p25.2	Immunodeficiency 57	618108	AR	3
618077	1q32.1	{Inflammatory bowel disease 29}	618077	_	3
618236	19p13.3	Mitochondrial complex I deficiency, nuclear type 14	618236	AR	3
614590	6p21.3	{Podoconiosis, susceptibility to}	614590	_	2
617756	12q13.13	Erythrokeratodermia variabilis et progressiva 5	617756	AR	3
615900	2p23.3	Retinitis pigmentosa 75	617023	AR	3
616540	19p13.3	?Epilepsy, progressive myoclonic, 9	616540	AR	3
615292	11q12.1	Gracile bone dysplasia	602361	AD	3
615292	11q12.1	Kenny-Caffey syndrome, type 2	127000	AD	3
612577	6q21	Amyotrophic lateral sclerosis 11	612577	AD	3
616126	1p36.33	Immunodeficiency 38	616126	AR	3
615996	22q12.3	?Bardet-Biedl syndrome 19	615996	AR	3
617244	15q15.1	?Fanconi anemia, complementation group R	617244	AD	3
617051	11q24.2	Mental retardation, autosomal recessive 55	617051	AR	3
618364	12q13.13	?Myoclonus, familial, 2	618364	AD	3
613949	12p13.31	OKT4 epitope deficiency	613949	_	3
617980	11p15.4	Erythrocytosis 6	617980	_	3
615838	5q23.3-q31.1	Mitochondrial complex III deficiency, nuclear type 8	615838	AR	3
617275	1q43	Tooth agenesis, selective, 9	617275	AD	3
618396	5q34	Epileptic encephalopathy, early infantile, 74	618396	AD	3
618428	8q22.3	Popov-Chang syndrome	618428	AD	3
618268	17q23.3	Trichohepatoneurodevelopmental syndrome	618268	AR	3
615548	3p22.2	Neuropathy, hereditary sensory and autonomic, type VII	615548	AD	3
615518	17q11.2	?Immunodeficiency 13	615518	AD	3
616286	17q21.2	Lethal congenital contracture syndrome 7	616286	AR	3
617021	3p21.31	?Hydrops, lactic acidosis, and sideroblastic anemia	617021	AR	3
618109	1q32.1	Mental retardation, autosomal recessive 65	618109	AR	3
617659	11q13.4	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities	617668	AR	3
614591	19q13.31-q13.32	Deafness, autosomal dominant 4B	614614	AD	3
614591	19q13.31-q13.32	Deafness, autosomal recessive 113	618410	AR	3
600747	17q23.2	Vertebral anomalies and variable endocrine and T-cell dysfunction	618223	AD	3
614044	7q34	Trypsinogen deficiency	614044	AR	1
617757	10q24.32	Joubert syndrome 32	617757	AR	3
617052	5p13.2	Bone marrow failure syndrome 3	617052	AR	3
616638	1p36.22	Smith-Kingsmore syndrome	616638	AD	3
613152	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	AR	3
616892	16q13	Nephrotic syndrome, type 12	616892	AR	3
612578	8q21.13	{Stature QTL 15}	612578	_	2
616541	5q14.2	Short stature, microcephaly, and endocrine dysfunction	616541	AR	3
618462	1p36.12	?Bleeding disorder, platelet-type, 22	618462	AR	3
617245	2q32.3	Neurodevelopmental disorder with hypotonia, seizures, and absent language	617268	AD	3
613726	3p22.1-p21.3	Spinocerebellar ataxia, autosomal recessive 10	613728	AR	3
616604	14q32	{Myeloproliferative neoplasms, familial, susceptibility to}	616604	AD	4
613823	15q21.1	Seckel syndrome 5	613823	AR	3
616158	5q31.3	Mental retardation, autosomal dominant 31	616158	AD	3
615549	16p11.2	ACTH-independent macronodular adrenal hyperplasia 2	615954	SMu,AD	3
617276	15q25.2	Epileptic encephalopathy, early infantile, 48	617276	AR	3
614592	10q26.13	Bent bone dysplasia syndrome	614592	AD	3
617660	2p21	Vertebral, cardiac, renal, and limb defects syndrome 1	617660	AR	3
614908	11q14.2	Leukodystrophy, hypomyelinating, 13	616881	AR	3
618110	14q32.33	?Spermatogenic failure 30	618110	AR	3
617022	14q24.3	Lethal congenital contracture syndrome 10	617022	AR	3
617595	4p13	?Birk-Landau-Perez syndrome	617595	AR	3
612636	2q34	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	616801	AR	3
617694	16q24.3	Al Kaissi syndrome	617694	AR	3
618429	3p22.2	Spermatogenic failure 37	618429	AR	3
617916	6q24.1	?Neurodegeneration with brain iron accumulation 7	617916	AR	3
616062	12q24.33	Microcephaly 16, primary, autosomal recessive	616681	AR	3
615902	14q13.2	Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy	618419	AR	3
615902	14q13.2	Spermatogenic failure 36	618420	AD	3
613727	15q22.31	Nemaline myopathy 6, autosomal dominant	609273	AD	3
613950	22q13.33	{Schizophrenia 15}	613950	AD	3
616893	7q33	?Nephrotic syndrome, type 13	616893	_	3
618173	10q24.32	Retinitis pigmentosa 83	618173	AD	3
615550	3p24.2	?Diamond-Blackfan anemia 12	615550	AD	3
612579	15q22.32	{Stature QTL 16}	612579	_	2
616127	10q24.31	Spinocerebellar ataxia, autosomal recessive 17	616127	AR	3
618300	17p12	Ciliary dyskinesia, primary, 40	618300	AR	3
617246	8q24.13	Seckel syndrome 10	617253	AR	3
617053	7q21.2	MIRAGE syndrome	617053	AD	3
616639	4q21.21	?Epilepsy, progressive myoclonic, 10	616640	AR	3
618205	17p13.1	Snijders Blok-Campeau syndrome	618205	AD	3
617661	2q22.2	Vertebral, cardiac, renal, and limb defects syndrome 2	617661	AR	3
614780	7p15.2	Osteopetrosis, autosomal recessive 8	615085	AR	3
616063	20q13.33	Porokeratosis 8, disseminated superficial actinic type	616063	AD	3
617308	3p14.3	Bile acid synthesis defect, congenital, 6	617308	AR	3
616449	19q13.33	Basel-Vanagait-Smirin-Yosef syndrome	616449	AR	3
616254	11q13.4	3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia	616271	AR	3
613728	3p22.1-p21.3	Spinocerebellar ataxia, autosomal recessive 10	613728	AR	3
617023	2p23.3	Retinitis pigmentosa 75	617023	AR	3
618464	17p13.2	Paragangliomas 6	618464	AD	3
617596	14q24.3	[Maleylacetoacetate isomerase deficiency]	617596	AR	3
618237	6q16.1	Mitochondrial complex I deficiency, nuclear type 15	618237	AR	3
615551	3p22.2	Episodic pain syndrome, familial, 2	615551	AD	3
618112	16q22.2	Spermatogenic failure 31	618112	AR	3
615903	22q11.23	?Myopathy, isolated mitochondrial, autosomal dominant	616209	AD	3
615903	22q11.23	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	615911	AD	3
615903	22q11.23	Spinal muscular atrophy, Jokela type	615048	AD	3
612580	16q24.3	Mental retardation, autosomal dominant 3	612580	_	3
617629	20q11.22	{Schizophrenia 19, susceptibility to}	617629	AD	3
600749	14q11.2	Specific granule deficiency	245480	AR	3
617278	11p15.4	Epileptic encephalopathy, early infantile, 49	617281	AR	3
614594	17p13.2	Olmsted syndrome	614594	AD	3
612637	3q26.2-q26.33	Febrile seizures, familial, 10	612637	_	2
618430	22q13.2	Developmental delay with variable intellectual impairment and behavioral abnormalities	618430	AD	3
616255	9p13.3	Short stature with nonspecific skeletal abnormalities	616255	AD	3
616606	Chr.14	Ring chromosome 14 syndrome	616606	IC	4
617662	20p11.21	Joint laxity, short stature, and myopia	617662	AR	3
617054	16q22.1-q22.2	Striatonigral degeneration, childhood-onset	617054	AR	3
617917	9q34.11	?Neurodegeneration with brain iron accumulation 8	617917	AR	3
616287	12q13.12	?Lethal congenital contracture syndrome 8	616287	AR	3
613824	17q11.2	?Nephronophthisis 9	613824	_	3
617439	15q22.31	{Craniosynostosis 7, susceptibility to}	617439	AD	3
612581	11q24.2	Mental retardation, autosomal dominant 4	612581	AD	2
616640	4q21.21	?Epilepsy, progressive myoclonic, 10	616640	AR	3
618302	19p13.13	Mental retardation, autosomal recessive 68	618302	AR	3
618431	22q13.2	Hydatidiform mole, recurrent, 3	618431	_	3
614595	4p12	Preeclampsia/eclampsia 5	614595	_	3
616544	8p11.2-p11.1	Retinitis pigmentosa 73	616544	AR	3
612638	19p13.3	Mitochondrial complex I deficiency, nuclear type 14	618236	AR	3
618113	11q12.2	Encephalitis/encephalopathy, mild, with reversible myelin vacuolization	618113	AD	3
617055	7p15.3	Cold-induced sweating syndrome 3	617055	AR	3
616451	1q42.13	?Spastic paraplegia 74, autosomal recessive	616451	AR	3
614782	16p11.2	Essential tremor, hereditary, 4	614782	AD	3
617663	12q21.31	Deafness, autosomal dominant 73	617663	AD	3
617631	7p22.3	?Polydactyly, postaxial, type A7	617642	AR	3
615905	17p13.1	Epileptic encephalopathy, early infantile, 25	615905	AR	3
617280	17q21.32	?Atrial fibrillation, familial, 18	617280	AD	3
618174	2p12	Cortical dysplasia, complex, with other brain malformations 9	618174	AR	3
612639	12q15	{Inflammatory bowel disease 26}	612639	_	2
613756	4p12	Retinitis pigmentosa 49	613756	_	3
617982	3p21.31	Ververi-Brady syndrome	617982	AD	3
617056	3q21.3	Hyperuricemic nephropathy, familial juvenile, 4	617056	AD	3
614783	3p21.2	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813	AR	3
613825	5p13.1	C9 deficiency	613825	_	3
617598	5p15.33	Mosaic variegated aneuploidy syndrome 3	617598	AR	3
618175	1q23.3	Warburg-Cinotti syndrome	618175	AD	3
616192	13q32.1	?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	616192	AR	3
618269	20q11.22	Hyper-IgE recurrent infection syndrome 3, autosomal recessive	618282	AR	3
617664	16p13.3	Combined oxidative phosphorylation deficiency 32	617664	AR	3
613850	20p13	[Inosine triphosphatase deficiency]	613850	_	3
618304	17q25.1	Spermatogenic failure 35	618341	AR	3
613826	14q11.2	Leber congenital amaurosis 6	613826	_	3
613757	19p13.3	?Macular degeneration, age-related, 6	613757	_	3
617441	6p21.33	?Thrombocytopenia, anemia, and myelofibrosis	617441	AR	3
616289	22q13.2	?Optic atrophy 9	616289	AR	3
612641	8p11.21	Spherocytosis, type 1	182900	AR,AD	3
617920	7p15.3	Amyloidosis, primary localized cutaneous, 3	617920	AR	3
613827	6p21.1	Retinitis pigmentosa 48	613827	_	3
617695	3q12.1-q12.2	Pontocerebellar hypoplasia, type 11	617695	AR	3
618176	17q25.1	Nephrotic syndrome, type 17	618176	AR	3
617633	19q13.31	?Spinocerebellar ataxia, autosomal recessive 26	617633	AR	3
612642	11p14.2-q12.3	Deafness, autosomal dominant 59	612642	AD	2
614784	12q21.33	Cone-rod dystrophy 20	615973	AR	3
616193	1q43	Mental retardation, autosomal recessive 47	616193	AR	3
618177	1q42.13	Nephrotic syndrome, type 18	618177	AR	3
613852	19p13.3	Fucosyltransferase 6 deficiency	613852	_	3
617442	6p21.33	?Premature ovarian failure 13	617442	AR	3
616291	1p36.11	?Lichtenstein-Knorr syndrome	616291	AR	3
617665	7q11.23	Epileptic encephalopathy, early infantile, 56	617665	AD	3
613828	6q16.3-q22.31	Epilepsy, generalized, with febrile seizures plus, type 8	613828	_	2
618307	4p14	{?Epidermodysplasia verruciformis, susceptibility to, 4}	618307	AR	3
617635	3q22.3	Mental retardation, autosomal dominant 47	617635	AD	3
614785	2q36.3	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	617086	AR	3
618178	11p11.2	?Nephrotic syndrome, type 19	618178	AR	3
613758	2q37.1	Retinitis pigmentosa 47	613758	_	3
616067	8q23.1	46XY sex reversal 9	616067	AD	3
617698	19q13.2	3-methylglutaconic aciduria, type IX	617698	AR	3
613854	19p13.11	Congenital heart defects, multiple types, 6	613854	AD	3
617599	21q22.13	?Epileptic encephalopathy, early infantile, 55	617599	AR	3
617666	13q13.3	Fraser syndrome 2	617666	AR	3
616645	20q13.12	Epileptic encephalopathy, early infantile, 34	616645	AR	3
618469	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1B	618469	AR	3
612643	13q12.11	Deafness, autosomal dominant 3B	612643	AD	3
618179	12q23.2	?Microcephaly 24, primary, autosomal recessive	618179	AR	3
613855	2q23.3	Episodic ataxia, type 5	613855	AD	3
613759	11q13.3	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations	613759	AR	3
618309	8q21.13	{?Epidermodysplasia verruciformis, susceptibility to, 5}	618309	AR	3
228520	1p21.1	Fibrochondrogenesis 1	228520	AR	3
617600	19q13.2	Mental retardation, autosomal dominant 45	617600	AD	3
616294	4q26	Cole-Carpenter syndrome 2	616294	AR	3
618470	7q22.1	Intellectual developmental disorder with severe speech and ambulation defects	618470	AD	3
613829	19q13.33	Leber congenital amaurosis 7	613829	_	3
613856	1p13.3	Achromatopsia 4	613856	_	3
616069	7p11.2	?Inflammatory skin and bowel disease, neonatal, 2	616069	AR	3
618310	19q13.33	?Diamond-Blackfan anemia 18	618310	AD	3
618180	21q22.3	Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis	618180	AR	3
612644	1p34.3	Deafness, autosomal dominant 2B	612644	AD	3
616295	5q15	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	616295	AR	3
228550	5q32	Myofibromatosis, infantile, 1	228550	AD	3
613830	15q22.31	Night blindness, congenital stationary (complete), 1D, autosomal recessive	613830	AR	3
613761	10q11.23	{Macular degeneration, age-related, susceptibility to, 5}	613761	_	3
618181	3q12.3	Intellectual developmental disorder, autosomal recessive 69	618383	AR	3
600754	14q11.2	?Winchester syndrome	277950	_	3
612645	13q12.11	Deafness, autosomal recessive 1B	612645	AR	3
617601	6q13	Mental retardation, autosomal dominant 46	617601	AD	3
613762	5q11.2	46XY sex reversal 6	613762	AD	3
617057	16q24.3	Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome	618142	AR	3
618182	17q23.3	Orthostatic hypotension 2	618182	AR	3
617602	9q34.12	Congenital heart defects and skeletal malformations syndrome	617602	AD	3
616617	6p21.1	Heimler syndrome 2	616617	AR	3
613763	11q23.1	Cataract 16, multiple types	613763	AR,AD	3
618183	19p13.11	Diarrhea 10, protein-losing enteropathy type	618183	AR	3
600755	3p25.2	{Schizophrenia, susceptibility to}	181500	AD	3
612647	6q22.1	Ciliary dyskinesia, primary, 11	612649	_	3
228600	4q21.21	Hyaline fibromatosis syndrome	228600	AR	3
618313	16p12.3	?Diamond-Blackfan anemia 20	618313	AD	3
618184	1q23.3	Hypomyelinating neuropathy, congenital, 2	618184	AD	3
616298	9p21.1	Singleton-Merten syndrome 2	616298	AD	3
612648	6p21.1	Ciliary dyskinesia, primary, 12	612650	_	3
617604	21q22.11	Microcephaly, short stature, and limb abnormalities	617604	AR	3
613765	2q31.2	Cardiomyopathy, familial hypertrophic, 9	613765	AD	3
618185	1q42.13	Periventricular nodular heterotopia 8	618185	AD	3
617706	16p13.3	?Spermatogenic failure 22	617706	AR	3
618475	14q24.3	Paragangliomas 7	618475	AD	3
616299	2q11.2	Lipoyltransferase 1 deficiency	616299	AR	3
617605	15q21.2	?Deafness, autosomal dominant 71	617605	AD	3
612649	6q22.1	Ciliary dyskinesia, primary, 11	612649	_	3
131300	19q13.2	Camurati-Engelmann disease	131300	AD	3
312612	Xp21.3-p21.2	?Retinitis pigmentosa, X-linked recessive, 6	312612	XL	2
618476	5q32	Brain abnormalities, neurodegeneration, and dysosteosclerosis	618476	AR	3
612650	6p21.1	Ciliary dyskinesia, primary, 12	612650	_	3
312700	Xp22.13	Retinoschisis	312700	XLR	3
617606	6p21.33	?Deafness, autosomal dominant 72	617606	AD	3
242900	2q35	Schimke immunoosseous dysplasia	242900	AR	3
616300	5q23.2	Short-rib thoracic dysplasia 13 with or without polydactyly	616300	AR	3
618477	15q25.3	[Uridine-cytidineuria]	618477	AR	3
613767	16q21	Retinitis pigmentosa 45	613767	AR	3
105210	18q12.1	Amyloidosis, hereditary, transthyretin-related	105210	AD	3
131320	10p14	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	AD	3
617061	5p15.2	Mental retardation, autosomal dominant 44	617061	AD	3
613768	17q25.3	{Moyamoya disease 2, susceptibility to}	607151	_	3
617062	20p13	Okur-Chung neurodevelopmental syndrome	617062	AD	3
617707	17q22	?Spermatogenic failure 23	617707	AR	3
613769	10q23.1	Retinitis pigmentosa 44	613769	_	3
243060	19q13.43	Spermatogenic failure 5	243060	AR	3
617607	4q13.3	?Amelogenesis imperfecta, type IIIB	617607	AD	3
105250	5p13.1	Amyloidosis, primary localized cutaneous, 1	105250	AD	3
131340	20p13	Spinocerebellar ataxia 23	610245	AD	3
617063	22q11.21	Meier-Gorlin syndrome 7	617063	AR	3
617064	4p12	?Epileptic encephalopathy, early infantile, 40	617065	AR	3
616078	18q12.3	Mental retardation, autosomal dominant 29	616078	AD	3
616079	13q14.2	?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities	616079	AD	3
131370	17p13.2	?Glycogen storage disease XIII	612932	AR	3
617608	15q25.3	Cardiomyopathy, familial hypertrophic 27	618052	AR	3
617709	1p13.3	?Neurodevelopmental disorder with microcephaly, ataxia, and seizures	617709	AR	3
616304	11p11.2	?Myasthenic syndrome, congenital, 17	616304	AR	3
617710	1p12	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	617710	AR	3
617609	7q21.11	Nephrotic syndrome, type 15	617609	AR	3
617065	4p12	?Epileptic encephalopathy, early infantile, 40	617065	AR	3
616080	7q21.2	?Microcephaly 12, primary, autosomal recessive	616080	AR	3
616305	10p13	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia	616819	AR	3
616081	13q13.3	Pontocerebellar hypoplasia, type 1C	616081	AR	3
617066	15q22.31	?Muscular dystrophy, congenital, Davignon-Chauveau type	617066	AR	3
603448	1p32.2	Spinocerebellar ataxia 37	615945	AD	3
618479	13q13.3	Cerebellar, ocular, craniofacial, and genital syndrome	618479	AR	3
151430	18q21.33	Leukemia/lymphoma, B-cell, 2	_	_	3
151440	19p13.13	Leukemia, T-cell acute lymphoblastoid	151440	_	2
616307	4p14	Senior-Loken syndrome 8	616307	AR	3
618480	19p13.13	Neurodevelopmental disorder with seizures and speech and walking impairment	618480	_	3
618481	17q12	?Deafness, autosomal recessive 99	618481	_	3
617068	2p13.1	Portal hypertension, noncirrhotic	617068	AR	3
618482	5p12	Generalized epilepsy with febrile seizures plus, type 10	618482	_	3
617069	16q21	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	617069	AR	3
603453	6p25.2	Immunodeficiency 57	618108	AR	3
617070	2p13.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	617070	AR	3
603454	12q22	Mental retardation, autosomal recessive 34, with variant lissencephaly	614499	AR	3
243150	2p21	Gastrointestinal defects and immunodeficiency syndrome	243150	AR	3
617072	1q25.2	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures	617072	AR	3
617073	12q13.12	Tooth agenesis, selective, 8	617073	AD	3
603457	18p11.32	Bosma arhinia microphthalmia syndrome	603457	AD	3
608000	4q31.1	Mental retardation, autosomal dominant 50	617787	AD	3
617075	3p21.31	{Nasopharyngeal carcinoma, susceptibility to, 3}	617075	AD	3
616311	7q36.2	Mental retardation, autosomal dominant 33	616311	_	3
616312	6p21.31	Cataract 46, juvenile-onset	212500	AR	3
603464	16q24.3	Al Kaissi syndrome	617694	AR	3
608002	3q22.1	Meckel syndrome 7	267010	AR	3
608002	3q22.1	Nephronophthisis 3	604387	AR	3
608002	3q22.1	Renal-hepatic-pancreatic dysplasia 1	208540	AR	3
105500	15q21.2	{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	AD	3
603465	22q11.21	Meier-Gorlin syndrome 7	617063	AR	3
605998	1q21.3	Neutropenia, severe congenital 3, autosomal recessive	610738	AR	3
105550	9p21.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	105550	AD	3
603552	6q24.2	Hemophagocytic lymphohistiocytosis, familial, 4	603552	AR	3
105580	11q22-qter	?Anal canal carcinoma	105580	AD	2
105590	2p23.2-p23.1	{Neuroblastoma, susceptibility to, 3}	613014	_	3
105600	15q21	Dyserythropoietic anemia, congenital, type III	105600	AD	2
608005	5q31.2	Marinesco-Sjogren syndrome	248800	AR	3
603553	10q22.1	Hemophagocytic lymphohistiocytosis, familial, 2	603553	AR	3
608010	7p13	[Ezetimibe, nonresponse to]	617966	_	3
608010	7p13	[Low density lipoprotein cholesterol level QTL 7]	617966	_	3
613435	10p13	Amyotrophic lateral sclerosis 12	613435	_	3
613436	11q13.3-q13.4	{Autism susceptibility 17}	613436	_	3
115210	19q13.42	Cardiomyopathy, familial restrictive, 1	115210	AD	3
300660	Xq25-q27	Leukoencephalopathy with metaphyseal chondrodysplasia	300660	XLR	2
147569	21q22.11	Immunodeficiency 28, mycobacteriosis	614889	AR	3
150800	1q43	Leiomyomatosis and renal cell cancer	150800	AD	3
192340	20p13	Diabetes insipidus, neurohypophyseal	125700	AD	3
172430	1p36.23	Enolase deficiency	_	_	1
176894	10q11.2-q21.1	Aortic aneurysm, familial thoracic 8	615436	AD	3
113200	2q31.1	Brachydactyly, type D	113200	AD	3
147720	2q14.1	{Gastric cancer risk after H. pylori infection}	137215	AD	3
223900	9q31.3	Dysautonomia, familial	223900	AR	3
300255	Xq13.1	Mental retardation, X-linked 106	300997	XLR	3
188740	7q36.3	Hypoplastic or aplastic tibia with polydactyly	188740	AD	3
233100	16p11.2	Renal glucosuria	233100	AR,AD	3
188070	19p13.3	{Bleeding disorder, platelet-type, 13, susceptibility to}	614009	AD	3
142250	11p15.4	Cyanosis, transient neonatal	613977	AD	3
142250	11p15.4	Fetal hemoglobin quantitative trait locus 1	141749	AD	3
300108	Xq21.33	?Premature ovarian failure 2A	300511	XLD	3
208050	20q13.12	Arterial tortuosity syndrome	208050	AR	3
180721	11q12.3	Retinitis pigmentosa 7, digenic form	608133	AR,AD	3
236270	5p15.31	Homocystinuria-megaloblastic anemia, cbl E type	236270	AR	3
170993	8q21.13	Peroxisome biogenesis disorder 5A (Zellweger)	614866	AR	3
170993	8q21.13	Peroxisome biogenesis disorder 5B	614867	AR	3
166200	17q21.33	Osteogenesis imperfecta, type I	166200	AD	3
251270	22q13.33	Microcephaly and chorioretinopathy, autosomal recessive, 1	251270	AR	3
300842	Xp21.1	McLeod syndrome with or without chronic granulomatous disease	300842	XL	3
162332	4q24	Hypogonadotropic hypogonadism 11 with or without anosmia	614840	AR	3
300964	Xq12	Wilson-Turner syndrome	309585	XLR	3
119100	1q42.2-q43	Split-hand/foot malformation with long bone deficiency 1	119100	AD	2
123890	2q33.2	Autoimmune lymphoproliferative syndrome, type V	616100	AD	3
123890	2q33.2	{Celiac disease, susceptibility to, 3}	609755	_	3
123890	2q33.2	{Diabetes mellitus, insulin-dependent, 12}	601388	_	3
123890	2q33.2	{Hashimoto thyroiditis}	140300	AD	3
123890	2q33.2	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
222470	5q15	Trichohepatoenteric syndrome 1	222470	AR	3
252650	19p13.2	Mucolipidosis IV	252650	AR	3
179616	11p12	Combined cellular and humoral immune defects with granulomas	233650	AR	3
179616	11p12	Omenn syndrome	603554	AR	3
179616	11p12	Severe combined immunodeficiency, B cell-negative	601457	AR	3
300390	Xq21.2	Choroideremia	303100	XLD	3
194355	22q12.1	{Major affective disorder-7, susceptibility to}	612371	_	3
179035	17q25.3	Cutis laxa, autosomal recessive, type IIB	612940	AR	3
179035	17q25.3	Cutis laxa, autosomal recessive, type IIIB	614438	_	3
159460	19q13.12	Spastic paraplegia 75, autosomal recessive	616680	AR	3
148760	10q23.33	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	AD	3
127550	3q26.2	Dyskeratosis congenita, autosomal dominant 1	127550	AD	3
270970	1q23.1	Spherocytosis, type 3	270970	AR	3
108721	3p14.3	Atelosteogenesis, type III	108721	AD	3
142830	6p21.33	{Abacavir hypersensitivity, susceptibility to}	_	_	3
142830	6p21.33	{Drug-induced liver injury due to flucloxacillin}	_	_	3
142830	6p21.33	{Spondyloarthropathy, susceptibility to, 1}	106300	Mu	3
142830	6p21.33	{Stevens-Johnson syndrome, susceptibility to}	608579	_	3
142830	6p21.33	{Synovitis, chronic, susceptibility to}	_	_	3
142830	6p21.33	{Toxic epidermal necrolysis, susceptibility to}	608579	_	3
152390	10q11.21	{Asthma, diminished response to antileukotriene treatment in}	600807	AD	3
152390	10q11.21	{Atherosclerosis, susceptibility to}	_	_	3
167320	9p13.3	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	AD	3
229700	9q22.32	Fructose-1,6-bisphosphatase deficiency	229700	AR	3
134790	19q13.33	Hyperferritinemia-cataract syndrome	600886	AD	3
134790	19q13.33	L-ferritin deficiency, dominant and recessive	615604	AR,AD	3
134790	19q13.33	Neurodegeneration with brain iron accumulation 3	606159	AD	3
111750	1p34.2	[Blood group, Scianna system]	111750	_	3
206500	5q22.3	?Anencephaly	206500	AR	3
107323	5q23.2	Epilepsy, pyridoxine-dependent	266100	AR	3
116790	22q11.21	{Panic disorder, susceptibility to}	167870	?AD	3
116790	22q11.21	{Schizophrenia, susceptibility to}	181500	AD	3
300600	Xp11.23	Aland Island eye disease	300600	XL	3
231095	7q34	Ghosal hematodiaphyseal syndrome	231095	AR	3
191100	9q34.13	Tuberous sclerosis-1	191100	AD	3
122720	19q13.2	Coumarin resistance	122700	AD	3
122720	19q13.2	{Lung cancer, resistance to}	211980	SMu,AD	3
122720	19q13.2	{Nicotine addiction, protection from}	188890	_	3
126380	19q13.32	Cerebrooculofacioskeletal syndrome 4	610758	AR	3
300210	Xp11.4	Mental retardation, X-linked 58	300210	XLR	3
300429	Xq11.1	Epileptic encephalopathy, early infantile, 8	300607	XLR	3
202650	1q24.2	Agnathia-otocephaly complex	202650	AR,AD	3
113300	2q31.1	Brachydactyly, type E	113300	AD	3
102630	7p22.1	?Dystonia, juvenile-onset	607371	AD	3
102630	7p22.1	Baraitser-Winter syndrome 1	243310	AD	3
246450	1p36.11	HMG-CoA lyase deficiency	246450	AR	3
300843	Xq28	Bornholm eye disease	300843	XLR	2
300013	Xq28	?Microphthalmia, syndromic 1	309800	XL	3
300013	Xq28	Ogden syndrome	300855	XLR,XLD	3
266900	2q13	Senior-Loken syndrome-1	266900	AR	3
184757	9q33.3	46, XX sex reversal 4	617480	AD	3
184757	9q33.3	46XY sex reversal 3	612965	AD	3
184757	9q33.3	Adrenocortical insufficiency	612964	AD	3
184757	9q33.3	Premature ovarian failure 7	612964	AD	3
184757	9q33.3	Spermatogenic failure 8	613957	AD	3
182900	8p11.21	Spherocytosis, type 1	182900	AR,AD	3
300998	Xq28	Mental retardation, X-linked, syndromic, 35	300998	XLR	3
133170	7q22.1	?Diamond-Blackfan anemia-like	617911	AR	3
133170	7q22.1	Erythrocytosis, familial, 5	617907	AD	3
133170	7q22.1	{Microvascular complications of diabetes 2}	612623	_	3
180500	4q25	Axenfeld-Rieger syndrome, type 1	180500	AD	3
159465	6p22.1	?Narcolepsy 7	614250	AD	3
180385	11p13	Leukemia, acute T-cell	180385	_	2
194360	19q13.31	?Spinocerebellar ataxia, autosomal recessive 26	617633	AR	3
125490	4q22.1	Dentinogenesis imperfecta, Shields type II	125490	AD	3
100650	12q24.12	Alcohol sensitivity, acute	610251	AD	3
100650	12q24.12	{Esophageal cancer, alcohol-related, susceptibility to}	_	_	3
100650	12q24.12	{Hangover, susceptibility to}	610251	AD	3
100650	12q24.12	{Sublingual nitroglycerin, susceptibility to poor response to}	_	_	3
313440	Xp11.3-p11.2	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	300491	XLR,XLD	3
213980	1q24.1	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	213980	AR	3
167400	2q24.3	Paroxysmal extreme pain disorder	167400	AD	3
180073	17q25.3	Retinitis pigmentosa 57	613582	AR	3
212065	16p13.2	Congenital disorder of glycosylation, type Ia	212065	AR	3
179617	15q15.1	?Fanconi anemia, complementation group R	617244	AD	3
179617	15q15.1	Mirror movements 2	614508	AD	3
179617	15q15.1	{Breast cancer, susceptibility to}	114480	SMu,AD	3
300211	Xp22.3	Episodic muscle weakness, X-linked	300211	_	2
109150	14q32.12	Machado-Joseph disease	109150	AD	3
138130	10q23.2	Hyperinsulinism-hyperammonemia syndrome	606762	AD	3
190900	7q32.1	Colorblindness, tritan	190900	AD	3
264300	9q22.32	Pseudohermaphroditism, male, with gynecomastia	264300	AR	3
119300	1q32.2	van der Woude syndrome	119300	AD	3
135940	1q21.3	Ichthyosis vulgaris	146700	AD	3
135940	1q21.3	{Dermatitis, atopic, susceptibility to, 2}	605803	_	3
300494	Xq13.1	{Asperger syndrome susceptibility, X-linked 1}	300494	IC,XL,Mu	3
120550	1p36.12	C1q deficiency	613652	AR	3
108725	19p13.3-p13.2	{Atherosclerosis, susceptibility to}	108725	AD	2
103600	4q13.3	Analbuminemia	616000	_	3
103600	4q13.3	[Dysalbuminemic hyperthyroxinemia]	615999	_	3
300848	Xp11.3	Mental retardation, X-linked 89	300848	XLD	2
311200	Xp22.2	Orofaciodigital syndrome I	311200	XLD	3
254110	9q33.1	Muscular dystrophy, limb-girdle, autosomal recessive 8	254110	AR	3
300046	Xq23-q24	Mental retardation, X-linked 23	300046	XL	2
142840	6p21.33	{HIV-1 viremia, susceptibility to}	609423	_	3
142840	6p21.33	{Psoriasis susceptibility 1}	177900	Mu	3
309510	Xp21.3	Partington syndrome	309510	XLR	3
170995	1p21.3	?Bile acid synthesis defect, congenital, 5	616278	AR	3
233300	2p16.3	Ovarian dysgenesis 1	233300	AR	3
145505	16p12.3	{?Hypertension, essential}	_	_	1
300179	Xq25-q26	X inactivation, familial skewed, 2	300179	_	2
164780	1p36.33-p36.32	Shprintzen-Goldberg syndrome	182212	AD	3
114580	2p22.3-p21	Candidiasis, familial, 1, autosomal dominant	114580	AD	2
300814	Xp22.2	Nystagmus 6, congenital, X-linked	300814	_	3
600110	6q14.1	Stargardt disease 3	600110	AD	3
157700	16p12.1-p11.2	Mitral valve prolapse, myxomatous 1	157700	AD	2
215700	9q34.11	Citrullinemia	215700	AR	3
182920	5q31.2	Myopathy, spheroid body	182920	AD	3
193200	6p21.3	{Vitiligo-associated multiple autoimmune disease susceptibility 6}	193200	AR	2
304150	Xq21.1	Occipital horn syndrome	304150	XLR	3
156845	3p13	COMMAD syndrome	617306	AR	3
156845	3p13	Tietz albinism-deafness syndrome	103500	AD	3
156845	3p13	Waardenburg syndrome, type 2A	193510	AD	3
156845	3p13	Waardenburg syndrome/ocular albinism, digenic	103470	AD	3
156845	3p13	{Melanoma, cutaneous malignant, susceptibility to, 8}	614456	_	3
161900	1q21	Nephropathy-hypertension	161900	AD	2
201000	6p12.1-p11.2	Carpenter syndrome	201000	AR	3
600244	2q37.3	{Multiple sclerosis, disease progression, modifier of}	126200	Mu	3
600244	2q37.3	{Systemic lupus erythematosus, susceptibility to, 2}	605218	_	3
182410	22q11.1	?Sneddon syndrome	182410	AR	3
600079	7q11.23	Colon cancer, somatic	114500	_	3
119500	1q32.2	Popliteal pterygium syndrome 1	119500	AD	3
250460	9p13.3	Metaphyseal dysplasia without hypotrichosis	250460	AR	3
300849	Xq28	Mental retardation, X-linked 41	300849	XLD	3
300180	Xp22.33	Chondrodysplasia punctata, X-linked recessive	302950	XLR	3
150230	8q24.11-q24.13	Trichorhinophalangeal syndrome, type II	150230	AD	4
178110	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1A	178110	AD	3
127600	4q35	Dyskeratosis, hereditary benign intraepithelial	127600	AD	2
181270	18q11.2	Scalp-ear-nipple syndrome	181270	AD	3
600111	5p13.2	Episodic ataxia, type 6	612656	AD	3
214100	7q21.2	Peroxisome biogenesis disorder 1A (Zellweger)	214100	AR	3
600144	12p11.23	?Anhidrosis, isolated, with normal sweat glands	106190	AR	3
151600	3p22.2	Nail disorder, nonsyndromic congenital, 3, (leukonychia)	151600	AR,AD	3
168000	11q23.1	Paragangliomas 1, with or without deafness	168000	AD	3
137290	1p32.1	Corneal dystrophy, gelatinous drop-like	204870	AR	3
300047	Xp11-q21	Mental retardation, X-linked 20	300047	XL	2
212066	14q21.3	Congenital disorder of glycosylation, type IIa	212066	AR	3
269840	2q11.2	Immunodeficiency 48	269840	AR	3
161950	6q22-q23	{IgA nephropathy, susceptibility to, 1}	161950	?AD	2
191110	2q35	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	616208	AD	3
300075	Xp22.12	Coffin-Lowry syndrome	303600	XLD	3
300075	Xp22.12	Mental retardation, X-linked 19	300844	XLD	3
190160	3p24.2	Thyroid hormone resistance	188570	AD	3
190160	3p24.2	Thyroid hormone resistance, autosomal recessive	274300	AR	3
190160	3p24.2	Thyroid hormone resistance, selective pituitary	145650	AD	3
300391	Xp22.2	Amelogenesis imperfecta, type 1E	301200	XLD	3
600673	17q21.31	Neurodegeneration, childhood-onset, with brain atrophy	617672	AD	3
107400	14q32.13	Emphysema due to AAT deficiency	613490	AR	3
107400	14q32.13	Emphysema-cirrhosis, due to AAT deficiency	613490	AR	3
107400	14q32.13	Hemorrhagic diathesis due to antithrombin Pittsburgh	613490	AR	3
107400	14q32.13	{Pulmonary disease, chronic obstructive, susceptibility to}	606963	_	1
225750	3p21.31	Aicardi-Goutieres syndrome 1, dominant and recessive	225750	AR,AD	3
156850	16p13.3	Microphthalmia with cataract 1	156850	AD	2
157800	6q15	Cardiospondylocarpofacial syndrome	157800	AD	3
192430	22q11.21	Velocardiofacial syndrome	192430	AD	3
134797	15q21.1	Acromicric dysplasia	102370	AD	3
134797	15q21.1	Ectopia lentis, familial	129600	AD	3
134797	15q21.1	Geleophysic dysplasia 2	614185	AD	3
134797	15q21.1	Marfan lipodystrophy syndrome	616914	AD	3
134797	15q21.1	Marfan syndrome	154700	AD	3
134797	15q21.1	MASS syndrome	604308	_	3
134797	15q21.1	Stiff skin syndrome	184900	AD	3
134797	15q21.1	Weill-Marchesani syndrome 2, dominant	608328	AD	3
300496	Xq28	{Autism susceptibility, X-linked 3}	300496	XL	3
300110	Xp11.23	Aland Island eye disease	300600	XL	3
300110	Xp11.23	Cone-rod dystrophy, X-linked, 3	300476	XLR	3
300110	Xp11.23	Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	XL	3
600924	16p13.3	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay	613076	_	3
180090	15q26.1	Bothnia retinal dystrophy	607475	AR	3
180090	15q26.1	Fundus albipunctatus	136880	AR,AD	3
180090	15q26.1	Newfoundland rod-cone dystrophy	607476	_	3
180090	15q26.1	Retinitis punctata albescens	136880	AR,AD	3
150240	7q31.1	Lissencephaly 5	615191	AR	3
600969	20q13.33	Epiphyseal dysplasia, multiple, 3, with or without myopathy	600969	AD	3
600016	12q12	?Myopathy, congenital, Compton-North	612540	AR	3
153245	4q25	Sebaceous tumors, somatic	_	_	3
162350	20q13.33	Ceroid lipofuscinosis, neuronal, 4, Parry type	162350	AD	3
600342	10q23.1	Retinitis pigmentosa 44	613769	_	3
167409	10q24.31	Glomerulosclerosis, focal segmental, 7	616002	AD	3
167409	10q24.31	Papillorenal syndrome	120330	AD	3
214110	12p13.31	Peroxisome biogenesis disorder 2A (Zellweger)	214110	AR	3
300850	Xq13.1	Mental retardation, X-linked 90	300850	XLR	3
163000	9q21.2	Capillary malformations, congenital, 1, somatic, mosaic	163000	_	3
307030	Xp21.2	Glycerol kinase deficiency	307030	XLR	3
172471	16p11.2	Cirrhosis due to liver phosphorylase kinase deficiency	_	_	3
172471	16p11.2	Glycogen storage disease IXc	613027	AR	3
257850	6q22.31	Oculodentodigital dysplasia, autosomal recessive	257850	AR	3
300497	Xp22.32-p22.31	{Asperger syndrome susceptibility, X-linked 2}	300497	XL	3
300076	Xq26-qter	Woods-Black-Norbury syndrome	300076	XLD	2
601202	17p13	Cataract 24, anterior polar	601202	AD	2
231300	2p22.2	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	AR	3
185605	12q21.2	Baker-Gordon syndrome	618218	AD	3
600145	1p13.1	Caudal regression syndrome	600145	AD	3
278250	12q24.31	Wrinkly skin syndrome	278250	AR	3
140600	2p24.1	{Osteoarthritis susceptibility 2}	140600	AD	3
119530	6p24.3	Orofacial cleft-1	119530	AD	2
600112	14q32.31	Charcot-Marie-Tooth disease, axonal, type 20	614228	AD	3
600112	14q32.31	Mental retardation, autosomal dominant 13	614563	AD	3
600112	14q32.31	Spinal muscular atrophy, lower extremity-predominant 1, AD	158600	AD	3
601103	12p13.31	Aortic aneurysm, familial thoracic 9	616166	AD	3
151050	8q22.1	Lenz-Majewski hyperostotic dwarfism	151050	AD	3
300703	Xq25-q27.1	Spinocerebellar ataxia, X-linked 5	300703	XLR	2
225753	17q25.1	Pontocerebellar hypoplasia type 4	225753	AR	3
162000	16p12.3	Hyperuricemic nephropathy, familial juvenile 1	162000	AD	3
180750	7p21.1	Robinow-Sorauf syndrome	180750	AD	3
137350	9q33.2	Amyloidosis, Finnish type	105120	AD	3
134820	4q31.3	Afibrinogenemia, congenital	202400	AR	3
134820	4q31.3	Amyloidosis, familial visceral	105200	AD	3
134820	4q31.3	Dysfibrinogenemia, congenital	616004	_	3
134820	4q31.3	Hypodysfibrinogenemia, congenital	616004	_	3
311250	Xp11.4	Ornithine transcarbamylase deficiency	311250	XLR	3
167410	1p36.13	Rhabdomyosarcoma 2, alveolar	268220	SMu	3
601068	8q24.11-q24.12	Epilepsy, familial adult myoclonic, 1	601068	AD	3
179060	3p14.3	Pyruvate dehydrogenase E1-beta deficiency	614111	_	3
601369	14q12	Deafness, autosomal dominant 9	601369	AD	3
601527	12q21.31	?Frontonasal dysplasia 3	613456	_	3
150250	3p14.3	Larsen syndrome	150250	AD	3
300851	Xp11.3	Mental retardation, X-linked 92	300851	XLR	2
192605	3p21.31	Ventricular tachycardia, idiopathic	192605	AD	3
601664	2q11.2	Retinitis pigmentosa 33	610359	AD	3
601592	11p11.2	Fetal akinesia deformation sequence 2	618388	_	3
601592	11p11.2	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	616326	AR	3
600211	6p21.1	Cleidocranial dysplasia	119600	AD	3
600211	6p21.1	Cleidocranial dysplasia, forme fruste, dental anomalies only	119600	AD	3
600211	6p21.1	Cleidocranial dysplasia, forme fruste, with brachydactyly	119600	AD	3
600211	6p21.1	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	AD	3
600925	11p11.2	Colon cancer, somatic	114500	_	3
300392	Xp11.23	Neutropenia, severe congenital, X-linked	300299	XLR	3
300392	Xp11.23	Thrombocytopenia, X-linked	313900	XLR	3
300392	Xp11.23	Thrombocytopenia, X-linked, intermittent	313900	XLR	3
300392	Xp11.23	Wiskott-Aldrich syndrome	301000	XLR	3
123825	4p12	Retinitis pigmentosa 49	613756	_	3
202700	19p13.3	Neutropenia, severe congenital 1, autosomal dominant	202700	AD	3
217300	12q21.33	Cornea plana 2, autosomal recessive	217300	AR	3
172480	7p11.2	Phosphoserine phosphatase deficiency	614023	AR	3
601243	17p11.2	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5	618098	AR	3
601243	17p11.2	Microcephaly, growth restriction, and increased sister chromatid exchange 2	618097	AR	3
300256	Xp11.22	HSD10 mitochondrial disease	300438	XLD	3
601887	1q32.1	{Malignant hyperthermia susceptibility 5}	601887	AD	3
602368	4q22.1-q22.2	Spinocerebellar ataxia, autosomal recessive 18	616204	AR	3
601528	4q34.3	Lymphatic malformation 4	615907	AD	3
602397	18q21.31	Cholestasis, benign recurrent intrahepatic	243300	AR	3
602397	18q21.31	Cholestasis, intrahepatic, of pregnancy, 1	147480	AD	3
602397	18q21.31	Cholestasis, progressive familial intrahepatic 1	211600	AR	3
300852	Xq24	Mental retardation, X-linked 88	300852	XL	2
191130	6p21.33	Cortical dysplasia, complex, with other brain malformations 6	615771	AD	3
191130	6p21.33	Symmetric circumferential skin creases, congenital, 1	156610	AD	3
601692	5q31.1	Corneal dystrophy, Avellino type	607541	AD	3
601692	5q31.1	Corneal dystrophy, epithelial basement membrane	121820	AD	3
601692	5q31.1	Corneal dystrophy, Groenouw type I	121900	AD	3
601692	5q31.1	Corneal dystrophy, lattice type I	122200	AD	3
601692	5q31.1	Corneal dystrophy, lattice type IIIA	608471	AD	3
601692	5q31.1	Corneal dystrophy, Reis-Bucklers type	608470	_	3
601692	5q31.1	Corneal dystrophy, Thiel-Behnke type	602082	AD	3
100678	6q25.3	?ACAT2 deficiency	614055	IC	1
601404	14q32.11	Amelogenesis imperfecta, hypomaturation type, IIA6	617217	AR	3
108730	16p11.2	Brody myopathy	601003	AR	3
163500	4p16.3	Night blindness, congenital stationary, autosomal dominant 2	163500	AD	3
601104	17q21.31	Supranuclear palsy, progressive	601104	AD	3
151100	12q24.13	LEOPARD syndrome 1	151100	AD	3
601336	2p13.1	Congenital disorder of glycosylation, type IIb	606056	AR	3
300393	Xq26.3	Pituitary adenoma 2, GH-secreting	300943	XL	3
167411	20p11.22	?Otofaciocervical syndrome 2	615560	AR	3
600147	17q21.31	Klippel-Feil syndrome 2	214300	AR	3
601693	11q13.4	{Obesity, susceptibility to, BMIQ4}	607447	_	3
134830	4q31.3	Afibrinogenemia, congenital	202400	AR	3
134830	4q31.3	Dysfibrinogenemia, congenital	616004	_	3
134830	4q31.3	Hypofibrinogenemia, congenital	202400	AR	3
601791	1p36.22	Peroxisome biogenesis disorder 13A (Zellweger)	614887	AR	3
300257	Xq24	Danon disease	300257	XLD	3
600480	15q21.3	Craniosynostosis 3	615314	AD	3
257920	3q27.3	3MC syndrome 1	257920	AR	3
602235	20q13.33	Epileptic encephalopathy, early infantile, 7	613720	AD	3
602235	20q13.33	Myokymia	121200	AD	3
602235	20q13.33	Seizures, benign neonatal, 1	121200	AD	3
602938	9q31.1	Hypercholanemia, familial	607748	AR	3
191135	17q21.2	Cortical dysplasia, complex, with other brain malformations 4	615412	AD	3
601855	19q13.2	?Immunodeficiency 62	618459	AR	3
601920	20p12.2	?Deafness, congenital heart defects, and posterior embryotoxon	617992	_	3
601920	20p12.2	Alagille syndrome 1	118450	AD	3
601920	20p12.2	Tetralogy of Fallot	187500	AD	3
151200	8q22.1	Leri pleonosteosis chromosome duplication syndrome	151200	AD	4
602851	5q14.3	?Febrile seizures, familial, 4	604352	AD	3
602851	5q14.3	Usher syndrome, type 2C	605472	AR	3
602851	5q14.3	Usher syndrome, type 2C, GPR98/PDZD7 digenic	605472	AR	3
184840	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal dominant	184840	AD	3
602398	1p32.3	Desmosterolosis	602398	AR	3
602302	8p21.3	Alopecia universalis	203655	AR	3
602302	8p21.3	Atrichia with papular lesions	209500	AR	3
602302	8p21.3	Hypotrichosis 4	146550	AD	3
600450	10p15.1	46XY sex reversal 8	614279	AR	3
300394	Xq28	Barth syndrome	302060	XLR	3
301000	Xp11.23	Wiskott-Aldrich syndrome	301000	XLR	3
193400	12p13.31	von Willebrand disease, type 1	193400	AD	3
601694	2p21	[Leptin serum levels QTL1]	601694	_	2
603539	11q13.2	Ceroid lipofuscinosis, neuronal, 13, Kufs type	615362	AR	3
603805	15q15.2	Peeling skin syndrome 2	609796	AR	3
601530	5q35.3	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	616437	AD	3
601530	5q35.3	Myopathy, distal, with rimmed vacuoles	617158	AD	3
601530	5q35.3	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	617145	AR	3
601530	5q35.3	Paget disease of bone 3	167250	AD	3
601205	14q23.1	Branchiootic syndrome 3	608389	AD	3
601205	14q23.1	Deafness, autosomal dominant 23	605192	AD	3
604539	5q35.3	Ehlers-Danlos syndrome, dermatosparaxis type	225410	AR	3
601309	9q22.32	Basal cell carcinoma, somatic	605462	_	3
601309	9q22.32	Basal cell nevus syndrome	109400	AD	3
601309	9q22.32	Holoprosencephaly 7	610828	AD	3
151210	12q13.11	Platyspondylic skeletal dysplasia, Torrance type	151210	AD	3
171833	5q13.1	?Agammaglobulinemia 7, autosomal recessive	615214	AR	3
171833	5q13.1	Immunodeficiency 36	616005	AD	3
171833	5q13.1	SHORT syndrome	269880	AD	3
600576	8p23.1	?Testicular anomalies with or without congenital heart disease	615542	AD	3
600576	8p23.1	Atrial septal defect 2	607941	AD	3
600576	8p23.1	Atrioventricular septal defect 4	614430	AD	3
600576	8p23.1	Tetralogy of Fallot	187500	AD	3
600576	8p23.1	Ventricular septal defect 1	614429	AD	3
172490	16q12.1	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	261750	AR	3
134850	4q32.1	Afibrinogenemia, congenital	202400	AR	3
134850	4q32.1	Dysfibrinogenemia, congenital	616004	_	3
134850	4q32.1	Hypodysfibrinogenemia	616004	_	3
134850	4q32.1	Hypofibrinogenemia, congenital	202400	AR	3
601888	5p	{Malignant hyperthermia susceptibility 6}	601888	_	2
603107	22q13.2	Developmental delay with variable intellectual impairment and behavioral abnormalities	618430	AD	3
146550	8p21.3	Hypotrichosis 4	146550	AD	3
185620	9q34.2	Charcot-Marie-Tooth disease, type 4K	616684	AR	3
185620	9q34.2	Leigh syndrome, due to COX IV deficiency	256000	Mi,AR	3
603937	8q11.2-q12.1	Retinitis pigmentosa 1	180100	AR,AD	3
604065	17q21.33	Spinocerebellar ataxia 42	616795	AD	3
604065	17q21.33	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	618087	AD	3
603332	3p21.1	?Ciliary dyskinesia, primary, 37	617577	AR	3
603332	3p21.1	Spermatogenic failure 18	617576	AR	3
604895	17q21.32	Asthma and nasal polyps	208550	AR	3
604895	17q21.32	{Asthma, aspirin-induced, susceptibility to}	208550	AR	3
600451	10p15.1	{46XY sex reversal 8, modifier of}	614279	AR	3
150270	6p21.3-p21.2	?Laryngeal adductor paralysis	150270	AD	2
603175	6q13-q26	{Schizophrenia}	181500	AD	2
133171	19p13.2	[Erythrocytosis, familial, 1]	133100	AD	3
604001	7q21.2	?Long QT syndrome-11	611820	AD	3
605309	10q23.31	Macrocephaly/autism syndrome	605309	AD	3
605021	16p13.3	Myoclonic epilepsy, infantile, familial	605021	AR	3
604352	5q14.3	?Febrile seizures, familial, 4	604352	AD	3
227810	3q26.2	Fanconi-Bickel syndrome	227810	AR	3
604123	2p25.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	616479	AR	3
604190	5q31.1	{Rheumatoid arthritis, susceptibility to}	180300	_	3
604766	1q25.2	Nephrotic syndrome, type 2	600995	AR	3
171834	3q26.32	Breast cancer, somatic	114480	_	3
171834	3q26.32	CLAPO syndrome, somatic	613089	_	3
171834	3q26.32	CLOVE syndrome, somatic	612918	_	3
171834	3q26.32	Colorectal cancer, somatic	114500	_	3
171834	3q26.32	Cowden syndrome 5	615108	_	3
171834	3q26.32	Gastric cancer, somatic	613659	_	3
171834	3q26.32	Hepatocellular carcinoma, somatic	114550	_	3
171834	3q26.32	Keratosis, seborrheic, somatic	182000	_	3
171834	3q26.32	Macrodactyly, somatic	155500	_	3
171834	3q26.32	Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	_	3
171834	3q26.32	Nevus, epidermal, somatic	162900	_	3
171834	3q26.32	Nonsmall cell lung cancer, somatic	211980	_	3
171834	3q26.32	Ovarian cancer, somatic	167000	_	3
190180	19q13.2	Camurati-Engelmann disease	131300	AD	3
190180	19q13.2	Inflammatory bowel disease, immunodeficiency, and encephalopathy	618213	AR	3
190180	19q13.2	{Cystic fibrosis lung disease, modifier of}	219700	AR	3
601105	1q21.3	Pycnodysostosis	265800	AR	3
603634	1p22.1	Diamond-Blackfan anemia 6	612561	AD	3
300259	Xq	{Mycobacterium tuberculosis, susceptibility, X-linked}	300259	_	2
603295	13q13.3	Pulmonary hypertension, primary, 2	615342	AD	3
603736	10q22.2	SBBYSS syndrome	603736	AD	3
133180	12q13.2	{?Erythroleukemia, familial, susceptibility to}	133180	AD	3
603176	13q32	{Schizophrenia}	181500	AD	2
600577	9q34.3	Pituitary hormone deficiency, combined, 3	221750	AR	3
184900	15q21.1	Stiff skin syndrome	184900	AD	3
603013	8p21	{Schizophrenia}	181500	AD	2
604124	18q11.2	Jawad syndrome	251255	AR	3
604124	18q11.2	Pancreatic carcinoma, somatic	_	_	3
604124	18q11.2	Seckel syndrome 2	606744	AR	3
602911	22q12.3	?Mental retardation, autosomal dominant 10	614256	AD	3
180430	2p11.2	Ribose 5-phosphate isomerase deficiency	608611	AR	3
602978	12p13.31	?Microcephaly 11, primary, autosomal recessive	615414	AR	3
606142	4p16.1	Hypouricemia, renal, 2	612076	AR,AD	3
606142	4p16.1	{Uric acid concentration, serum, QTL 2}	612076	AR,AD	3
605194	2q21.1	Heterotaxy, visceral, 2, autosomal	605376	AD	3
600346	17q12	Turnpenny-Fry syndrome	618371	AD	3
600150	10q22.3	?Cerebellar atrophy, developmental delay, and seizures	617643	AR	3
600150	10q22.3	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	609446	AD	3
605267	20q13.12	Cardiomyopathy, hypertrophic, 17	613873	AD	3
190181	9q22.33	Loeys-Dietz syndrome 1	609192	AD	3
190181	9q22.33	{Multiple self-healing squamous epithelioma, susceptibility to}	132800	AD	3
606082	3q26.1-q26.3	Goiter, multinodular, 3	606082	_	2
606551	8p21.3	Esophageal squamous cell carcinoma, somatic	133239	_	3
605130	11q23.3	Wiedemann-Steiner syndrome	605130	AD	3
300260	Xq28	Mental retardation, X-linked syndromic, Lubs type	300260	XLR	3
228000	8p22	Farber lipogranulomatosis	228000	AR	3
605437	14q23.1	{Cerebral infarction, susceptibility to}	601367	Mu	3
600151	3q11.2	Bardet-Biedl syndrome 3	600151	AR	3
605911	1p12	HMG-CoA synthase-2 deficiency	605911	AR	3
600937	11p15.1	Diabetes mellitus, transient neonatal, 3	610582	AD	3
600937	11p15.1	Diabetes, permanent neonatal, with or without neurologic features	606176	AR,AD	3
600937	11p15.1	Hyperinsulinemic hypoglycemia, familial, 2	601820	AR	3
600937	11p15.1	Maturity-onset diabetes of the young, type 13	616329	AD	3
600937	11p15.1	{Diabetes mellitus, type 2, susceptibility to}	125853	AD	3
190182	3p24.1	Colorectal cancer, hereditary nonpolyposis, type 6	614331	_	3
190182	3p24.1	Esophageal cancer, somatic	133239	_	3
190182	3p24.1	Loeys-Dietz syndrome 2	610168	AD	3
604125	19q13.33	Ichthyosis, congenital, autosomal recessive 14	617571	AR	3
605724	13q13.1	Fanconi anemia, complementation group D1	605724	AR	3
180435	1q25.3	Prostate cancer 1	601518	AD	3
603109	15q22.33	Loeys-Dietz syndrome 3	613795	AD	3
605239	7q34	Renal tubular acidosis, distal, autosomal recessive	602722	_	3
606972	14q23	{Epilepsy, idiopathic generalized, susceptibility to, 2}	606972	_	2
606520	6p21.33	?Thrombocytopenia, anemia, and myelofibrosis	617441	AR	3
606144	6p12.1-p11.2	Carpenter syndrome	201000	AR	3
605799	14q32.32	Megaloblastic anemia-1, Norwegian type	261100	AR	3
606766	6p21.31	Spermatogenic failure 3	606766	AD	3
606014	1p13.3	Frontonasal dysplasia 1	136760	AR	3
606798	4p16.1	{Blepharospasm, primary benign}	606798	AD	3
606854	16q21	Polymicrogyria, bilateral frontoparietal	606854	AR	3
607131	15q26.1	?Al-Gazali-Bakalinova syndrome	607131	AR	3
604574	9q31.3	Epileptic encephalopathy, early infantile, 37	616981	AR	3
607408	13q33.2	{Schizophrenia}	181500	AD	2
604296	9p13.2	Hyperoxaluria, primary, type II	260000	AR	3
607100	2q13	Joubert syndrome 4	609583	AR	3
607100	2q13	Nephronophthisis 1, juvenile	256100	AR	3
607100	2q13	Senior-Loken syndrome-1	266900	AR	3
605947	17p11.2	CHIME syndrome	280000	AR	3
607035	10q24.32	Basal cell nevus syndrome	109400	AD	3
607035	10q24.32	Joubert syndrome 32	617757	AR	3
607035	10q24.32	Medulloblastoma, desmoplastic	155255	AR,AD	3
607035	10q24.32	{Meningioma, familial, susceptibility to}	607174	AD	3
185000	6p12.3	Overhydrated hereditary stomatocytosis	185000	AD	3
604067	17q24.1	Bradyopsia	608415	_	3
603846	11p11.2	Mitochondrial complex I deficiency, nuclear type 8	618230	AR	3
607557	12q23.1	Deafness, autosomal dominant 25	605583	AD	3
605268	16q24.2	Huntington disease-like 2	606438	AD	3
300261	Xq28	Mental retardation syndrome, X-linked, Armfield type	300261	XLR	2
605828	17q25.3	Epidermodysplasia verruciformis	226400	AR	3
606460	6q21	[Longevity 2]	606460	_	2
163729	7q36.1	{Alzheimer disease, late-onset, susceptibility to}	104300	AD	3
163729	7q36.1	{Coronary artery spasm 1, susceptibility to}	_	_	3
163729	7q36.1	{Hypertension, pregnancy-induced}	189800	AD	3
163729	7q36.1	{Hypertension, susceptibility to}	145500	Mu	3
163729	7q36.1	{Ischemic stroke, susceptibility to}	601367	Mu	3
163729	7q36.1	{Placental abruption}	_	_	3
607592	19q	{Prostate cancer aggressiveness QTL}	607592	_	2
606799	5q12	{Stroke, susceptibility to, 1}	606799	_	2
605632	1p21.2	?Arthrogryposis, mental retardation, and seizures	615553	AR	3
603941	1q24.2	Thiamine-responsive megaloblastic anemia syndrome	249270	AR	3
607313	11q24.2	Gaze palsy, familial horizontal, with progressive scoliosis, 1	607313	AR	3
607008	1p31.1	Acyl-CoA dehydrogenase, medium chain, deficiency of	201450	AR	3
600348	14q32.2	Band heterotopia	600348	AR	3
605407	11p15.5	Segawa syndrome, recessive	605407	AR	3
606521	17q25.1	Microcephaly, Amish type	607196	AR	3
606521	17q25.1	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	AR	3
607498	6p21.1-p12.2	{Migraine with or without aura, susceptibility to, 3}	607498	AD	2
608358	14q11.2	Myopathy, myosin storage, autosomal dominant	608358	AD	3
607468	1p21.2	?Chorea, childhood-onset, with psychomotor retardation	616939	AR	3
603700	13q12.3	{Stroke, susceptibility to}	601367	Mu	3
608264	22q11.21-q12.1	Deafness, autosomal recessive 40	608264	AR	2
604297	21q22.11	Epileptic encephalopathy, early infantile, 53	617389	AR	3
604297	21q22.11	Parkinson disease 20, early-onset	615530	AR	3
606973	17q25.1	Congenital disorder of glycosylation, type IIg	611209	AR	3
300262	Xq13.2	Mental retardation, X-linked syndromic, Abidi type	300262	_	2
608423	7q32.1	Muscular dystrophy, limb-girdle, autosomal dominant 2	608423	AD	3
603178	14q24.3	Methylmalonate semialdehyde dehydrogenase deficiency	614105	AR	3
606800	17q25.3	Glycogen storage disease II	232300	AR	3
608232	22q11.23	Leukemia, chronic myeloid, somatic	608232	_	3
607250	14q32.11	?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1	607250	AR	3
163730	17q11.2	{Hypertension, susceptibility to}	145500	Mu	2
163730	17q11.2	{Malaria, resistance to}	611162	_	3
608665	17q21.2	Ovarian dysgenesis 3	614324	AR	3
607036	15q15.1	Isovaleric acidemia	243500	AR	3
605025	17q21.33	Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	614748	AR	3
608576	8q22.3	Corneal dystrophy, posterior polymorphous, 4	618031	AD	3
608576	8q22.3	Deafness, autosomal dominant 28	608641	AD	3
608576	8q22.3	Ectodermal dysplasia/short stature syndrome	616029	AR	3
605441	3q27.3	Adiponectin deficiency	612556	_	3
193500	2q36.1	Waardenburg syndrome, type 1	193500	AD	3
605829	17q25.3	Epidermodysplasia verruciformis 2	618231	_	3
608548	1q25.3-q31.1	{Macular degeneration, age-related, 1}	603075	AD	3
607101	10p12.1	Deafness, autosomal recessive 30	607101	AR	3
607009	9q21.13	Hypomagnesemia 1, intestinal	602014	AR	3
603848	5p15.33	Mitochondrial complex I deficiency, nuclear type 9	618232	AR	3
605913	1q23	Bleeding disorder, east Texas type	605913	_	2
607499	10p	{Bulimia nervosa, susceptibility to}	607499	Mu	2
600154	14q24.1	Glycosylphosphatidylinositol biosynthesis defect 17	618010	AR	3
300263	Xp11.22	Mental retardation syndrome, X-linked, Siderius type	300263	XLR	3
608323	1p35.1	Charcot-Marie-Tooth disease, dominant intermediate C	608323	AD	3
603909	2q33.1	Autoimmune lymphoproliferative syndrome, type II	603909	AD	3
608166	7q21.11	?CHARGE syndrome	214800	AD	3
606974	1q42.2	?Congenital disorder of glycosylation, type IIq	617395	AR	3
606621	3q13.12-q13.13	?Orofaciodigital syndrome XVIII	617927	AR	3
608233	5q14.1	Hermansky-Pudlak syndrome 2	608233	AR	3
607965	10q22.3	{Systemic lupus erythematosus with nephritis, susceptibility to, 1}	607965	_	2
600939	9p13.3	Craniosynostosis and dental anomalies	614188	AR	3
608894	6q23.3	Joubert syndrome 3	608629	AR	3
604127	1p12	Cousin syndrome	260660	AR	3
608549	11q23.3	Leukodystrophy, hypomyelinating, 12	616683	AR	3
606856	4q32.3	{Pancreatic cancer, susceptibility to, 1}	606856	_	3
606207	15q25.3	[Uridine-cytidineuria]	618477	AR	3
608360	9q34.11	?Agammaglobulinemia 5	613506	AD	3
606367	10p15.1	Immunodeficiency 41 with lymphoproliferation and autoimmunity	606367	AR	3
607343	20q13.2	Duane-radial ray syndrome	607323	AD	3
607343	20q13.2	IVIC syndrome	147750	AD	3
605634	6q15	Congenital disorder of glycosylation, type IIf	603585	AR	3
607102	11p13	Denys-Drash syndrome	194080	SMu,AD	3
607102	11p13	Frasier syndrome	136680	SMu,AD	3
607102	11p13	Meacham syndrome	608978	_	3
607102	11p13	Mesothelioma, somatic	156240	_	3
607102	11p13	Nephrotic syndrome, type 4	256370	AD	3
607102	11p13	Wilms tumor, type 1	194070	SMu,AD	3
193510	3p13	Waardenburg syndrome, type 2A	193510	AD	3
607134	13q21	Specific language impairment QTL, 3	607134	_	2
607560	1q22	?Neurodevelopmental disorder with midbrain and hindbrain malformations	617523	AR	3
604484	3q12.2	Hereditary motor and sensory neuropathy, Okinawa type	604484	AD	3
607037	3q27.2	?Fanconi renotubular syndrome 3	615605	AD	3
608728	2p24.1	?Spondyloepimetaphyseal dysplasia	608728	AR	3
607594	2q33.2	Immunodeficiency, common variable, 1	607594	AR	3
609245	1p13.3	Chudley-McCullough syndrome	604213	AR	3
608167	9q34.3	Epilepsy, nocturnal frontal lobe, 5	615005	AD	3
608167	9q34.3	Epileptic encephalopathy, early infantile, 14	614959	AD	3
608638	3q25-q27	{Asperger syndrome susceptibility 1}	608638	IC,Mu	2
163800	15q24.1	Sick sinus syndrome 2	163800	AD	3
606857	6p12.1	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	230450	AR	3
606857	6p12.1	{Myocardial infarction, susceptibility to}	608446	_	3
606622	2q35	Schimke immunoosseous dysplasia	242900	AR	3
604004	22q13.33	Megalencephalic leukoencephalopathy with subcortical cysts	604004	AR	3
603942	3q24	?Glycogen storage disease XV	613507	AR	3
603942	3q24	Polyglucosan body myopathy 2	616199	AR	3
602855	14q13.2	{Myocardial infarction, susceptibility to}	608446	_	3
604860	18q21.32	Immunodeficiency 12	615468	AR	3
607966	2q34-q35	{Systemic lupus erythematosus with nephritis, susceptibility to, 2}	607966	_	2
606919	19p13.11	?Epilepsy, progressive myoclonic, 8	616230	AR	3
605270	17q25.3	Mucopolysaccharidosis type IIIA (Sanfilippo A)	252900	AR	3
609469	11q24	Nephropathy, progressive, with deafness	609469	_	2
603850	12p11.21	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	614388	AR,AD	3
603850	12p11.21	Optic atrophy 5	610708	AD	3
603147	1p31.3	Congenital disorder of glycosylation, type Ic	603147	AR	3
608798	7p15.3	Deafness, autosomal dominant 5	600994	AD	3
601893	5p15.2	Mental retardation, autosomal dominant 44	617061	AD	3
605635	3q27.1	Hyperaldosteronism, familial, type II	605635	AD	3
607252	22q12.3	{Schizophrenia}	181500	AD	1
604577	6q21	Muscular dystrophy, limb-girdle, autosomal recessive 25	616812	AR	3
606976	16q22.1	Congenital disorder of glycosylation, type IIj	613489	AR	3
606976	16q22.1	Saul-Wilson syndrome	618150	AD	3
607998	11p15.4	Ceroid lipofuscinosis, neuronal, 2	204500	AR	3
607998	11p15.4	Spinocerebellar ataxia, autosomal recessive 7	609270	AR	3
608361	15q26.1	?Spondyloepiphyseal dysplasia, Kimberley type	608361	AD	3
604299	3p14.3	{Maturity-onset diabetes of the young, type 14}	616511	AD	3
609113	14q23.2	[Telomere length, mean leukocyte]	609113	_	2
193520	17q11.2	Watson syndrome	193520	AD	3
603851	4p13	Central hypoventilation syndrome, congenital, with or without Hirschsprung disease	209880	AD	3
603851	4p13	Neuroblastoma with Hirschsprung disease	613013	_	3
603851	4p13	{Neuroblastoma, susceptibility to, 2}	613013	_	3
604485	15q23	Enhanced S-cone syndrome	268100	AR	3
604485	15q23	Retinitis pigmentosa 37	611131	AR,AD	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	AR	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2	613156	AR	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	613158	AR	3
609637	13q32.3	Holoprosencephaly 5	609637	AD	3
605060	17p13.2	[Sedoheptulokinase deficiency]	617213	AR	3
608862	1q22	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	617186	AR	3
607070	3p21.31	Ciliary dyskinesia, primary, 22	615444	AR	3
609404	10q22.1	Preeclampsia/eclampsia 4	609404	_	3
608611	2p11.2	Ribose 5-phosphate isomerase deficiency	608611	AR	3
608730	12q13.3	Myopia 24, autosomal dominant	615946	AD	3
608829	6q25.1	{Diabetes mellitus, insulin-dependent, 5}	600320	_	3
606977	13q14.11	Congenital disorder of glycosylation, type IIl	614576	AR	3
606977	13q14.11	Shaheen syndrome	615328	AR	3
607038	16p12.2	Deafness, autosomal recessive 22	607039	AR	3
609346	19p13.3	Retinitis pigmentosa 77	617304	AR	3
609638	6p24.3	Epidermolysis bullosa, lethal acantholytic	609638	AR	3
609286	10q24.31	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	609286	AD	3
608174	5q31-q33	{Autoimmune thyroid disease, susceptibility to, 2}	608174	_	2
607411	12q24	{Patent ductus arteriosus, susceptibility to}	607411	AR	2
600253	7p21.1	?Retinitis pigmentosa 85	618345	AR	3
607967	11p15.5	{Systemic lupus erythematosus with nephritis, susceptibility to, 3}	607967	_	2
601894	2q35	Glomerulopathy with fibronectin deposits 2	601894	AD	3
603701	12q13.2	Diamond-Blackfan anemia 10	613309	AD	3
609952	4q12-q13.2	Deafness, autosomal recessive 55	609952	AR	2
163890	4q22.1	Dementia, Lewy body	127750	AD	3
163890	4q22.1	Parkinson disease 1	168601	AD	3
163890	4q22.1	Parkinson disease 4	605543	AD	3
607472	10p12.1	?Optic atrophy 11	617302	AR	3
605637	17p13.1	Proximal myopathy and ophthalmoplegia	605637	AR,AD	3
609347	5q31.2	?Spastic paraplegia 72, autosomal dominant	615625	AR,AD	3
609347	5q31.2	?Spastic paraplegia 72, autosomal recessive	615625	AR,AD	3
134934	4p16.3	Achondroplasia	100800	AD	3
134934	4p16.3	Bladder cancer, somatic	109800	_	3
134934	4p16.3	CATSHL syndrome	610474	AR,AD	3
134934	4p16.3	Cervical cancer, somatic	603956	_	3
134934	4p16.3	Colorectal cancer, somatic	114500	_	3
134934	4p16.3	Crouzon syndrome with acanthosis nigricans	612247	AD	3
134934	4p16.3	Hypochondroplasia	146000	AD	3
134934	4p16.3	LADD syndrome	149730	AD	3
134934	4p16.3	Muenke syndrome	602849	AD	3
134934	4p16.3	Nevus, epidermal, somatic	162900	_	3
134934	4p16.3	SADDAN	616482	AD	3
134934	4p16.3	Spermatocytic seminoma, somatic	273300	_	3
134934	4p16.3	Thanatophoric dysplasia, type I	187600	AD	3
134934	4p16.3	Thanatophoric dysplasia, type II	187601	AD	3
608552	15q26.1	Arthrogryposis, renal dysfunction, and cholestasis 1	208085	AR	3
606978	16p12.2	Congenital disorder of glycosylation, type IIe	608779	AR	3
605950	4q31.1	Smith-McCort dysplasia 2	615222	AR	3
607071	3p21.31	?Mucopolysaccharidosis type IX	601492	AR	3
609924	3p21.2	Aminoacylase 1 deficiency	609924	AR	3
608241	1p34.3	Psychomotor retardation, epilepsy, and craniofacial dysmorphism	614501	AR	3
608799	20q13.13	Congenital disorder of glycosylation, type Ie	608799	AR	3
606680	7q34	Hyperparathyroidism, transient neonatal	618188	AR	3
607039	16p12.2	Deafness, autosomal recessive 22	607039	AR	3
610222	20p11.23	Macrocephaly, alopecia, cutis laxa, and scoliosis	613075	AR	3
606019	13q13.3	Pontocerebellar hypoplasia, type 1C	616081	AR	3
605446	14q11.2	Cone-rod dystrophy 13	608194	_	3
605446	14q11.2	Leber congenital amaurosis 6	613826	_	3
608363	22q11.2	Chromosome 22q11.2 microduplication syndrome	608363	IC,AD	4
607968	7p14.3	Bardet-Biedl syndrome 9	615986	AR	3
607473	16p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 2	607473	_	3
608830	14q24.1	Leber congenital amaurosis 13	612712	AR,AD	3
610185	17p13.3	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	610185	AR	3
610017	20q11.22	Multiple synostoses syndrome 2	610017	AD	3
600944	19p13.13	Neurodevelopmental disorder with seizures and speech and walking impairment	618480	_	3
610463	6q22.1	?Congenital disorder of glycosylation, type 1aa	617082	AR	3
610463	6q22.1	Mental retardation, autosomal dominant 55, with seizures	617831	AD	3
608553	1p36.22	Leber congenital amaurosis 9	608553	AR	3
607040	16q12.1	[Axillary odor, variation in]	117800	AD	3
607040	16q12.1	[Colostrum secretion, variation in]	117800	AD	3
607040	16q12.1	[Earwax, wet/dry]	117800	AD	3
605833	1q21-q23	[Bone mineral density QTL 2]	605833	_	2
605951	1q22	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15	612937	AR	3
608996	3q22.3	Premature ovarian failure 3	608996	AD	3
606681	5q35.3	Leukemia, acute myeloid	601626	SMu,AD	1
606681	5q35.3	Sotos syndrome 1	117550	AD	3
608428	10q23.33	Focal facial dermal dysplasia 4	614974	AR	3
603702	1q21.3	?Diamond-Blackfan anemia 17	617409	AD	3
606806	21q22.3	Glutamate formiminotransferase deficiency	229100	AR	3
609470	11p15	Left ventricular noncompaction 2	609470	_	2
608612	1p34.2	Mandibuloacral dysplasia with type B lipodystrophy	608612	AR	3
193670	2q22.1	WHIM syndrome	193670	AD	3
610685	6q14.1	Split-hand/foot malformation with long bone deficiency 2	610685	_	2
608800	6q22.1	Sudden infant death with dysgenesis of the testes syndrome	608800	AR	3
610498	10q22.2	Combined oxidative phosphorylation deficiency 2	610498	AR	3
609023	2q35	Paroxysmal nonkinesigenic dyskinesia 1	118800	AD	3
609570	5q21	{Migraine, susceptibility to, 8}	609570	_	2
609186	2q37.3	D-2-hydroxyglutaric aciduria	600721	AR	3
603150	19p13.3	Mitochondrial complex V (ATP synthase) deficiency	618120	AR	3
610019	3p21.31	Cataract 18, autosomal recessive	610019	AR	3
608176	10q	{Autoimmune thyroid disease, susceptibility to, 4}	608176	_	2
610648	12q24.11-q24.12	Epileptic encephalopathy, early infantile, 67	618141	AD	3
608957	2p11.2	CD8 deficiency, familial	608957	AR	3
609289	15q26	Syncope, familial vasovagal	609289	AD	2
608429	15q15.1	Ehlers-Danlos syndrome, musculocontractural type 1	601776	AR	3
604862	2p13.3	[?Birbeck granule deficiency]	613393	_	3
608831	14q13-q21	{Restless legs syndrome 2}	608831	_	2
610187	8q23.1	Diaphragmatic hernia 3	610187	_	3
609640	14q22.1-q22.3	Frias syndrome	609640	AD	4
609706	6p21.32	Deafness, autosomal recessive 53	609706	AR	3
610713	2q31.1	?Brachydactyly-syndactyly syndrome	610713	_	3
610224	9q34.3	Ovarian dysgenesis 5	617690	AR	3
610224	9q34.3	Spermatogenic failure 32	618115	AD	3
609187	7p14.1	Glutaric aciduria III	231690	AR	3
609898	22q12.1	Ectodermal dysplasia 13, hair/tooth type	617392	AR	3
609471	9p13.3	Spastic paraplegia 46, autosomal recessive	614409	AR	3
603084	2q21.3	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	615281	AR	3
610649	8q24	[Bone size quantitative trait locus 3]	610649	_	2
603183	19q13.32	Spastic paraplegia 12, autosomal dominant	604805	AD	3
608832	1q43	Tooth agenesis, selective, 9	617275	AD	3
608177	8q24.11	Chondrosarcoma	215300	AR	3
608177	8q24.11	Exostoses, multiple, type 1	133700	AD	3
610188	12q21.32	Joubert syndrome 5	610188	AR	3
606807	3p14.3	Hypogonadotropic hypogonadism 18 with or without anosmia	615267	AR,AD	3
610931	8q24.22	{Autoimmune thyroid disease, susceptibility to, 3}	608175	_	3
604863	4q32.1	Leber congenital amaurosis 14	613341	AR	3
604863	4q32.1	Retinal dystrophy, early-onset severe	613341	AR	3
604863	4q32.1	Retinitis pigmentosa, juvenile	613341	AR	3
608958	20q13.12	Adenosine deaminase deficiency, partial	102700	AR,SMo	3
608958	20q13.12	Severe combined immunodeficiency due to ADA deficiency	102700	AR,SMo	3
608801	19p13.13	Glutaricaciduria, type I	231670	AR	3
608614	4q35.1-q35.2	Bietti crystalline corneoretinal dystrophy	210370	AR	3
603704	17p13.1	?Diamond-Blackfan anemia 11	614900	AD	3
610687	14q13.1	Nemaline myopathy 7, autosomal recessive	610687	AR	3
610865	14q24.3	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	225790	AR	3
610897	20q11.22	Cataract 31, multiple types	605387	AD	3
609572	13q31.3	Photoparoxysmal response 2	609572	_	2
609025	12q13.13	{Pseudofolliculitis barbae, susceptibility to}	612318	_	3
610048	12q21.33	Corneal dystrophy, congenital stromal	610048	AD	3
610189	12q21.32	Senior-Loken syndrome 6	610189	AR	3
606808	10p12.1	Deafness, autosomal recessive 30	607101	AR	3
603089	3p21.1	Tumor predisposition syndrome	614327	AD	3
604305	6p21.32	{Celiac disease, susceptibility to}	212750	AR,Mu	3
604305	6p21.32	{Creutzfeldt-Jakob disease, variant, resistance to}	123400	AD	3
604305	6p21.32	{Multiple sclerosis, susceptibility to, 1}	126200	Mu	3
609506	12q14.1	Vitamin D-dependent rickets, type I	264700	AR	3
610021	1p13.2	Hyperinsulinemic hypoglycemia, familial, 7	610021	AD	3
610688	8q22.1	Joubert syndrome 6	610688	AR	3
607976	20q11.21	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis	612714	AR	3
609573	7q32	Photoparoxysmal response 3	609573	_	2
610898	11p12-p11	Supranuclear palsy, progressive, 3	610898	_	2
610651	2q14.3	Xeroderma pigmentosum, group B	610651	AR	3
611379	12q13.12	Mental retardation, FRA12A type	136630	AD	3
608179	19p13.3	Ataxia, cerebellar, Cayman type	601238	AR	3
606628	6p21.1	Glycine N-methyltransferase deficiency	606664	AR	3
609026	6p12-q12	{Cataract 28, age-related cortical, susceptibility to}	609026	_	2
611236	9q31.2	Osteogenesis imperfecta, type XIV	615066	_	3
610933	9q33.3-q34.1	Charcot-Marie-Tooth disease, axonal, type 2P	614436	AR,AD	3
610190	19q13.11	?Peeling skin syndrome 3	616265	AR	3
193700	17p13.1	Arthrogryposis, distal, type 2A (Freeman-Sheldon)	193700	AD	3
601896	14q32.32	{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}	614849	_	3
610652	6q27	Dyskinesia, limb and orofacial, infantile-onset	616921	AR	3
610652	6q27	Striatal degeneration, autosomal dominant	616922	AD	3
609507	9p21.1	Retinitis pigmentosa 31	609923	_	3
611472	2q23.1	Mental retardation, autosomal dominant 1	156200	AD	3
607776	15q24.2	Witteveen-Kolk syndrome	613406	AD	3
609188	7p14.1	Trichothiodystrophy 4, nonphotosensitive	234050	AR	3
606629	6q13	Cone-rod dystrophy 7	603649	_	3
608180	22q13.31	Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses	608180	AD	4
610934	7q35	Premature ovarian failure 5	611548	AD	3
611664	12q21.32	[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	_	3
611531	12p13.31	Bowen-Conradi syndrome	211180	AR	3
601897	3q21.2	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	617260	AD	3
610690	2q32.2	3-hydroxyisobutryl-CoA hydrolase deficiency	250620	AR	3
605275	22q11.21	Noonan syndrome 2	605275	AR	3
609708	8p21.3	Combined hyperlipidemia, familial	144250	AD	3
609708	8p21.3	Lipoprotein lipase deficiency	238600	AR	3
609708	8p21.3	[High density lipoprotein cholesterol level QTL 11]	238600	AR	3
609508	12q13.11	Stickler sydrome, type I, nonsyndromic ocular	609508	AD	3
608804	1q42.13	Leukodystrophy, hypomyelinating, 2	608804	AR	3
603707	6p21.2	Molybdenum cofactor deficiency A	252150	AR	3
606810	22q11.21	Hyperprolinemia, type I	239500	AR	3
606810	22q11.21	{Schizophrenia, susceptibility to, 4}	600850	AD	3
608181	15q22.31	Mast syndrome	248900	AR	3
611381	1p22	{Kala-azar, susceptibility to, 2}	611381	_	2
611634	3p24.2-p23	Febrile seizures, familial, 9	611634	AD	2
611565	4q27	Alkuraya-Kucinskas syndrome	617822	AR	3
612010	6q25.3	{Celiac disease, susceptibility to, 12}	612010	_	2
604307	2q33.3	Cataract 2, multiple types	604307	AD	3
603708	5q11.2	Molybdenum cofactor deficiency B	252160	AR	3
612269	15q12	{Epilepsy, childhood absence, susceptibility to, 5}	612269	_	3
612051	16q21	Spinocerebellar ataxia 31	117210	AD	3
611053	9p13.3	Mental retardation, autosomal recessive 61	617773	AR	3
611382	6q27	{Kala-azar, susceptibility to, 3}	611382	_	2
606811	1p36.13	Hyperprolinemia, type II	239510	AR	3
609575	17p13.1	VLCAD deficiency	201475	AR	3
607778	2q35	Acrocapitofemoral dysplasia	607778	AR	3
612357	10q21	{Major affective disorder-8, susceptibility to}	612357	_	2
611637	4p16	Primary lateral sclerosis, adult, 1	611637	AD	2
610936	9q21.2	?Phosphoserine aminotransferase deficiency	610992	AR	3
610936	9q21.2	Neu-Laxova syndrome 2	616038	AR	3
611943	3q29	RIDDLE syndrome	611943	AR	3
612387	6p21.32	{Sarcoidosis, susceptibility to, 2}	612387	AD	3
611974	17q25.1	?Combined oxidative phosphorylation deficiency 34	617872	AR	3
612228	20q11.22	{Stature QTL 14}	612228	_	2
604308	15q21.1	MASS syndrome	604308	_	3
612011	12q24	{Celiac disease, susceptibility to, 13}	612011	_	2
611638	7q36.3	Microphthalmia with coloboma 5	611638	AD	3
612358	3q27.3	[High molecular weight kininogen deficiency]	228960	AR	3
612358	3q27.3	[Kininogen deficiency]	228960	AR	3
603709	7q21.12	?Epileptic encephalopathy, early infantile, 61	617933	AR	3
612169	1q23.3	Thrombocytopenic purpura, autoimmune	188030	AD	1
610937	16q12.2	COACH syndrome	216360	AR	3
610937	16q12.2	Joubert syndrome 7	611560	AR	3
610937	16q12.2	Meckel syndrome 5	611561	AR	3
611913	16p11.2	Chromosome 16p11.2 deletion syndrome, 593kb	611913	_	4
611913	16p11.2	{Autism susceptibility 14A}	611913	_	2
612719	11q23.1	Hyperphenylalaninemia, BH4-deficient, A	261640	AR	3
611944	6q16.2-q22.1	Lymphatic malformation 2	611944	AD	2
612584	17p13.2	?Deafness, autosomal recessive 115	618457	AR	3
605955	10q26.3	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy	617560	AR	3
609510	5q11.2	?Amyloidosis, primary localized cutaneous, 2	613955	AD	3
603714	2p21	Holoprosencephaly 2	157170	AD	3
603714	2p21	Schizencephaly	269160	_	3
611177	3q25.33	Short-rib thoracic dysplasia 2 with or without polydactyly	611263	AR	3
612813	15q26.1	Spondyloepimetaphyseal dysplasia, aggrecan type	612813	AR	3
612388	10q22.3	{Sarcoidosis, susceptibility to, 3}	612388	_	2
606438	16q24.2	Huntington disease-like 2	606438	AD	3
606812	1q43	Fumarase deficiency	606812	AR	3
612513	2p16.1-p15	Chromosome 2p16.1-p15 deletion syndrome	612513	IC	4
609734	2p23.3	Obesity, adrenal insufficiency, and red hair due to POMC deficiency	609734	AR	3
609712	1q22	Adenosine triphosphate, elevated, of erythrocytes	102900	AD	3
609712	1q22	Pyruvate kinase deficiency	266200	AR	3
612012	14q24.1	Spastic paraplegia 15, autosomal recessive	270700	AR	3
612271	9p23	[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)]	612271	_	3
609577	6p21.1	3-M syndrome 1	273750	AR	3
612691	6q21	?Polymicrogyria, bilateral temporooccipital	612691	AR	3
604310	15q21.1	?Hermansky-pudlak syndrome 9	614171	AR	3
600257	8q12.2-q21.2	Bor-Duane hydrocephalus contiguous gene syndrome	600257	AD	4
613061	12q13	{Basal cell carcinoma, susceptibility to, 4}	613061	_	2
613159	22q13.2	Nephronophthisis-like nephropathy 1	613159	AR	3
613027	16p11.2	Glycogen storage disease IXc	613027	AR	3
612360	20p12.1	Mitochondrial complex I deficiency, nuclear type 16	618238	AR	3
613121	1p31.1	Cardiomyopathy, dilated, 1CC	613122	AD	3
613121	1p31.1	Cardiomyopathy, hypertrophic, 20	613876	AD	3
612389	3p25.2	Pontocerebellar hypoplasia type 2B	612389	AR	3
603722	9q31.3	Dysautonomia, familial	223900	AR	3
607261	4p16.2	Ellis-van Creveld syndrome	225500	AR	3
607261	4p16.2	Weyers acrofacial dysostosis	193530	AD	3
613093	10q23.33	Cone dystrophy 4	613093	AR	3
612937	1q22	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15	612937	AR	3
613282	22q13	{Fatty liver disease, nonalcoholic, susceptibility to, 1}	613282	Mu	2
612692	17q23.3	Agammaglobulinemia 6	612692	AR	3
606439	14q22.1	Neuropathy, hereditary sensory, type ID	613708	AD	3
606439	14q22.1	Spastic paraplegia 3A, autosomal dominant	182600	AD	3
610991	2q35	3-M syndrome 2	612921	AR	3
609578	10q23.3	Cardiomyopathy, familial restrictive, 2	609578	_	2
613312	6q23.2	Hypophosphatemic rickets, autosomal recessive, 2	613312	AR	3
603164	6q24.2	?Peroxisome biogenesis disorder 10B	617370	AR	3
603164	6q24.2	Peroxisome biogenesis disorder 10A (Zellweger)	614882	AR	3
612361	2q32.1	{Schizophrenia, susceptibility to, 14}	612361	_	2
605956	16q12.1	Blau syndrome	186580	AD	3
605956	16q12.1	{Inflammatory bowel disease 1, Crohn disease}	266600	Mu	3
605956	16q12.1	{Psoriatic arthritis, susceptibility to}	607507	_	2
605956	16q12.1	{Yao syndrome}	617321	Mu	3
613122	1p31.1	Cardiomyopathy, dilated, 1CC	613122	AD	3
613255	10q22.2	Cardiomyopathy, hypertrophic, 15	613255	AD	3
601898	3q26.31	Growth hormone deficiency, isolated partial	615925	AR,AD	3
612938	16q12.2	Growth retardation, developmental delay, facial dysmorphism	612938	AR	3
613028	10q23.31	{Glioma susceptibility 2}	613028	_	3
612967	17q23.2-q25.1	[Body mass index QTL 15]	612967	_	2
612881	5q14.3-q15	Periventricular nodular heterotopia 5	612881	_	4
609512	3p11.2	Amyotrophic lateral sclerosis 17	614696	AD	3
609512	3p11.2	Dementia, familial, nonspecific	600795	AD	3
613345	17q23.3	Hypokalemic periodic paralysis, type 2	613345	AD	3
613283	4p13	Deafness, autosomal recessive 25	613285	AR	3
610992	9q21.2	?Phosphoserine aminotransferase deficiency	610992	AR	3
613313	19q13.12	Hemochromatosis, type 2B	613313	AR	3
607440	9q31.2	Cardiomyopathy, dilated, 1X	611615	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	AR	3
612997	11q13.1	Spermatogenic failure 7	612997	AR	3
613160	12p13.31	von Willebrand disease, type 1	193400	AD	3
613160	12p13.31	von Willebrand disease, types 2A, 2B, 2M, and 2N	613554	AR,AD	3
613160	12p13.31	von Willibrand disease, type 3	277480	AR	3
613123	15q24.1	Brugada syndrome 8	613123	_	3
613453	6p25.2	?Deafness, autosomal recessive 91	613453	AR	3
612362	5q15	{Obesity, susceptibility to, BMIQ12}	612362	_	3
610743	6q25.2	Spinocerebellar ataxia, autosomal recessive 8	610743	AR	3
606440	15q15.3	Deafness, autosomal recessive 16	603720	AR	3
603165	3q21	{Dermatitis, atopic, susceptibility to, 1}	603165	AD	2
612882	6q21	{Menarche, age at, QTL2}	612882	_	2
613488	12q13.1	Myxoid liposarcoma	613488	_	4
613517	2q37.1	Microphthalmia, isolated 6	613517	AR	3
613029	13q13.1	{Glioblastoma 3}	613029	AR	3
604312	20p11.21	Cerebral amyloid angiopathy	105150	AD	3
604312	20p11.21	{Macular degeneration, age-related, 11}	611953	_	3
609607	1q23.3	Ectodermal dysplasia-syndactyly syndrome 1	613573	AR	3
613284	22q12-q13	[Hematocrit/hemoglobin quantitative trait locus 3]	613284	_	2
613548	1p32	{Stature QTL 23}	613548	_	2
609579	10q26.13	Scaphocephaly, maxillary retrusion, and mental retardation	609579	_	3
612458	7q22.1	Intellectual developmental disorder with severe speech and ambulation defects	618470	AD	3
611383	9q32	Usher syndrome, type 2D	611383	AR	3
612390	19q13.42	?Pontocerebellar hypoplasia type 2C	612390	_	3
611182	16q22.1	Congenital disorder of glycosylation, type IIh	611182	_	3
611875	12p13.33	Brugada syndrome 3	611875	_	3
613549	2p16	{Stature QTL 24}	613549	_	2
612274	15q24-q25	Ciliary dyskinesia, primary, 8	612274	_	2
612998	6q25.2	Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	AD	3
613285	4p13	Deafness, autosomal recessive 25	613285	AR	3
606633	12q13.13	Osteogenesis imperfecta, type XII	613849	AR	3
611302	17p13.2	Spastic ataxia 2, autosomal recessive	611302	AR	3
613030	9p21.3	{Glioma susceptibility 5}	613030	_	2
604313	17q25.1	Galactokinase deficiency with cataracts	230200	AR	3
606441	2p13.1	3-methylglutaconic aciduria, type VIII	617248	AR	3
606441	2p13.1	{Parkinson disease 13}	610297	_	3
612940	17q25.3	Cutis laxa, autosomal recessive, type IIB	612940	AR	3
605958	3p21.31	Seckel syndrome 9	616777	AR	3
610745	15q24.1	Microphthalmia, isolated, with coloboma 8	601186	AR	3
610745	15q24.1	Microphthalmia, syndromic 9	601186	AR	3
613347	13q13.1	{Pancreatic cancer 2}	613347	_	3
613224	1p13.2	Noonan syndrome 6	613224	AD	3
613418	9q34.11	[Bone mineral density QTL 15]	613418	AR,AD	3
613286	19q13.42	Cardiomyopathy, dilated, 1FF	613286	_	3
611384	10p15	{Plasmodium falciparum fever episodes QTL1}	611384	_	2
610746	9q34.11	Congenital disorder of glycosylation, type Im	610768	AR	3
613642	5p15.33	Cardiomyopathy, dilated, 1GG	613642	_	3
613348	16p12.2	{Pancreatic cancer, susceptibility to, 3}	613348	_	3
613518	4q22.1	{Dermatitis, atopic, susceptibility to, 8}	613518	_	2
613489	16q22.1	Congenital disorder of glycosylation, type IIj	613489	AR	3
612724	9q31.1	Fructose intolerance, hereditary	229600	AR	3
613519	3p24	{Dermatitis, atopic, susceptibility to, 9}	613519	_	2
613676	13q12.12-q12.13	?Seckel syndrome 4	613676	AR	3
610906	1p31	{Asthma-related traits, susceptibility to, 4}	610906	_	2
613225	6p25.1	Factor XIIIA deficiency	613225	AR	3
613349	10q26.13	Gyrate atrophy of choroid and retina with or without ornithinemia	258870	AR	3
613031	20q13.33	{Glioma susceptibility 6}	613031	_	2
613454	14q12	Rett syndrome, congenital variant	613454	AD	3
611184	16q24.3	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	AD	3
611184	16q24.3	Lymphatic malformation 6	616843	AR	3
613032	8q24.21	{Glioma susceptibility 7}	613032	_	2
613710	17q25.1	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	AR	3
613420	18q11.2	Scalp-ear-nipple syndrome	181270	AD	3
613227	8q12.1	Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3	613227	AR	3
601906	12q13.12	Split-hand/foot malformation 6	225300	AR	3
601906	12q13.12	Tooth agenesis, selective, 8	617073	AD	3
613677	11q24.3	Hyperaldosteronism, familial, type III	613677	AD	3
612999	14q23.2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999	AD	3
606635	21q21.1	Enterokinase deficiency	226200	AR	3
611876	10p12.33-p12.31	Brugada syndrome 4	611876	_	3
613799	17q25.3	Ciliary dyskinesia, primary, 15	613808	_	3
614034	22q12.3	Heme oxygenase-1 deficiency	614034	_	3
612943	7p15.3	Retinitis pigmentosa 42	612943	AD	3
611386	20q13.13	Helsmoortel-van der Aa syndrome	615873	AD	3
614069	6q21	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	614069	AR	3
609520	8p11.21	Dystonia 6, torsion	602629	AD	3
611185	6p21	{Restless legs syndrome 6}	611185	_	2
613800	2q23.1	Meier-Gorlin syndrome 2	613800	AR	3
613350	20p13	?Fazio-Londe disease	211500	AR	3
613350	20p13	Brown-Vialetto-Van Laere syndrome 1	211530	AR	3
600259	7p22.1	Colorectal cancer, hereditary nonpolyposis, type 4	614337	_	3
600259	7p22.1	Mismatch repair cancer syndrome	276300	AR	3
610908	12q14.2	{Autism susceptibility 13}	610908	_	2
614098	21q22.13	Keppen-Lubinsky syndrome	614098	AD	3
613977	11p15.4	Cyanosis, transient neonatal	613977	AD	3
613062	9p21	{Basal cell carcinoma, susceptibility to, 5}	613062	_	2
614070	6q21	{Psoriasis susceptibility 13}	614070	_	3
613882	10q24.32	Hypomagnesemia 6, renal	613882	AD	3
614250	6p22.1	?Narcolepsy 7	614250	AD	3
614434	14q32.12	Cutis laxa, autosomal dominant 2	614434	_	3
613352	3q25.32	Intellectual developmental disorder, autosomal recessive 70	618402	AR	3
614186	2q37.1	Leber congenital amaurosis 16	614186	AR	3
606636	17p13.2	Autoinflammation with arthritis and dyskeratosis	617388	AR,AD	3
606636	17p13.2	Palmoplantar carcinoma, multiple self-healing	615225	AD	3
606636	17p13.2	{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	_	3
613801	4p16.3	Retinitis pigmentosa-40	613801	AR	3
614158	7q34	?Thromboxane synthase deficiency	614158	AD	1
614128	12p12.1	[Lactate dehydrogenase-B deficiency]	614128	_	3
614557	7p14.3	Ehlers-Danlos syndrome, kyphoscoliotic type, 2	614557	AR	3
613915	14q32.33	?Lethal congenital contracture syndrome 6	616248	AR	3
614251	3q27.1	{Parkinson disease 18}	614251	AD	3
614435	5q35.1	Hypoplastic left heart syndrome 2	614435	AD	3
613643	4p13	{?Parkinson disease 5, susceptibility to}	613643	_	3
613063	7q32	{Basal cell carcinoma, susceptibility to, 6}	613063	_	2
614747	1q21.1	[Uric acid concentration, serum, QTL6]	614747	_	2
614377	4p14	Nephronophthisis 13	614377	AR	3
614159	1p22.2	Myopia 21, autosomal dominant	614167	AD	3
614343	18p11.3	Mental retardation, autosomal recessive 19	614343	AR	2
613521	1p34.1	Porphyria cutanea tarda	176100	AR,AD	3
613521	1p34.1	Porphyria, hepatoerythropoietic	176100	AR,AD	3
614436	9q33.3-q34.1	Charcot-Marie-Tooth disease, axonal, type 2P	614436	AR,AD	3
614252	8p22	Aneurysm, intracranial berry, 11	614252	_	2
